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The response to DNA damage is imperative to deciding the future of a cell. Damage 
needs to be repaired before the cell cycle is allowed to continue, or the cell must be 
destroyed. We study the role of the budding yeast telomeric protein Rif1 during arrest 
of the cell cycle, primarily in the temperature sensitive cdc13-1 strains, which 
undergoes telomere uncapping and DNA strand resection. 
Rap-interacting factor 1 (Rif1) forms a complex with Rap1 and Rif2 to antagonise the 
action of telomerase at telomeres. Rif1 has since been shown to be conserved across 
eukaryotes, with roles in a number of processes such as a globally conserved role in 
regulation of replication timing, and repair pathway choice at mammalian double 
strand breaks. 
We further develop an observed anti-checkpoint role of Rif1 during telomere 
uncapping, which correlates to a cell cycle arrest dependent phosphorylation of Rif1. 
In this we have demonstrated the likely phosphorylation sites of Rif1 during cell cycle 
arrest, as well as the importance of these sites for this anti-checkpoint role. Through 
substitution of these amino acid residues we have demonstrated that cdc13-1 strains 
containing non-phosphorylated Rif1 protein show increased sickness. We have further 
demonstrated that this phosphorylation is downstream of the activity of the CDK1 
equivalent, Cdc28, and also occurs in cell cycle arrest resulting from multiple arresting 
reagents. 
We propose that Rif1 binds to regions of resected DNA and thereby shields ssDNA 
from recognition by checkpoint proteins, and that this interaction is regulated by the 
addition of phosphoryl groups at Serine-57 and Serine-110. The potentially conserved 
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53BP1 – p53 Binding Protein 1 
ALT – Alternate Lengthening of Telomeres 
APC – Anaphase Promoting Complex 
ARS – Autonomously Replicating Sequence 
ASE1 – Anaphase Spindle Elongation 1 
ASK1 – Associated with Spindles and Kinetochores 1 
ATM – Ataxia Telangiectasia Mutated 
ATR – Ataxia Telangiectasia and Rad53-related 
BEM2 – Bud Emergence 2 
BEM3 – Bud Emergence 3 
BFA1 – Byr-Four-Alike 1 
BIR1 – Baculoviral IAP Repeat-containing 
BRCA1 – Breast Cancer Associated 1 
BUB2 – Budding Uninhibited by Benzimidazole 
BUR1 – Bypass UAS Requirement 1 (?) 
CAK1 – Cdk Activating Kinase 
CDC13 – Cell Division Cycle 13 
CDC14 – Cell Division Cycle 14 
CDC20 – Cell Division Cycle 20 
CDC24 – Cell Division Cycle 24 
CDC28 – Cell Division Cycle 28, also known as CDK1 
CDC42 – Cell Division Cycle 42 




CDC5 – Cell Division Cycle 5 
CDC6 – Cell Division Cycle 6 
CDC7 – Cell Division Cycle 7 
CDH1 – CDC20 Homolog 1 
CDK – Cyclin Dependent Kinase 
CDK1 – Cyclin Dependent Kinase 1, also known as CDC28 in yeast. 
CDT1 – Chromosome Licensing and DNA Replication Factor 1 
CHK1 – Checkpoint Kinase 1 
ChIP – Chromatin Immunoprecipitation 
CKB1 – Casein Kinase Beta subunit 1 
CKB2 – Casein Kinase Beta subunit 2 
CKI – Cyclin-dependent Kinase Inhibitor 
CLB1 – Cyclin B 1 
CLB2 – Cyclin B 2 
CLB3 – Cyclin B 3 
CLB4 – Cyclin B 4 
CLB5 – Cyclin B 5 
CLB6 – Cyclin B 6 
CLN1 – Cyclin 1 
CLN2 – Cyclin 2 
CLN3 – Cyclin 3 
CNM67 – Chaotic Nuclear Migration 67 
CST – Cdc13-Stn1-Ten1 




CTK1 – Carboxy-Terminal domain Kinase 
DBD – DNA Binding Domain 
DDC1 – DNA Damage Checkpoint 1 
DDC2 – DNA Damage Checkpoint 2 
DDK – Dbf4 Dependent Kinase 
DDR – DNA Damage Response 
DMSO – Dimethyl sulfoxide  
DNA – Deoxyribonucleic Acid 
DNA2 – DNA Synthesis Defective 
dNTPs – Deoxyribonucleotide Triphosphate 
DPB11 – DNA Polymerase B (II) 11 
DSB – Double Strand Break 
dsDNA – double stranded DNA 
DUN1 – DNA-damage Uninducible 1 
ESCs – Embryonic Stem Cells 
EST1 – Ever Shorter Telomeres 1 
EST2 – Ever Shorter Telomeres 2 
EST3 – Ever Shorter Telomeres 3 
EXO1 – Exonuclease 1 
FAR1 – Factor Arrest 1 
FEAR – cell division cycle Fourteen Early Anaphase Release 
FIN1 – Filaments In between Nuclei 1 
FUS3 – Cell Fusion 3 




GLC7 – Glycogen 7 
H2A – Histone 2A 
HCM1 – High Copy suppressor of Calmodulin 1 
HEAT – Huntingtin, Elongation factor 3, protein phosphatase 2A, TOR1 
HML – Mating type cassette left 
HMR – Mating type cassette right 
HR – Homologous recombination 
KAR9 – Karygomay 9 
MCM – Mini-chromosome Mating complex 
MEC1 – Mitosis Entry Checkpoint 1 
MEC3 – Mitosis Entry Checkpoint 3 
MEN – Mitotic Exit Network 
MIH1 – Mitotic Inducer Homolog 1 
MPS1 – Monopolar Spindle 1 
MRE11 – Meiotic Recombination 11 
MRN – Mre11 Rad50 Nbs1 complex 
MRX – Mre11 Rad50 Xrs2 complex 
NHEJ – Non-Homologous End Joining 
ORC – Origin Recognition Complex 
PCNA – Proliferating Cell Nuclear Antigen  
PDS1 – Precocious Dissociation of Sister 1 
PGD – Phospho-Gate Domain 
PHO85 – Phosphate Metabolism 85 




POL-α – Polymerase alpha 
POL12 – Polymerase 12 
PP1 – Protein Phosphatase 1 
Pre-RC – pre-Replication Complex 
PTC2 – Phosphatase type two C 2 
PTC3 – Phosphatase Two C 3 
RAD17 – Radiation Sensitive 17 
RAD24 – Radiation Sensitive 24 
RAD50 – Radiation Sensitive 50 
RAD51 – Radiation Sensitive 51 
RAD52 – Radiation Sensitive 52 
RAD53 – Radiation Sensitive 53 
RAD9 – Radiation Sensitive 9 
RAP1 – Repressor-Activator site binding Protein 
RBM – Rap1 Binding Module 
RFA2 – Replication Factor A 2 
RFC – Replication Factor C 
RIF1 – Rap1 Interacting Factor 1 
RIF1-CΔ – RIF1 mutant containing a deletion of amino acids residues 1351-1916 
RIF1-NΔ – RIF1 mutant containing a deletion of amino acids 2-176 
RIF2 – Rap1 Interacting Factor 2 
RNA – Ribonucleic Acid 
RPA – Replication Protein A 




SAE2 – Sporulation in the Absence of spo Eleven 
SGS1 – Slow Growth Suppressor 1 
SGS2 – Slow Growth Suppressor 2 
SIC1 – Substrate/Subunit Inhibitor of Cycle-dependent protein kinase 
SIR2 – Silent Information Regulator 2 
SIR3 – Silent Information Regulator 3 
SIR4 – Silent Information Regulator 4 
SLD2 – Synthetically Lethal with Dpb11-2 
SLD3 - Synthetically Lethal with Dpb11-3 
SLI15 – Synthetically Lethal with Ipl1 15 
SPB – Spindle Pole Body 
SPC110 – Spindle Pole Component 110 
SPC42 – Spindle Pole Component 42 
SRS2 – Suppressor of Rad Six 2 
ssDNA – single stranded DNA 
SSN3 – Suppressor of Snf1-3 
STE11 – Sterile 11 
STE18 – Sterile 18 
STE4 – Sterile 4 
STE5 – Sterile 5 
STE7 – Sterile 7 
STN1 – Suppressor of CDC13 
STU2 – Suppressor of Tubulin 




TEL1 – Telomere maintenance 1 
TEN1 – Telomeric pathways with Stn1 
TERT – Telomerase Reverse Transcriptase 
TLC1 – Telomerase Component 1 
TOR – Target of Rapamycin 
TPE – Telomere Position Effect 
TR - Telomerase RNA component 
TRF2 – Telomeric Repeat Binding Factor 2 
WHI5 – Whiskey 5 
WT – Wild Type  
YKU70 – Yeast Ku protein 70 
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1.1 The architecture of the Telomere 
In eukaryotic cells, the ends of a linear chromosome are protected by specialised structures 
called telomeres. There are two main documented functions of the telomere: 
1 To distinguish chromosome ends from double strand breaks (DSBs) and thereby “hide” 
them from the DNA damage response machinery 
2 To protect the chromosome from the “end-replication problem”, whereby the canonical 
DNA replication machinery leads to loss of terminal DNA through successive rounds of 
replication. 
The structure of the telomeres are a complex network of DNA sequence elements, RNA, 
and proteins.  
Telomeric DNA is found across almost all eukaryotic species and consists of short tandem-
repeats, however the length of these repeats varies dramatically. Whilst telomere length is 
dynamic, in budding yeast these repeats are typically ~300bp length and can be described 
by the consensus sequence C1-3A/TG1-3, the loss of these telomeric repeats leads to high 
rates of chromosomal loss. The telomeric sequence is further characterised by a widely 
conserved single-stranded overhang occurring on the G-rich 3’ strand, the formation of 
which is dependent on Cdk1(Cdc28)-regulated resection of the C-strand (Wellinger et al., 
1993; Frank et al., 2006; Vodenicharov and Wellinger, 2006). The length of this overhang 
varies throughout the cell cycle in budding yeast, during a short period in late S/G2 phase it 
can stretch up to 100nt long (Wellinger et al., 1993). However, through the rest of the cell 
cycle this overhang is typically between 12 and 15nt in length. The G’ overhang is crucial 
for the recruitment of telomere capping proteins. 
Beyond the telomeric repeats, the telomeres of most eukaryotes are also made up of 
additional subtelomeric repetitive DNA sequences known as TAS (Telomere associated 
sequences) elements. In budding yeast there are two classes of TAS elements, X’ and Y’. 
Whilst Y’ elements are not found at all telomeres, when present they are immediately 
proximal to the telomeric repeats and are found in up to 4 tandem repeats (C. S. Chan and 
Tye, 1983). In a given strain, up to half of telomeres may lack Y’ elements, the identity of 
these telomeres will differ between strains (Horowitz et al., 1984; Zakian et al., 1986). These 




deletions (Louis and Haber, 1992). Alternatively, the X’ elements are much shorter, ~475bp, 
and more heterogeneous, X’ elements are present at all yeast telomeres. 
These subtelomeric regions contain multiple potential replication origins or ARS 
(Autonomously Replicating Sequences), which likely contributes to the dynamic and 
diverging nature of these sequences. Unlike the telomeric repeat sequences, telomeres 
lacking X’ or Y’ elements at one end appear to have normal stability through mitosis (Sandell 
and Zakian, 1993). 
In human cells, the telomeric sequence repeat unit is 5’-TTAGGG-3’, stretching 5-15kb in 
length (Samassekou et al., 2010). As with the length of the repeat sequence, the 3’ G-
overhang is also much larger in these cells than in budding yeast, typically ~200bp in length 
(Makarov et al., 1997; McElligott and Wellinger, 1997; Wright et al., 1997). This long 
overhang is related to the much different structure of the mammalian telomere compared to 
budding yeast. As well as numerous protein structures associated with the telomere, 
mammalian telomeres also form larger structures referred to as T-loops which are up to 
25kb in length. In these structures the chromosome ends are looped back to form a closed 
structure, this is carried out by strand invasion of the 3’ overhang into the double-stranded 
telomeric DNA and pairing with the C-strand, thereby sequestering DNA ends from the 








Figure 1.1 The DNA Structure of Budding Yeast Telomeres 
The structure of the end of yeast chromosomes. Short (~475bp) X’ elements are the most 
centromeric-adjacent element of the telomere. Y’ elements are not found at all telomeres 
but occur between the X’elements and the telomeric repeats, these are much longer (5.2-
6.7kb each) and occur in up to 4 tandem repeats. Finally, at the end of the chromosome 
there are typically ~300bp of the consensus telomeric repeat sequence C1-3A/TG1-3. Short 
tracts of telomeric repeats are usually found between the X’ and Y’ elements. Figure partially 





1.2 Telomere Replication & Telomere Stability 
1.2.1 Telomerase 
Telomeres present a unique problem for the DNA replication machinery. In each replication 
cycle a short region at 5’ of the lagging strand will be not be replicated, and over multiple 
cycles this leads to gradual shortening of the chromosome. The telomeric repeats are 
themselves a partial counter to this problem, delaying shortening into single-gene loci by 
providing a buffer. However, this alone is not enough as it would only last a finite number of 
cell cycles. To compensate for this loss the holoenzyme telomerase acts to extend the 
telomeric repeats as required. In eukaryotes the core telomeric components are the catalytic 
subunit – telomerase reverse transcriptase (TERT), and the RNA component – telomerase 
RNA (TR). In telomere extension, TR acts as a template from which TERT synthesises new 
telomere repeats (Greider and Blackburn, 1987). Telomerase function does however also 
require additional factors for recruitment to telomeres, and subsequent complex assembly. 
In budding yeast, the essential genes for telomerase action are TLC1, EST1, EST2, EST3, 
and CDC13. From these EST2 and TLC1 encode TERT and TR respectively and are 
required for enzymatic activity (Singer and Gottschling, 1994; Lingner et al., 1997). The 
protein structure of Est2 contains similar domains to many other eukaryotic TERTs, 
including a long basic N-terminal (TEN) domain essential for telomerase activity. This 
domain supports multiple interactions with Tlc1 and Est3, and cellular levels of Est2 are Tlc1 
dependent (Friedman and Cech, 1999; Taggart et al., 2002). Tlc1, the budding yeast TR, is 
>1000nt in length, however, shorter derivatives are capable of maintaining short but stable 
telomeres. The RNA structure centres on a pseudoknot domain containing the template 
sequence that interacts with Est2, the rest of the structure is made up of three duplex arms 
that scaffold to organise interacting proteins. One of these binds Est1 and is an essential 
function, another binds Yku80 and is not essential but does bring Tlc1 to the nucleus and 
recruits Est1 to telomeres in G1 phase (Lemon et al., 2019). The final arm binds the Sm 
protein ring, an association dispensable for telomerase activity (Singer and Gottschling, 
1994; Seto et al., 1999; Zappulla et al., 2005). 
 Est1 and Cdc13 regulate the recruitment of the holoenzyme. The interaction of Est1-Tlc1 is 
shown to be essential to recruitment of Est1 and Est2 to telomeres in late S/G2 phase (Chan 
et al., 2008). Furthermore, the interaction of Cdc13 and Est1 recruits the holoenzyme. In 
cells expressing a Cdc13-Est2 fusion protein, Est1 is dispensable for telomerase function 
(Evans and Lundblad, 1999). Suggesting the critical function of Est1 is to mediate the 




 Est3 association as a subunit is Est1-dependent, it is also seen to interact with Est2. 
However, the precise role played by this protein remains unconfirmed (Tuzon et al., 2011).   
 
1.2.2 Telomere Replication 
The replication of the yeast telomeres is one of the last events in the S phase. This is due 
to the late firing of origins proximal to telomeric sequences, this was later to be determined 
to be due to the repressive effect of Rif1 on origin firing (discussed in Section 1.10.2). 
Telomere length appears to be particularly sensitive to mutations in the conventional 
replication proteins, in manner which seems to reflect competition between 
semiconservative DNA replication and telomere-dependent extension, both occurring in late 
S-phase. The CST complex is a key regulator of this as both Cdc13 and Stn1 interact with 
subunits of the DNA polymerase α complex, whilst Cdc13 also interacts with telomerase 
(Nugent et al., 1996; Qi and Zakian, 2000; Grossi et al., 2004) 
Semi-conservative DNA replication begins of origins at replication recognised by the 
polymerase α-primase complex. As the polymerase can only function 5’ to 3’, one DNA 
strand is synthesised continuously (the leading strand) and the other is synthesised in short 
5’ to 3’ sections called Okazaki fragments which are processed to fill any gaps and ligate 
these fragments together (the lagging strand). At telomeres these correspond to the G 
strand and the C strand respectively. However, the activity of polymerase requires binding 
to a short primer sequence within the DNA, in the leading strand this is at the origin and 
replication then carries through to the chromosome end. However, on the lagging strand 
Okazaki fragment synthesis requires the binding of the polymerase to multiple primer 
sequence, inevitably meaning that a short sequence at the telomere end will go unreplicated. 
This creates what is known as the “end replication problem”, whereby semiconservative 
DNA replication must inevitably lead to progressive shortening of the telomere, a problem 
faced by mammalian somatic cells. In budding yeast and many other organisms, as well as 
immortalised cell lines, this problem is solved by the presence of telomerase to lengthen the 
telomeric repeats. Interestingly however, this is not the only problem created by the 
replication of telomeres in yeast, and the end processing of both leading and lagging strands 
are processed separately (Faure et al., 2010). Following leading strand synthesis, the 
chromosome is left with a blunt end rather than the G-tail required for telomere capping, 
meaning that the chromosome end will now be recognised as a DSB. Generation of the 3’ 




Mec1/Tel1/Cdk1(also known as Cdc28) recruitment of the MRX complex to resect the 5’ 
DNA strand at the telomere (Faure et al., 2010). This creates an overhang for CST 
association, which is also a substrate for telomerase binding, which is recruited by the 
interaction of MRX and Tel1 (Faure et al., 2010). Cdc13 is then able to recruit telomerase 
for extension of the telomeric repeats, and Cdc13 and Stn1 interact with polymerase 
subunits to promote C-strand synthesis (Parenteau and Wellinger, 2002). On the lagging 
strand the G-tail already exists as replication is unable to completely replicate the DNA end 
via Okazaki fragments. Therefore C-strand degradation is unnecessary, and the CST 
complex is able to bind.  
In budding yeast telomerase recruitment does not occur in every cell cycle, telomerase is 
shown to only associate with short telomeres during late S-phase, this is not mediated by 
Cdc13. Tel1 appears instead to preferentially target telomerase recruitment to short 
telomeres (McGee et al., 2010). Telomere extension is inhibited by a molecular counting 
method of Rif1 and Rif2, which appear to inhibit Tel1 in a dosage dependent manner 
(Marcand et al., 1997). When these proteins are depleted then long telomere phenotypes 
are seen.  
In mammalian cells telomerase is active during embryogenesis and in stem cells. Enzyme 
expression is downregulated in somatic cells ultimately leading to gradual telomere 




1.3 Telomere Binding Proteins  
Whilst the DNA structure of the telomere is important for chromosome maintenance, it alone 
is not sufficient. Telomeres are bound by a diverse array of proteins with versatility to carry 
out a range of functions; from facilitating end replication to capping the telomeres, a number 
of these proteins can also be found carrying out a variety of other genomic functions.  
 
1.3.1 The CST Complex 
In yeast cells the protection of the telomere ends is largely dependent on the CST complex. 
This complex is made up of the three proteins Cdc13, Stn1, and Ten1 arranged in a trimeric 
structure, together these directly bind to the G-tail (Lin and Zakian, 1996; Grandin et al., 
1997; Grandin et al., 2001). Interestingly, these subunits have been shown to have similarity 
to the subunits of the single-stranded binding complex RPA. Much like the CST complex, 
RPA is made up three subunits however, where the RPA complex binds to all ssDNA the 
CST complex shows a preference to binding ssDNA in the telomeric repeat. Structural 
similarities between proteins in these complexes may suggest a common origin, and the 
development of CST as a telomeric-specific form of RPA (Gao et al., 2007; Gelinas et al., 
2009). 
As the key telomeric complex, the two main functions of the CST reflect the main functions 
of the telomere. The complex caps the telomere, to prevent recognition by damage 
checkpoint proteins, and to recruit telomerase for telomere length maintenance.  
The telomere capping function of the CST complex was first demonstrated in cells containing 
the mutant allele cdc13-1. This mutant is temperature sensitive, cdc13-1 cells at restrictive 
temperatures accumulate ssDNA in subtelomeric regions which activates a DNA damage 
response to arrest the cells at G2/M phase (Weinert and Hartwell, 1993; Garvik et al., 1995). 
Temperature sensitive mutations of stn1 and ten1 also showed similar phenotypes to cdc13-
1, likewise interruption of the interaction between Stn1 and Ten1 was also shown to induce 
uncapping of the telomere (Grandin et al., 1997; Sun et al., 2009). The capping function of 
Cdc13 is dependent on the factors Stn1 and Ten1, overexpression of these factors was 
shown to be able to compensate for the absence of Cdc13 and maintain telomere protection 
(Petreaca et al., 2006).  
The second major function of the CST complex is in replication of the telomere. This has 




interaction between Cdc13 and the telomerase subunit Est1. The CDC13 mutant cdc13-2est 
was shown to lead to senescence and telomere shortening, similar to telomerase negative 
cells (Nugent et al., 1996). A physical interaction between Cdc13 and Est1 in late S-phase 
was further demonstrated, and shown to be necessary to activate telomerase function at 
telomeres (Taggart et al., 2002; Bianchi et al., 2004). This interaction is controlled by 
phosphorylation of Cdc13 by Mec1, Tel1, and Cdk1, these proteins promote the interaction 
in a cell cycle dependent manner (Tseng et al., 2006; Li et al., 2009). Interestingly, Mec1 
also appears to control telomerase recruitment to DSBs via phosphorylation of Cdc13 to 
instead inhibit its interaction with DNA (Zhang and Durocher, 2010).  
The CST complex also appears to play a second role in telomere replication, acting in aid 
of lagging strand replication at the terminal of the chromosome. Cdc13 has been shown to 
not only have an interaction with Est1 for recruitment of telomerase, but a further interaction 
with the DNA pol-α molecule (Qi and Zakian, 2000). Further to this, Stn1 has also been 
shown to interact with Pol12, the regulatory subunit of polymerase α (Grossi et al, 2004). It 
has since been shown that this function of the CST complex may be highly conserved in 
vertebrates and mammals  and may function by promoting RNA-priming on the C-strand as 
well as primase-to-polymerase shift (Miyake et al., 2009; Surovtseva et al., 2009; Chen et 
al., 2013; Lue et al., 2014).  
Initially, the CST complex was thought to be a unique complex in yeast, however it was 
since shown that an equivalent complex is seen in a range of eukaryotes; from fission yeast, 
to plants, and to humans. Stn1 and Ten1 are highly conserved, and homologs are found in 
the human CST complex, in humans the protein CTC1 is seen in place of Cdc13 (Rice and 
Skordalakes, 2016). This complex however does appear to play a somewhat different role 
to that seen in budding yeast, whilst it is seen at telomeres it may be disposable due to the 
role of shelterin, and the ssDNA binding of the complex does not appear to be sequence 
specific (Miyake et al., 2009). However, current evidence suggests Stn1 and Ten1 function 
together genome-wide in an RPA-like complex that rescues stalled replication forks 
independently of Cdc13 (Stewart et al., 2012; Wang et al., 2014).  
 
1.3.2 Yku70/80 
The Ku complex was initially discovered in humans and homologs were quickly identified in 
budding yeast as the genes HDF1 and HDF2, already known to be key for non-homologous 




(Feldmann and Winnacker, 1993). Comprising of a heterodimer complex of 70kDa and 
80kDa, referred to as Yku70 and Yku80 respectively, the complex was seen to bind double-
stranded DNA ends, both blunt or 3’/5’ overhangs, in a manner that is not sequence-
dependent (Tuteja and Tuteja, 2000; Fisher and Zakian, 2005). To bind DNA, the Yku70 
and Yku80 form a ring-like structure with dsDNA threaded through the central cavity, Yku is 
then capable of translocation along the duplex to allow the threading of multiple Yku 
molecules along the DNA.  
Deletion of either Yku subunit leads to telomere shortening as first shown by Boulton and 
Jackson (Boulton and Jackson, 1996). This was later shown to be independent of Tel1 
activity, and that these telomeres further showed elongated G-tails throughout the cell cycle 
(Gravel et al., 1998). This suggested two possible mechanisms; the Yku complex may 
protect the telomeres from degradation, or it may positively regulate the elongation of 
telomeres, such as by the recruitment of telomerase. The latter of these was first suggested 
by studies in cdc13 alleles which demonstrated a role for Ku in a telomerase dependent 
hyper-extension of telomeres, when expressed as a fusion protein with Cdc13 (Grandin et 
al., 2000). Ku was then further demonstrated to interact with TLC1, the RNA subunit of the 
telomerase complex. Through this interaction it then helps to recruit the telomerase catalytic 
subunit, EST2, in G1 (Fisher et al., 2004).  
However, it has been further identified that the Ku complex does also play some role in the 
protection of telomeres from degradation. In WT cells, the G-tails are extended during the 
S-phase of the cell cycle, corresponding to the phase at which the telomeres are extended. 
However, it was observed that in Yku-deficient cells, both yku70∆ and yku80∆, these G-tails 
are present at all times (Gravel et al., 1998). This suggests that in these cells, the 
mechanisms required for degradation of the C-strand are constitutively activated. The long 
tail phenotype can be partially suppressed by the deletion of EXO1, however, without this 
deletion then at temperatures above 37⁰C the growth of these cells is arrested (Bertuch and 
Lundblad, 2004). This is demonstrated to be due to the accumulation of ssDNA in sub-
telomeric loci, similar to cdc13-1 mutants (Maringele and Lydall, 2004b). This suggests that 
the presence of Yku functions to inhibit the C-strand degradation of the telomere outside of 
S-phase.  
The Yku proteins have also been seen to contribute to the Telomere Positioning Effect 
(TPE), generated by Rap1. This effect is a mediation of the silencing of telomeric genes 
carried out by the interaction of Rap1 with the Sir complex (Sir2, Sir3, Sir4) to deacetylate 




localization to the telomeres, an effect overcome by the elongation of the telomeric repeats 
in RIF1 or RIF2 mutants (Tsukamoto et al., 1997; Roy et al., 2004). This suggests that Yku 
proteins aid in recruitment of the Sir proteins to the telomeres and aid their binding to Rap1 
by antagonizing the effect of the competing Rif1 and Rif2 proteins.  
 
1.3.3 Rap1-Rif1-Rif2 Complex 
In S. cerevisiae the second key complex found at telomeres is made up of Rap1, Rif1, and 
Rif2, also known as the “shelterin-like” complex.  
Rap1 has been established as a general transcription factor at nearly 300 sites in the yeast 
genome, which equates to ~5% of all genes, and is found at the silencer elements of the 
silent mating-type loci HMR and HML (Shore and Nasmyth, 1987; Lieb et al., 2001). 
However, despite the established ability of Rap1 to bind to multiple genomic sites, its role is 
best characterised at the telomeres where it directly binds to the double-stranded telomeric 
repeat sequences (Longtine et al., 1989). In the telomeric repeats it has been shown that 
Rap1 molecules bind approximately every 15-20bp (Gilson et al., 1993), which means there 
will may be 15-20 individual complexes in 300bp of telomeric repeats.   
The protein Rap1 is comprised of 827 amino acid residues and contains multiple functional 
domains. The DNA-binding-Doman (DBD) of Rap1 falls within the middle of the protein, 
residues 361 to 596, which form two helix-turn-helix motifs (König et al., 1996). The C-
terminal of the protein is the required for interaction with a number of associated proteins, 
mutation within this region is shown to lead to elongation of telomeric tracts in S. cerevisiae 
(Wotton and Shore, 1997). The loss of interaction with Rif1 and Rif2 was shown to be 
responsible for this phenotype, both of which were discovered as interaction partners in two-
hybrid assays (Hardy et al., 1992; Wotton and Shore, 1997). 
The budding yeast RIF1 encodes a large 1916 amino acid residue protein and was shown 
to directly colocalize with Rap1 at telomeres, through an interaction located in the C-terminal 
domains of both proteins (Mishra and Shore, 1999). Rif1 was also shown to interact with 
Rap1 through a secondary independent site, albeit with lower affinity. The C-terminal 
domain of Rif1 was shown to be capable of tetramerization which may act to form a binding 
interface with Rap1 (Shi et al., 2013).  
Rif2 is a much smaller protein, only 395 amino acid residues, which contains two binding 




molecules of Rap1 simultaneously. This network of interactions creates a “molecular Velcro” 
promoting synergistic binding of Rif1 and Rif2 to arrays of telomere-bound Rap1, linking 
multiple Rap1 molecules together along the length of the telomere (Shi et al., 2013). In this 
function, Rif1 and Rif2 have both been shown to be necessary for maintenance of the 
telomeric repeats, in what appears to be a negative feedback loop. Initial studies suggested 
that the length of telomeres directly correlated to the binding of Rap1, with overexpressed 
Rap1 leading to shortening of telomeres and the introduction of extra telomeric DNA to 
samples leading to telomere extension (Conrad et al., 1990). It was proposed that a protein-
counting mechanism was responsible for telomere length, with telomere-bound Rap1-
termini being inversely proportional to telomere length (Marcand et al., 1997). It became 
clear that counting of Rap1 was in reality counting of Rap1-bound Rif proteins, particularly 
when shown that mutations of RAP1 leading to telomere instability did not need to perturb 
the DBD of Rap1, only the C-terminal responsible for protein interactions (Kyrion et al., 
1992). The mechanism proposed is that bound Rif1 and Rif2 act synergistically to inhibit the 
association of the Tel1 kinase with the telomere, and thus inhibit the telomerase complex 
from extending the telomeric repeats. When telomeres are longer, this inhibitory effect is 
stronger whereas at short telomeres this effect is weak and Tel1 is able to promote telomere 
extension (Levy and Blackburn, 2004).  
Interestingly, Rif1 and Rif2 appear to inhibit telomere extension through independent 
pathways, shown by the additive effects of deletions of RIF1 and RIF2 on telomere length. 
Recent studies have suggested that Rif1 functions to repress Tel1 recruitment and activation 
through a known interaction with PP1 (Kedziora et al., 2018). In contrast, Rif2 is proposed 
to compete with Tel1 for binding to the C-terminus of Xrs2 in the MRX complex, delocalising 
Tel1 and reducing the association of MRX (Hirano et al., 2009). The ability of Rif2 to exert 
telomere length regulation is not affected by deletion of RAD52, indicating that this function 
is likely unrelated to the role of Rap1 and Rif2 in inhibiting NHEJ, that is not shared by Rif1 
(Marcand et al., 2008; Shi et al., 2013). Perplexingly some studies have since suggested 
that Rif2 levels may be more important for Tel1 inhibition than Rif1, with Tel1 binding short 
and wild-type length telomeres equally effectively in the absence of Rif2, and other studies 
suggesting a short region of Rif2 tethered to Rap1 is sufficient to restore telomere length 
regulation in even rif1∆ cells (McGee et al., 2010; Kaizer et al., 2015). Whilst this may be 
supported by studies demonstrating the potency of a single Rif2 molecule in restoring WT-
phenotype in rif2∆ cells, compared to the requirement of multiple Rif1 molecules, this would 




telomeric repeats are increased to between 0.5-1kb total in length, whereas in rif2∆ cells the 
repeats are increased to 0.35-0.5kb in total (Hardy et al., 1992; Wotton and Shore, 1997; 
Levy and Blackburn, 2004).  
The Rap1-Rif1-Rif2 complex is also established to play a role in maintaining the TPE through 
the interaction of Rap1 carboxyl-terminal with the Sir3 and Sir4 subunits of SIR complex, 
which in turn recruits Sir3 further as well as Sir2 (Moretti et al., 1994; Luo et al., 2002). Rif1 
and Rif2 compete with the Sir complex for binding to Rap1 which mediates the TPE.   
The Rap1-Rif1-Rif2 complex is not found outside of budding yeast. Whilst orthologues of 
RAP1 and RIF1 can be found in fission yeast and in humans, there is currently no known 
orthologue of RIF2 in higher eukaryotes.  
In Schizosaccharomyces pombe both rap1 (spRAP1) and rif1 (spRIF1) encode proteins that 
are still found at telomeres, however Taz1 instead binds to the telomeric DNA and both 
spRap1 and spRif1 bind Taz1 in turn. S. pombe cells defective for spRAP1 show severe 
defects in telomere length control, TPE, and telomere clustering to the spindle pole body, 
whilst S. pombe defecient for rif1 shows defects in telomere length control but shows no 
effect on telomere silencing (Kanoh and Ishikawa, 2001).  
In humans only hRAP1 is typically found at telomeres, where it binds as part of the shelterin 
complex through an interaction with the DNA-binding protein TRF2, as it only contains one 
helix-turn-helix motif and is unable to bind DNA directly (B. Li and de Lange, 2003). Whilst 
RIF1 is found as part of the damage response in human cells, and as such can be found at 
aberrant telomeres (a role detailed later in this chapter), it does not bind the telomeres as 
part of normal telomere homeostasis (Silverman et al., 2004; L. Xu and Blackburn, 2004). 
Interestingly, reports suggest that RIF1 may be vital for the regulation of telomere length in 
mice embryonic stem cells, however this role is hypothesised to be through control of 
chromatin state influencing telomere access rather than a direct binding to the telomere 
(Dan et al., 2014). 
Further to this RIF1 has been found to be involved with a range of non-telomeric activities, 
and is conserved across a range of higher eukaryotes (Sreesankar et al., 2012). These 
further functions will be discussed in-depth later in this chapter, one of which is the focal 








Figure 1.3 Structure of the Telomere and Telomere-Related Complexes 
The telomere is bound multiple protein complexes which interact to manage telomere length 
and protect telomeres from resection. Progressive telomere loss affects the dynamics of the 
interaction between complexes to promote telomere extension. Information for figure from 





1.4 Models of Telomere Damage 
Without the telomere capping complex the chromosomes would closely resemble DSBs. As 
such mutants defective in telomere capping have been valuable in the elucidation of the 




The model system first used to study telomere uncapping is cdc13-1 (Garvik et al., 1995). 
In this temperature sensitive mutant, the CST component Cdc13 has a single point mutation 
(P371S) which leads to dissociation of the capping complex. This mutation has been shown 
to only affect the capping function and does not influence telomerase recruitment, nor does 
it affect the binding of Cdc13 to DNA or its association with Stn1 and Ten1 (Nugent et al., 
1996; Hughes et al., 2000; Grandin et al., 2001).  
Below 26⁰C, the growth of cdc13-1 is unimpeded and the cells progress through the cell 
cycle, this is referred to as permissive temperatures. Above 26⁰C the temperature sensitive 
phenotype manifests, this is the restrictive temperature. At restrictive temperatures cells 
arrest in G2/M phase of the cell cycle, distinguishable by a characteristic dumbbell shape. 
This occurs due to the failure of the telomere cap in cdc13-1, leading to extensive resection 
of the 5’ strand and ssDNA spanning up to 30kb into the chromosome (Garvik et al., 1995; 
Booth et al., 2001). This resection is the result of exonuclease activity, which interestingly is 
both up- and down-regulated by the activity of checkpoint proteins. The first identified 
exonuclease activity at uncapped telomeres was by Exo1, which was found to be essential 
for extended resection through the sub-telomeric X’ elements, and into single-copy genes. 
However it was also seen to be dispensable for resection of the sub-telomeric Y’ repeats, 
suggesting a second exonuclease was required for the initial resection activity (Zubko et al., 
2004). As the MRX complex, Sae2, Sgs1 and Dna2 were all shown to promote resection at 
DSBs these were likely candidates for this role. However, it was also shown that unlike its 
activity in promoting resection at DSBs, MRX acts to protect telomeres against resection 
during telomere uncapping (Foster et al., 2006). Likewise, activity of Sae2, which functions 
in tandem with the MRX at DSBs, was also shown to improve the viability of cdc13-1 at 
restrictive temperatures. Sgs1-Dna2 were later shown to contribute to the exonuclease 
activity at telomeres, stimulated by the activity of the PCNA-like clamp Ddc1-Mec3-Rad17, 




RPA likely acts as the initial signal for damage in cdc13-1 cells, binding the ssDNA overhang 
left vulnerable by the dissociation of the CST. RPA in turn recruits the clamp loader Rad24-
Rfc, which loads the 9-1-1 clamp complex onto DNA, and Ddc2-Mec1 which begins the 
signalling cascade (Piya et al., 2015). Mec1 carries this signal to the transducer kinase 
Rad9, interestingly Rad9 has been shown to inhibit the formation of ssDNA in cdc13-1 cells 
both directly, by inhibiting the action of the Rad24-Rfc clamp loader, and indirectly via 
activation of Rad53 which inhibits the exonuclease activity of Exo1 (Jia et al., 2004; Zubko 
et al., 2004; Chappidi et al., 2019).  
Rad9 activates two parallel DNA damage checkpoint pathways which regulate arrest in 
cdc13-1. The previously mentioned Rad53, which works partially through Dun1, and Chk1, 
which acts through Pds1 (Gardner et al., 1999; Blankley and Lydall, 2004). Mitotic exit in 
budding yeast is controlled by two major pathways; the mitotic exit network (MEN) and the 
CDC-Fourteen early anaphase release (FEAR) network. Consequently, these two pathways 
are the targets of the Rad53 pathway and the Chk1 pathway respectively (Liang and Wang, 
2007). The action of Rad53-Dun1 is believed to regulate the MEN by the targeted inhibition 
of Cdc5 polo-like kinase, which normally inhibits the activity of Bfa1 and Bub2, negative 
regulators of the MEN (Hu et al., 2001; Valerio-Santiago et al., 2013). This pathway is 
believed to be the more important pathway for inhibition of mitotic progression in cdc13-1.  
During normal cell cycle progression Cdk1 acts to phosphorylate Pds1 and prevents its 
degradation, as Cdk1 activity falls Pds1 is degraded (H. Wang et al., 2001; Enserink and 
Kolodner, 2010). In cdc13-1 cells with uncapped telomeres Chk1 instead phosphorylates 
Pds1 and stabilizes it. Phosphorylated Pds1 binds the separin Esp1, which prevents 
chromosome segregation and arrests the cell cycle (Ciosk et al., 1998). This can only be 









Figure 1.4 Schematic diagram of the checkpoint arrest resulting in cdc13-1 cells 
having undergone telomere uncapping.  
Diagramatic representation of the checkpoint pathway in cdc13-1 cells at restrictive 
temperature. Green arrows represent activation of the target proteins, red indicates 
inhibition of a protein or pathway. Information for figure taken from (Enserink and Kolodner, 







The second major model system for studying telomere uncapping in budding yeast is 
yku70∆ cells. Similarly, to cdc13-1, deletions of YKU70 or YKU80 also lead to temperature 
induced telomere uncapping, leading to a G2/M checkpoint arrest at restrictive 
temperatures. This temperature is higher than that of cdc13-1 cells, with yku70∆ and yku80∆ 
mutants failing to form colonies at 37⁰C and up (Barnes and Rio, 1997). The defect in these 
cells is known to be telomere specific rather than an effect on the role of Yku in NHEJ, as 
overexpression of telomerase subunits is capable of partially suppressing this phenotype 
(Teo and Jackson, 2001). These Yku mutants are also seen to contain short telomeres, 
decreased telomeric silencing, altered telomere localisation, and critically, ssDNA is seen in 
the telomeric repeat sequence (Boulton and Jackson, 1998; Laroche et al., 1998; 
Polotnianka et al., 1998; Mishra and Shore, 1999).  
The resection in yku70∆ cells has been shown to be Exo1 dependent. However, unlike at 
DSBs where Exo1 and Mre11 both act in processing to create 3’ ssDNA ends, Mre11 instead 
acts to protect the telomere ends in yku70∆ cells. Double mutant yku70∆ mre11∆ cells 
actually display increased temperature sensitivity, and accumulate more ssDNA, dependent 
upon Exo1 activity. It is also noteworthy that in yku70∆ cells resection is slower than that 
seen in cdc13-1, and ssDNA reaches sub-telomeres but does not stretch as far as internal 
loci (Maringele and Lydall, 2002). Interestingly, whilst Mec1 and Rad9 both play important 
roles in checkpoint arrest in cdc13-1 and yku70∆, Chk1 is actually essential for the arrest in 
yku70∆ compared to the higher importance of Rad53 in cdc13-1. In further contrast to cdc13-
1, the 9-1-1 complex and Dun1 do not play significant roles in the G2/M arrest of yku70∆ 
cells grown at restrictive temperatures (Maringele and Lydall, 2002). It was also shown that 
the spindle checkpoint protein Mad2 contributes to the arrest in yku70∆ cells, this is contrast 
to Bub2 which contributes to the arrest of cdc13-1. Mad2 is seen to inhibit Cdc20, an 
essential factor of the Anaphase promoting complex/cyclosome (APC/C) (Hwang et al., 
1998).  
Unlike cdc13-1, the direct molecular mechanism triggering arrest at restrictive temperatures 
in yku70∆ cells was not immediately clear. Instead based on the various phenotypes of 
yku70/80∆ mutants described above, that the trigger may be progressive loss of telomeric 
repeats. It was shown by Gravel & Wellinger using a temperature-inhibited Yku complex, 
that the survival of strains after inhibition correlated with the lengths of telomeric repeats and 
the generation of G’ strand overhangs were independent of telomerase activity (Gravel and 




permanent feature of these telomeres. Furthermore, without the known function of Yku to 
recruit Tlc1 to telomeres, the telomere repeats become shortened (Zappulla et al., 2005). 
However, other studies have suggested that the role of Yku70/80 in telomere end protection 
may also be related to creating structures in the telomere to protect against excessive 
resection. Without Yku70/80 these structures are affect by both the loss of telomeric repeats 
and the presence of long G-tails, and at high temperatures these structures may be lost 
(Lopez et al., 2011).  
 
1.4.3 Telomerase negative survivors 
Cellular senescence is the term for the gradual decline in proliferation capacity of cells, 
ultimately leading to permanent growth arrest. This process is usually seen in multi-cellular 
organisms after a defined number of cell divisions, referred to as the “Hayflick limit”. A 
number of factors govern the onset of senescence, amongst which is the downregulation of 
telomerase activity in somatic mammalian cells and the subsequent arrest resulting from 
progressive loss of telomeric DNA. The immortalisation of cell lines, including in 
tumorigenesis, requires the reactivation of telomerase to overcome this limit. However, a 
secondary method of telomere rescue is also seen to be established through homologous 
recombination. This process and the resulting telomeres are referred to as ALT (Alternate 
Lengthening of Telomeres) (Henson et al., 2002). 
Despite the continual expression of telomerase in single celled eukaryotes, an equivalent to 
this process can also be seen in budding yeast. This can be seen in telomerase-null strains 
such as tlc1, where a small fraction of cells are seen to survive and form viable colonies 
(Lundblad and Szostak, 1989). The importance of recombination in this survival was 
demonstrated by the absence of survivors when telomerase mutations are combined with 
deletion of key HR genes such as RAD52 (Lundblad and Blackburn, 1993). These survivors 
are seen to form into one of two types, dubbed type I and type II survivors. Type I survivors 
are more common than type II, however due to their unstable nature these are easily 
converted to type II survivors which grow at a faster rate and rapidly take over liquid cultures 
(Teng et al., 2000).  
 
1.4.3.1 Type 1 Survivors 
In these survivors the majority of cells contain telomeres made up of multiple tandem Y’ 




survivors are further seen to also contain extrachromosomal circular Y’ elements that may 
serve as substrates for Y’ recombination. The generation of type I survivors is dependent 
upon the activity of RAD52, POL32, RAD51, RAD54, RAD57 and RAD55 (Chen et al., 
2001b; Larrivee and Wellinger, 2006).  
 
1.4.3.2 Type II survivors 
Telomeres in type II survivors only show small amplifications of the subtelomeric elements, 
however they instead have large increases in the TG1-3 telomeric repeats. The telomeres in 
these survivors are highly heterogenous, ranging from very short repeats to over 12kb in 
length. These telomeres are not stable and are progressively lost over multiple cell cycles, 
before short dramatic bursts of lengthening take place. Unlike in type I survivors, the 
generation of type II survivors requires the MRX complex, RAD59, and SGS1 (Teng and 
Zakian, 1999; Chen et al., 2001b). Interestingly the formation of Type II survivors can be 
inhibited by both Rif1 and Rif2 (Teng et al., 2000). 
 
1.4.3.3 PAL survivors 
In the absence of either process to generate type I or type II survivors, a percentage of cells 
are still seen to survive and proliferate. These were first seen in tlc1∆ rad52∆ exo1∆ strains, 
lacking both telomerase activity and capacity for homologous recombination. After an initial 
period of slow growth, survivors were seen to grow as well as WT cells, and appeared to 
have become immortalised. After 100 days, most survivors lacked telomeric sequence but 
maintained chromosomes with abnormal size. These survivors maintained viability by the 
amplification of large palindromes at chromosome ends, and these abnormal chromosomes 
contained large numbers of gene duplications and deletions. It was proposed that inverted 
repeats naturally present in the genome can catalyse palindrome formation, after formation 
these palindromes amplify essential genes close to the chromosome ends and improve cell 
viability (Maringele and Lydall, 2004).  
The emergence of survivors of all types led to a central question; how do cells overcome 
the checkpoint barrier to cell cycle progression? It was identified that after telomere loss 
there is an initial period of growth inhibition reliant on the DNA damage checkpoint proteins, 
together with Exo1 and Mre11 nucleases. In survivors, the checkpoint pathways become 
tolerant to the loss of telomeres yet remain responsive to new DNA damage. This study 




genomic modifications seen in survivors (Xue et al., 2016). This is related to the anti-






1.5.1 CDK1 & Mitotic Progression 
The eukaryotic cell cycle is heavily dependent on cyclin dependent kinases (CDKs). In 
budding yeast there are six evolutionary conserved CDKs; CDK1 (also referred to as 
CDC28), PHO85, KIN28, SSN3, CTK1, and BUR1 (Toh-e et al., 1988; Liu and Kipreos, 
2000); (Simon et al., 1986; J. M. Lee and Greenleaf, 1991; Yao et al., 2000). CDK1 ( is the 
only one of these required to drive the cell cycle, although many of the various roles are 
supported by the non-essential CDKs (Huang et al., 2007). Cdk1 preferentially 
phosphorylates the consensus sequence S/T-P-x-K/R, however it also phosphorylates a 
more minimal sequence of S/T-P if required (Nigg, 1993). Throughout the cell cycle Cdk1 
interacts with 9 separate cyclins to control kinase activity through the recruitment and 
selection of target substrates; Cln1-3, and Clb1-6. In the absence of cyclins, CDKs are 
completely inactive due to the active site being blocked by a T-loop within the protein 
structure. Phosphorylation of residues within this loop by Cak1 are believed to expose the 
binding site and increase the number of contacts between Cdk1 and cyclins. There is, 
however, substantial overlap in these cyclins, as overexpression of either Clb1 or Clb6 would 
be sufficient to rescue viability of a clb1∆ clb2∆ clb3∆ clb4∆ clb5∆ clb6∆ mutant (Schwob 
and Nasmyth, 1993; Haase and Reed, 1999). The activity of these cyclins, as well as 
multiple inhibitor kinases and phosphatases, regulates the activity of Cdk1 through the cell 
cycle. In G1 Cdk1 is inactive due to low cellular concentration of cyclin proteins and the 
presence of Cyclin dependent Kinase Inhibitors (CKIs). Activity begins to rise in late G1, as 
cyclin levels rise CKI levels fall. Cdk1 remains highly active until anaphase when cyclins are 
degraded and CKIs are re-expressed (Mendenhall and Hodge, 1998). This drop in activity 
is crucial for mitotic exit and the re-set of the cells into G1 of the next cycle.  
CLN1, 2, & 3 are all expressed in late G1 to interact with the Cdk1 protein. Cln1 and Cln2 
are believed to be required for spindle pole body duplication and initiation of bud 
morphogenesis, whilst Cln3 is involved in the regulation of transcriptional programs. All three 
are involved in the transition into S-phase and function redundantly, as only triple mutants 
of cln1∆ cln2∆ cln3∆ fail to progress into S-phase (Tyers et al., 1993; Griffith et al., 1999). 
After the transition to S-phase they are targeted for destruction by the action of Clb-Cdk 
complexes (Tyers et al., 1992; Marcand et al., 1997).  Clb5 and Clb6 take action next, these 
are induced during G1, and Clb5 remains stable until anaphase whilst Clb6 is degraded at 
the G1/S transition.  Both appear to be involved in ensuring origins of replication are not re-




from S phase until anaphase and are involved in the function of Cdk1 in DNA replication, 
spindle assembly and the G2/M transition (Richardson et al., 1992). Finally, Clb1 & 2 are 
expressed during G2-M-phase and degrade at the end of mitosis. These are involved in 
mitotic events such as spindle elongation and bud morphogenesis (Lew and Reed, 1993).  
As previously mentioned, this activity is countered in G1 by the activity of CKIs. Whilst the 
CKIs Far1 and Sic1 are active, cells are incapable of entering S-phase. These inhibitors 
bind cyclin-CDK complexes to prevent their interaction with substrates (Chang and 
Herskowitz, 1990; Mendenhall, 1993; Venta et al., 2012). Interestingly, the only essential 
function of the Cln-Cdk1 interaction appears to be the degradation of Sic1 (Schneider et al., 
1996). The re-expression of Sic1 in late mitosis contributes to mitotic exit and the reset of 
the cell cycle. There are other proteins also involved in the regulation of CDK activity. To 
promote the progression through G1, Cks1 acts to increase the activity of Cln-Cdk1 
complexes (Reynard et al., 2000). Swe1 phosphatase is present throughout G1 and peaks 
in late S-phase before degradation by the APC/C. Swe1 acts to dephosphorylate Cdk1 to 
inhibit activity and delay the cell cycle in response to cytoskeleton stresses (Sia et al., 1998; 
Keaton and Lew, 2006). Swe1 is in turn countered by the activity of Mih1, which acts to 
reverse the phosphatase activity and promote entry into mitosis (Russell et al., 1989). 
Finally, it has been shown that acetylation of Cdk1 on K40 is essential for kinase activity 








Figure 1.5.1 the activity of Cdk1 & cyclins through the Cell Cycle 
The activity of Cdk1 associated cyclins is indicated with green and blue arrows. The location 
shows the point in the cell cycle at which cyclins are induced and the point at which they are 
degraded or their interaction with Cdk1 inhibited. The red arrow indicates the activity of Far1 
and Sic1, the CKIs, which inhibit the activity of cyclins through G1 phase. Figure assembled 




1.5.2 Exit from Mitosis 
The final exit of cells from mitosis is carried out by a careful balance of the activity of Cdk1 
and of Cdc14 phosphatase, via the APC/C. Without Cdc14 activity cells arrest prior to 
cytokinesis, with long spindles and a divided nucleus (Wood and Hartwell, 1982). The 
process of mitotic exit is begun by the promotion of the APC/C by the action of Cdk1. The 
activity of the APC/C rises and falls according its association with the two subunits Cdc20 
and Cdh1. As mitosis progresses the APC/C associates highly with Cdc20 (APC/CCdc20). 
However, in late mitosis this rebalances and APC/C associates with Cdh1 (APC/CCdh1), this 
complex remains active through G1 (Sullivan and Morgan, 2007). Whilst both these two 
forms of the complex are required for full degradation of Clb2, they do have some differences 
in substrate specificity, such as APC/CCdc20 targeting of Pds1 and APC/CCdh1 targeting Ase1 
(Visintin et al., 1997; Wasch and Cross, 2002). During G1 phase, APC/CCdh1 degrades 
cyclins to inhibit Cdk1 activity. However, as cells enter into S-phase the interaction between 
Cdh1 and the APC/C is inhibited by the activity of Cln1, 2-Cdk1 and Clb5-Cdk1 (Crasta et 
al., 2008). Cdk1 phosphorylates the APC/C components Cdc16, Cdc23, and Cdc27 to 
promote the binding of the APC/C and Cdc20. This complex targets Pds1 for degradation. 
Normally Pds1 inhibits activity of Esp1, degradation of Pds1 therefore increases activity of 
Esp1 and leads to dissolution of chromosome cohesion and the activation of the FEAR 
network, followed by subsequent activation of the MEN (Shirayama et al., 1999; Rudner and 
Murray, 2000). During the majority of the cell cycle Cdc14 is sequestered in the nucleolus 
by Net1, the increased activity of Esp1 leads to decreases in PP2ACdc55 phosphatase activity 
and thereby increased phosphorylation of Net1, allowing the localisation of Cdc14 to the 
nucleus (Y. Wang and Ng, 2006). The phosphorylation is targeted by Clb-Cdk1, as well as 
Clb-Cdk1-activated Cdc5 (Rodriguez-Rodriguez et al., 2016).  
As Cdk1 activity drops during anaphase there is potential for Net1 to return to a hypo-
phosphorylated state and thereby return Cdc14 to the nucleolus prematurely. To ensure 
continued Cdc14 activity the MEN pathway is activated through Tem1 which triggers a 
signalling cascade through Cdc15 and Dbf2-Mob1 (Lee et al., 2001; Mah et al., 2001). The 
proper timing of MEN activation is maintained by the activity of Bfa1-Bub2, which prevent 
the activation of MEN prior completion of chromosome separation. Like Net1, Bfa1 
phosphorylation is controlled by PP2ACdc55 activity. Therefore, as Esp1 activity increases, 
the inhibitory phosphorylation of Bfa1 increases by action of Cdc5. Full activation of the MEN 
pathway also requires Cdc14 mediated dephosphorylation of Cdc15 and Mob1 during 




to an end Cdc14 dephosphorylates Cdh1 to permit its re-association with the APC/C 
complex (Visintin et al., 1998). APC/CCdh1 targets Cdc5 for degradation, downregulating 
Cdc14 activity by facilitating its return to the cytoplasm (Visintin et al., 2008). The removal 
of Cdc14 from the nucleus is also controlled by Dbf2-Mob1 mediated phosphorylation of 
Cdc14 at residues adjacent to its nuclear localisation signal (NLS) (Mohl et al., 2009). 
Finally, APC/CCdh1 targets the cyclins for degradation, resetting the cell cycle and 







Figure 1.5.2. A schematic diagram of the influence of Cdk1 and Cdc14 in promoting 
mitotic exit. 
Cdk1 promotes the activity of Cdc14 which in turn activates factors and pathways required 
for mitotic exit. As the cell exits mitosis the factors activate by Cdc14 feedback to inhibit 






1.5.2 Cdk1-Controlled Processes 
As a key driver of mitotic progression, it is clear that Cdk1 plays a vital range in a wide range 
of processes that are targeted by the association of cyclins at appropriate times. These 
include the arrangement of transcriptional programs, control of cell morphogenesis, 
restriction of pheromone signalling, control over DNA replication, regulation of chromosome 
separation, and the maintenance of genome stability.  
The proper transcription of genes at the correct time is a key element of maintaining cell 
cycle progression. In G1 phase, Cln3-Cdk1 control the expression of the G1 cluster, a set 
of ~200 genes specifically expressed in G1 phase (Spellman et al., 1998). This is mediated 
by the phosphorylation of Whi5 by Cdk1 and Pho85, repressing the inhibition of SBF 
transcription complex (Costanzo et al., 2004). Cyclin-Cdk complexes may also target the 
SBF and MBF directly to shut off transcription of the G1 cluster at the G1/S transition 
(Geymonat et al., 2004). As the cell transitions into S-phase a new cluster of genes are 
transcribed, stimulated by Hcm1 activity. The activity and degradation of Hcm1 are both 
controlled through phosphorylation by Cdk1 (Pramila et al., 2006). From S-phase until the 
end of nuclear division in mitosis Cdk1 is involved in the increased expression of a group of 
35 genes called the CLB2 cluster. This includes genes such as CDC5, CDC20, and CLB2 
itself. The stimulation of expression of this cluster is mediated by interaction of Clb2-Cdk1, 
and so Clb2 creates a positive feedback loop in which it stimulates its own synthesis. As 
mitosis progresses through the final stages before transition into G1 phase, Cdk1 is believed 
to be involved in the control of four gene clusters; the PHO regulon, the SIC1 cluster, MCM 
cluster, and the MAT cluster (Spellman et al., 1998). Of these, Cdk1 and Ph085 only serve 
to upregulate the activity of the PHO regulon. Transcription of the other three gene clusters 
are downregulated by Cdk1 activity, and so as Cdk1 activity falls towards the end of mitosis 
transcription of these clusters increases. The SIC1 and MAT cluster include the CKI genes 
FAR1 and SIC1 (Oehlen et al., 1996). The importance of Cdk1 in regulating these is unclear, 
as it appears there is at least 1 other major factor. Experimental inactivation of Cdk1 showed 
that around 70% of the genes in these clusters continued to be expressed on schedule 
(Orlando et al., 2008). This may imply that the function of Cdk1 is to fine-tune coordination 
of expression and the cell cycle, rather than being the prime determinant.  
During bud morphogenesis Cdk1 stimulates the activity of Cdc24. As the cell passes to S-
phase Cdk1 promotes removal of inhibition of Bem2/3 and Rfa2, which keep Cdc42 in an 
inactive state during G1 to prevent bud formation (Nern and Arkowitz, 2000; Sopko et al., 




Tgl4 and inducing expression of genes involved in lipid synthesis, it also coordinates 
membrane-trafficking dynamics and synthesis of the cell wall (Santos-Rosa et al., 2005). 
Without Cdk1 vesicles are mistargeted from the growing cell bud, and it has been implicated 
further in the proper inheritance of cell organelles (McCusker et al., 2012).  
The pheromone response pathway is triggered by binding of the mating pheromone to seven 
transmembrane receptors on the cell surface, stimulating a conformational change in the 
receptor. This ultimately leads to the activation of the Ste4-Ste18 complex bound to the cell 
membrane, through a series of effectors this complex recruits Ste5, which serves as an 
adaptor for Ste11, Ste7, and Fus3 (Herskowitz, 1995; Wu et al., 1995). Through alterations 
to the transcriptional program, interactions with the actin cytoskeleton, and inhibition of Cln-
Cdk1 this pathway arrests the cell in G1, the only phase of the cell cycle in which mating 
should occur (Yu et al., 2008). Mating outside of G1 would lead to aneuploidy, and therefore 
must be inhibited, as Cdk1 is inactive during G1 and active elsewhere it is an ideal 
candidate. Cln/Clb-Cdk1 activity prevents the activation of the response pathway through 
phosphorylation of a number of core components such as Ste20, Ste5, and Far1 (Gartner 
et al., 1998; Winters et al., 2005). 
DNA replication and its proper timing are crucial for an orderly cell cycle. If replication 
initiates too early, or late, it can lead to problems in the cell cycle. It is also important to 
ensure that DNA is replicated only once per cell cycle. Cdk1 has key roles in both of these 
elements of regulation. The initiation of replication begins with origin licensing, this is when 
the pre-replication complex (pre-RC) is assembled at origins of replication. The foundation 
of this complex is the ATP-binding Origin Recognition Complex (ORC), made up of six 
subunits (Orc1-6). This recruits Cdc6, Cdt1 and the MCM2-7 hexamer complex which 
functions as an ATP-dependent helicase, finally the GINS is required for initiation of 
replication (Randell et al., 2006; Z. Chen et al., 2007; Labib and Gambus, 2007). Once the 
pre-RC is assembled a second transition occurs to the pre-Initiation complex (pre-IC), this 
requires the recruitment of Cdc45 to the pre-RC dependent upon the action of Clb5/6-Cdk1 
(Zou and Stillman, 1998; Zou and Stillman, 2000). Cdk1 and DDK (Dbf4 dependent kinase) 
act together. DDK phosphorylates the MCM2-7 complex, leading to recruitment of Cdc45 
(Sheu and Stillman, 2006). Cdc45 and Dpb11 are required for recruitment and loading of 
the DNA polymerases alpha and epsilon (Masumoto et al., 2000). Initiation of replication 
then requires Cdk1 mediated phosphorylation of Sld2 and Sld3, which induces binding to 
Dbp11 (Zegerman and Diffley, 2007). The complex of Sld2, Sld3, DPb11 and Cdc45 at the 




After the initiation it is equally important to prevent the re-initiation of an origin of replication. 
Cdk1 targets the ORC, Cdc6, and the MCM2-7 complex for phosphorylation, leading to the 
dissociation of Mcm2-7 and Cdc6 from the origin. These proteins cannot reassemble until 
phosphorylation is removed, and re-replication could only occur if all three were 
simultaneously uncoupled from regulation (Nguyen et al., 2001).  
Cdk1 plays important roles in a number of aspects of proper chromosome segregation and 
interacts with many protein targets. As described previously, the phosphorylation of Pds1 
plays a key role in chromosome cohesion and separation. Further to this, it is seen to 
influence a range of segregation-related pathways through various protein interactions 
including; kinetochore attachment (Ask1), spindle pole body (SPB)-spindle attachment 
(Spc42), SPB duplication and separation (Spc110, Mps1), prevention of SPB re-duplication 
(unknown), spindle positioning (Kar9, Stu2, Cnm67), and spindle stability and elongation 
(Sli15, Fin1, Bir1, Ase1) (Enserink and Kolodner, 2010).  
Outside of the role of Cdk1 in controlling chromosome segregation and the related pathway 
timings, Cdk1 also plays a role in genomic stability through interaction with the DNA damage 
checkpoint response. Direct roles for Cdk1 within the checkpoint response are difficult to 
separate from indirect roles. As Cdk1 is a controlling factor of many of the cell cycle 
progression processes, the loss of Cdk1 can lead to checkpoint arrests at various points in 
the cell cycle. Furthermore, it may be an expected target for any pathway intended to halt 
the cell cycle. However, it has been shown that inhibitory phosphorylation of Cdk1 is not 
required for an effective checkpoint arrest as many checkpoint proteins will instead target 
the processes directly, such as Rad53 targeting the APC/C component Cdc20, or Cdc5. 
However, Cdk1 has been shown to be directly required for checkpoint arrest in some 
scenarios. At DSBs Cdk1 is required for the promotion of HR in repair pathway choice and 
the recruitment of Rad52 to the site (Ira et al., 2004; Barlow and Rothstein, 2009). Cdk1 
phosphorylation of Sae2 is required for removal of the MRX complex and end-processing at 
DSBs, which Cdk1 also promotes through phosphorylation of Exo1 (Tomimatsu et al., 2014). 
High activity of Cdk1 in G2/M arrest leads to Cdk1 promoting the activity of exonucleases to 
resect the DNA adjacent to DSBs. Increasing evidence in recent years has suggested that 
Cdk1-mediated phosphorylation may be required for a full checkpoint arrest at G2/M. A 
recent study suggested that phosphorylation of Rad9 by Cdk1 was required for activation of 
the effector kinase Chk1 (Abreu et al., 2013). Cdk1 has also been shown to directly 
phosphorylate Rad53, although its requirement during checkpoint arrest is uncertain (Diani 




phosphorylation during arrests occurring due to DNA damaging agents, which occur in 
G2/M, as opposed to replication-stress based damage occurring during S-phase (Liberi et 
al., 2000; Enserink et al., 2009).  
The wide range of functions of Cdk1 make it incredibly important for the stability of 
chromosomes and the genome at large. The vast interplay between Cdk1 activity and the 






1.6 The G2/M DNA Damage Checkpoint 
In yeast the primary response to DSBs, and uncapped telomeres, is the G2/M checkpoint. 
Once damage is detected components of this pathway arrest the cell cycle at the G2/M 
phase, and activate factors involved in DNA repair. This pathway is largely made up of a 
series of kinases acting in turn, beginning with sensor proteins binding the damage sites, 
which recruit sensor kinases. These sensor kinases in turn phosphorylate transducer 
kinases which carry the signal on to effector kinases, these interact with a range of cellular 
factors to halt the cell cycle and activate repair. 
During the G2/M stage of the cell cycle repair favours homologous recombination due to the 
presence of replicated DNA to act as a template. In this event, the DSB, or uncapped 
telomere is resected 5’-3’ by exonucleases recruited to the sites of damage. This resection 
is largely determined by Cdk1 activity, which controls repair pathway choice (Aylon et al., 
2004; Ira et al., 2004). The MRX (Mre11-Rad50-Xrs2) helicase complex detects the 
presence of a DSB and binds, Cdk1 in turn phosphorylates Sae2 which now targets 
resection to the DNA ends and promotes dissociation of the MRX complex (Huertas et al., 
2008). The exonuclease activity of Sae2 is supported by further resection carried out by 
Exo1, and the helicase activity of Sgs1 (Zhu et al., 2008). 
The second signal for damage is the RPA complex which coats the ssDNA exposed after 
resection. This damage signal is detected by the yeast ATR/ATM phosphatidylinositol 3-
kinase (PIKK) equivalents, Mec1 and Tel1. However, Mec1 is the primary sensor kinase in 
the yeast response to DSBs (Harrison and Haber, 2006).  Mec1 and Ddc2 form a 
heterodimer in which Ddc2 is responsible for the recruitment of Mec1 to sites of damage, 
and for DNA binding.  
The third damage sensor functions independently and is known as the 9-1-1 complex, or 
the checkpoint clamp and the clamp-loader complexes. The heterotrimeric complex is made 
up of Rad17, Mec3, and Ddc1 (mammalian homologues Rad9-Hus1-Rad1 which form the 
PCNA clamp) and is loaded onto the dsDNA by Rad24 acting in complex with the yeast Rfc 
homologues which bind at the ssDNA-dsDNA junction (Ellison and Stillman, 2003). This 
clamp complex promotes resection at the DSB and recruits the transducer kinases for Mec1 
interaction, thus the co-localisation of these proteins to a DSB is essential for a functional 
G2/M checkpoint (Emili, 1998; Jia et al., 2004; Majka et al., 2006).  
Mec1 phosphorylates the transducer protein Rad9, the recruitment of which further requires 




effector kinases Rad53 and Chk1 for recruitment to the damage site where they are 
phosphorylation. Rad53 and Chk1 start two pathways acting in parallel to arrest the cell 
cycle and initiate damage repair through shared mechanisms. Rad53 is thought to partially 
manage this through activation of the kinase Dun1 (Gardner et al., 1999; Sanchez et al., 
1999). These pathways include the maintenance of CDK activity, and the inhibition of mitotic 








Figure 1.6. The G2/M DNA damage checkpoint in S. cerevisiae 
(A) DSBs are initially processed by the activity of the MRX complex, Tel1, and Sae2. (B) 
DNA is resected 5’ to 3’ by exonuclease activity creating long stretches of ssDNA, which is 
bound by the RPA complex. RPA bound ssDNA acts to recruit the damage sensor kinases 
Mec1 (through Ddc2) and the 9-1-1 complex. (C) Once recruited the 9-1-1 complex acts to 
phosphorylate Rif1 and promote recruitment of the kinase Rad9 and the effector kinase 
Rad53. Rad53 and Rad9 create an auto-phosphorylation loop and Rad53 interacts with 








1.7 The Spindle Checkpoint 
The spindle-assembly checkpoint (SAC) was first identified by screens searching for 
mutations allowing budding yeast cells to bypass mitotic arrest in the presence of spindle 
poisons. Identified by these screens were the genes MAD1, MAD2, MAD3 (BUBR1 in 
humans), and BUB1. A further gene was identified, BUB3, as an extra-copy suppressor of 
the mutation bub1-1 (R. Li and Murray, 1991; Hoyt et al., 1992). These genes are conserved 
across all eukaryotes and are involved in the SAC, a prometaphase pathway which acts to 
prevent the separation of sister chromatids (Taylor et al., 2004). The SAC functions to detect 
potential defects in chromosome separation by monitoring the attachment of spindle-
microtubules to the kinetochores, and the tension that is generated by proper spindle 
attachment to connect the kinetochores and spindle pole bodies.  
The SAC acts to target Cdc20, a co-factor of the ubiquitin ligase complex, the APC/C. This 
creates the formation of the mitotic checkpoint complex (MCC), made up of Mad2, Mad3, 
Bub3, and Cdc20 (Hwang et al., 1998; Sudakin et al., 2001). Alternatively, the SAC proteins 
Mad1, Bub1, Mps1 and Aurora-B function to amplify the SAC signal and rate of MCC 
formation. After exposure to spindle poisons the components of the SAC, including the MCC, 
concentrate at the kinetochore in prometaphase. However it does not appear that the MCC 
simply sequesters Cdc20 at the kinetochore, as the MCC is found bound to the APC/C after 
SAC activation (Sudakin et al., 2001; Morrow et al., 2005). It instead appears that Mad2 
facilitates the binding of the components of the MCC, whilst Mad3 reduces the ability of the 
APC/C to recruit cyclin B1 and securin by interfering with substrate binding (Burton and 
Solomon, 2007). This inhibits the ubiquitin-ligase activity of the APC/C, and in turn inhibits 
the ubiquitination of Cyclin-B & Securin, which would usually constitute a signal for their 
degradation (Peters, 2006). This functions to inhibit mitotic progression in two ways: 
• The proteolysis of cyclin B serves to inactivate Cdk1, which promotes mitotic exit. 
Without ubiquitination of Cyclin B, Cdk1 remains active. 
• Securin continues to inhibit the activity of the protease separase. Separase activity is 
required to cleave the cohesin complex holding sister chromatids together, and 
thereby activate anaphase. 
Through these two actions the SAC prolongs metaphase until all chromosomes have are bi-
oriented between the spindle poles. The extinguishing of the SAC signal upon proper 
kinetochore attachment and tension, appears to be mediated by several factors. Aurora B 




proteins from the kinetochore, through the destabilisation of the kinetochore-microtubule 
attachments. (Gurden et al., 2018). The disassembly of the MCC plays a key role in its 
removal from the kinetochore, a process mediated by Cdc20 ubiquitination and TRIP13 








Figure 1.7 the spindle checkpoint prevents separation of chromatids in the presence 
of unattached kinetochores 
Improperly attached spindles are detected in prometaphase, triggering the assembly of the 
MCC, inhibiting the APC/C/C and preventing cohesin cleavage or mitotic exit. Figure 






1.8 Repair Pathway Choice – Non-Homologous End Joining or 
Homologous Recombination 
The formation of DSBs present severe threats to genomic stability. If broken chromosomes 
are not repaired this can result in the loss of the damaged chromosome during mitosis. 
Broken chromosomes can also become fused to other chromosomes, translocating large 
sections of the genome. Failure of the cells to properly deal with DSBs is a major cause of 
tumorigenesis. Therefore, two pathways have evolved to efficiently manage DSB repair; 
non-homologous end joining (NHEJ), and homologous recombination (HR).  
HR uses homologous sequence as a template to repair the DSB, this is the primary repair 
pathway in the G2 phase when the homologous sister chromatid is available after DNA 
replication. The DNA ends are processed to create resected overhangs that can be used to 
pair with the template invading strand from the sister chromatid. As this process uses 
template DNA, the DSB is repaired with high fidelity. NHEJ, however, does not make use of 
homologous sequence and is the primary repair pathway in G1 phase when a sister 
chromatid is not available. NHEJ uses a simple end-to-end ligation method to re-join the 
DNA flanking the DSB, and as such can be far more error prone, and may introduce small 
deletions and insertions into the sequence.  The processing of the DNA ends of the DSB 
partially dictated pathway choice, with the 5’-3’ resection being the major activity guided by 
Cdk1 (Ira et al, 2004). 
Upon a DSB in yeast the Yku70/Yku80 complex binds broken DNA ends, alongside the 
MRX complex. Typically, a small level of processing takes place to create regions of 
“microhomology”, the yeast DNA ligase complex Dnl4/Lif1 is then recruited to seal the break. 
NHEJ is estimated to account for 25-50% of DSBs in yeast and mammalian cells (L. Chen 
et al., 2001a; Clikeman et al., 2001).  
HR conversely is initiated with extensive 5’-3’ resection at broken ends, initiated by MRX, 
but further resection is carried out by Exo1 and Sgs1/Dna2, promoted by Cdk1 (Mimitou and 
Symington, 2008; Zhu et al., 2008). These extensive 3’ ssDNA tails are then coated by RPA, 
which is in turn displaced by Rad51 in a process mediated by Rad52, Rad55, and Rad57. 
The Rad51 bound filament facilitate the search for suitable regions of homology, both double 
stranded and single stranded. Srs2 helicase then strips Rad51 from the ssDNA to allow 
base-pairing of the complementary and invading strands, and the subsequent strand 
extension by DNA polymerase (Sugawara et al., 2003). Interestingly, whilst this process is 




involved in DSB repair are more error-prone than replicative polymerases, and point 








Figure 1.8 Pathways to repair DSBs by NHEJ or HR. 
Schematic of the NHEJ and HR pathways to repair DSBs. Low levels of end processing in 
NHEJ allow Lif1 and Dnl4 to act to religate the DNA ends to repair the chromosome. In HR 
end-processing is more substantial to create regions of homology to sister chromosomes. 
These tracts of resected DNA are coated in Rad51 which helps to perform strand invasion, 
and the sister chromosome is used as a template for strand extension. Figure adapted from 






1.9 Down regulating the Checkpoint 
The DNA checkpoint signal is intended to arrest the cell cycle and allow the time for cells to 
repair before continuing to proliferate. If the repair process is successful, then the checkpoint 
signal is extinguished, and the cells re-enter the cell cycle; this process is known as 
checkpoint recovery. However, if mechanisms exist to turn off the checkpoint signal in the 
case of repair, are these mechanisms ever co-opted and activated without the necessary 
repair step taking place?  
 
1.9.1 Checkpoint Adaptation  
In the persistence of damage, such as an unrepairable DSB, cells re-enter the cell cycle 12-
14h after arrest is initiated. This process is known as checkpoint adaptation and was first 
observed in budding yeast after the induction of an irreparable DSB near a telomere in wild 
type cells leading to elimination of the telomere (Sandell and Zakian, 1993). These cells 
were seen to arrest at G2/M initially, however it was seen that the majority of the cells were 
able to escape this arrest and resume the cell cycle despite the broken chromosome 
(Sandell and Zakian, 1993). It was even observed that this chromosome could be normally 
replicated and segregated for up to 10 cell divisions without triggering subsequent cell cycle 
arrest. Genes required for adaptation of the checkpoint can therefore be easily screened 
with this assay, as adaptation-defective mutants will remain arrested in G2/M indefinitely 
(Toczyski et al., 1997).  
A number of genes have been shown to be required for proper checkpoint adaptation. 
Amongst those first identified were CDC5, encoding an essential polo-like kinase which 
controls activation of the MEN, and CKB1 and CKB2, non-essential sub-units of casein 
kinase II (Toczyski et al., 1997). The Yku complex was also shown to be required for 
checkpoint adaptation independently of CDC5; yku70∆ cells were shown to have 
significantly increased resection at the unrepairable DSB, however the adaptation-deficient 
phenotype of these cells was suppressed by the deletion of MRE11, which led to reduced 
resection at these sites (S. E. Lee et al., 1998). The helicase genes SRS2 and SAE2 were 
also found to be required for adaptation. This has been shown to be related to the role of 
Sae2 in removing the MRX complex from DNA, without Sae2 this complex is not efficiently 
removed and leads to increased resection (H. Chen et al., 2015). Interestingly, whilst many 
adaptation-defective mutants are also strongly defective in checkpoint recovery (srs2∆, 




(ckb1∆, ckb2∆, yku70∆, cdc5-ad), this implies that different aspects of checkpoint adaptation 
may function through independent pathways (Vaze et al., 2002).  
It has been shown that during adaptation Ddc2 foci dissociate from damage sites, 
suggesting Mec1 activation and localisation is a governing factor in adaptation (Melo et al., 
2001). This supports that recovery from checkpoint arrest is generally reliant upon the 
removal of the checkpoint signal, and inactivation of effector kinases such as Rad53 and 
Chk1. However, it has since been suggested that many of the mechanisms controlling 
checkpoint adaptation are targeted towards the control of the effector kinases, rather than 
Mec1 binding. In cells undergoing checkpoint adaptation, loss of phosphorylation of Rad53 
and Chk1 can be seen to correlate to adaptation, and in the checkpoint adaptation-defective 
yku70∆ and cdc5-ad mutants Rad53 is seen to remain phosphorylated (Pellicioli and Foiani, 
2005; Clerici et al., 2006). It has been further shown that the hyper-phosphorylation of Rad53 
in response to DSBs is modulated in order to control the adaptation process. Studies 
removing the PPC2-like phosphatases PTC2 and PTC3 led to defects in adaptation. These 
were further shown to directly interact with the forkhead-associated domain 1 (FHA1) of 
Rad53. This interaction was modulated by CKB1 and CKB2, deletions of which are known 
to defective for checkpoint adaptation (Leroy et al., 2003; Guillemain et al., 2007). Cdc5 has 
also been shown to attenuate the phosphorylation of Rad53 during ongoing checkpoint 
arrest (Vidanes et al., 2010). It has therefore been suggested that Cdc5 may act in the same 
pathway as casein kinase II and the PPC2-like phosphatases, as inhibition of Cdc5 or Ptc2/3 
is capable of completely eliminating adaptation (Toczyski et al., 1997; Leroy et al., 2003; 
Syljuasen, 2007).   
There is a potential alternative hypothesis for the mechanism of adaptation, that is that over 
time the DNA structure triggering the checkpoint response, and the associated proteins, are 
modified into a non-signalling structure (Clemenson and Marsolier-Kergoat, 2006). This may 
be supported by the removal of the Mec1-Ddc2 complex from ssDNA, despite mechanisms 
in place to remove phosphorylation of Rad53 (Melo et al., 2001). The adaptation-defective 
phenotype of mutants affecting end processing activity such as sae2∆, srs2∆, and yku70∆. 
Srs2 was shown to remove Rad51, a signal for homologous recombination, from the DSBs 
during adaptation (Krejci et al., 2003; Veaute et al., 2003). Sae2 and Srs2 may also be 
involved in the removal of Mec1-Ddc2 from the ssDNA (Harrison and Haber, 2006). This 
hypothetical pathway would not be exclusive from the removal of phosphorylation from 




for up to 10 subsequent divisions without activation of the checkpoint signal, despite rising 
and falling Cdc5 activity throughout the cell cycle (Schleker et al., 2010).  
 
1.9.2 Anti-checkpoint Proteins 
Anti-checkpoint functions were first suggested at telomeres by Michelson et al., (2005) as a 
mechanism to prevent or reduce the initiation of a checkpoint signal (Michelson et al., 2005). 
It was previously observed that rapid elongation of telomeres, as well as shortening, was 
capable of activating the DNA damage checkpoint (IJpma and Greider, 2003; Viscardi et al., 
2007). Therefore, it was hypothesised that during the normal cell cycle the telomeres must 
have systems in place to recognise normal telomere homeostasis and prevent unnecessary 
delays in the G2/M transition from inappropriate over-activation of the checkpoint, 
particularly given the involvement of the Mec1 and Tel1 kinases in telomere replication. This 
study found that tracts of telomeric repeats adjacent to an induced DSB were capable of 
reducing the resulting checkpoint signals. This attenuated arrest was not the result of 
reductions in resection, nor successful repair or adaptation. This suggests that these repeats 
(and the telomeres themselves) act as a repository for factors capable of turning-down the 
checkpoint response. This is further supported by observations that after the induction of a 
DSB, resection must occur for several kb before a checkpoint signal is initiated, and that the 
ssDNA generated in cdc13-1 is as potent as a DSB. This implies that cells may have a 
threshold of ssDNA that must be reached before a checkpoint response is initiated, this may 
imply a role for anti-checkpoint proteins in setting this threshold, predicted to be 
approximately 10kb of ssDNA (Pellicioli et al., 2001; Vaze et al., 2002; Zubko et al., 2004). 
A number of studies have implicated Rif1 as playing an anti-checkpoint role in budding 
yeast, a role which will be discussed in detail later in this chapter (Chapter 1.10.4) 
(Anbalagan et al., 2011; Xue et al., 2011; Mattarocci et al., 2017). 
 
1.9.3 The purpose of adaptation & anti-checkpoints 
The question arising from checkpoint adaptation and anti-checkpoint proteins is relatively 
simple; why would these mechanisms exist and allow cells to proceed with irreparable 
damage? As previously discussed, many of the mechanisms for adaptation are independent 
from the checkpoint recovery process, therefore is not as simple as a misregulation of the 
checkpoint recovery pathways. Adaptation has been shown to promote the mis-segregation 
of acentric chromosome fragments in up to 95% of divisions, even leading to mis-




Kaye et al., 2004). This is a source of substantial genomic instability for these cells, so why 
has it evolved? It has been suggested that it may allow yeast cells the opportunity to repair 
damage in the following cell cycles, thereby increasing the individual cell’s odds of survival. 
It may also be a mechanism of generating genetic and phenotypic diversity. With this 
reasoning, it could be seen therefore how this may have been an evolutionary advantage 
for unicellular organisms such as budding yeast.  
Checkpoint adaptation is also been suggested in multicellular organisms. Studies suggested 
that adaptation is seen in Xenopus egg extracts in response to the replication inhibitor 
aphidicolin through interference with an interaction between claspin and the polo-kinase Plx 
(Yoo et al., 2004). Further studies have also suggested that human cells may demonstrate 
checkpoint adaptation in response to genotoxic stresses such as radiation (Syljuasen et al., 
2006). The genomic instability this introduces may be a driving factor in cancer development 
and as such is of greater risk to the organism. It has been suggested that the pathway may 
exist to drive the cell through the cell cycle until either the damage is sufficiently extensive, 
or the cell is in the correct phase that apoptosis can be triggered (Lupardus and Cimprich, 
2004). The risk introduced by this, and the increased genomic instability, may be a driving 





1.10The Roles of Rif1 in Eukaryotes 
1.10.1 Structural Conservation of Rif1 
Rif1 was first discovered at the telomeres in budding yeast, as an interacting factor of the 
telomeric protein Rap1. Here it acts to maintain telomere length as well as play a role in the 
negative regulation of telomeric silencing, as described earlier in this chapter (Hardy et al., 
1992). Since discovery Rif1 has been found to be conserved across a range of higher 
eukaryotes, as well as being involved with a multitude of pathways both in yeast and other 
species. As Rif1 contains multiple function-related domains, this subchapter will first detail 
the conservation of the gene and protein across higher eukaryotes before detailing some of 
the major functions in which it has been found to play a role.  
RIF1 homologs were discovered first in other yeast species such as Schizosaccharomyces 
pombe, where it was found to function alongside Rap1 at the telomeres and also assists in 
regulation of telomere elongation (Kanoh and Ishikawa, 2001). This was later expanded to 
mice, where it was found to be highly expressed in mice ESCs, also associating with 
telomeres. Eventually a homolog was demonstrated in humans, associated with damaged 
DNA (Adams and McLaren, 2004; Silverman et al., 2004; Xu and Blackburn, 2004). 
Phylogenetic analysis conducted by Sreesankar et al., (2012) identified RIF1 homologues 
in a total of 92 different species, 54 of these were in fungal species, 18 insects, and 16 were 
vertebrate species. This analysis suggested that insect and vertebrate RIF1 were more 
closely related to each other than they were fungal species. They did not however discover 
any Rif1 homologues in plant species (Sreesankar et al., 2012). This study identified a 
number of conserved domains which were later shown to correspond to shared functions of 
Rif, as well as the identification of specific domains seen in RIF1 for functions related only 
to vertebrates.  
Running from the N-terminal region of the protein in all species through approximately 1000 
amino acid residues of the protein are the HEAT repeats. Although there is general poor 
sequence homology in these repeats, a highly conserved Rif1-specific region of 101-149 
residues was identified (Sreesankar et al., 2012). The HEAT repeats are found in a diverse 
array of proteins and was named for the four in which it was first found (huntingtin, elongation 
factor 3, PR65/A, TOR). The most common function of these domains is in mediating 
protein-protein interactions, however, they are seen to be involved in a wide diversity of 




The phylogenetic analysis of RIF1 was the first study to identify the presence of RVxF-SILK 
domains within the Rif1 protein, highly conserved across species with varying lengths 
between the two domains (Sreesankar et al., 2012). RVxF-SILK domains are the consensus 
docking motif required for interaction with phosphatases of the PP1 family, an interaction 
earlier discovered in mammalian Rif1 by affinity chromatography (Egloff et al., 1995; 
Moorhead et al., 2008; Hendrickx et al., 2009). Interestingly, this domain appears to have 
moved within the protein across the course of evolution. In fungal species this domain is 
found at the N-terminal region in the structure SILK-RVxF, whereas in higher eukaryotes it 
appears to have moved to the C-terminal region and flipped to the structure RVxF-SILK. 
This domain has since been confirmed to interact with proteins of the PP1 family to carry 
out a global role in replication timing, a function which will be discussed in further detail.  
The third major conserved domain shown in Rif1 by this study was a DNA-binding domain 
in the C-terminal region (in all studied species). This domain had been earlier identified in 
mammalian Rif1 with homology to the alpha-CTD of bacterial polymerases. The DNA-
binding capability has only been demonstrated in RIF1, this domain was later identified as 
being present in all RIF1 homologues (Xu et al., 2010; Sreesankar et al., 2012; Mattarocci 
et al., 2016). 
In budding yeast, the interaction of Rif1 with Rap1 has been shown to be via a short alpha-
helical peptide motif referred to as the Rap1-binding-module (RBM) that is found close to 
the C-terminal domain of Rif1. This interaction is further controlled by a lower affinity site 
created through a tetramer-forming C-terminal domain (Shi et al., 2013).  
Interestingly, it appears that the telomeric role of Rif1 may only be seen in fungal species. 
There is no evidence that Rif1 is found at the telomeres of multi-cellular organisms outside 
of damage. In mammals, RIF1 has instead been shown to localize to sites of DNA damage, 
the loss of the protein leads to increased cell sensitivity to ionizing radiation, reduced HR-


































































 Xu and Blackburn, 2004; Buonomo et al., 2009; Wang et al., 2009). From this RIF1 has 
been determined in mammalian cells to play a key role in repair pathway choice.  
 Recent studies suggest that the telomeric functions of Rif1 may actually be an evolutionary 
divergence from the original function of the protein. Rif1 has been shown to play a highly 
conserved global role in replication timing, acting to delay the firing of origins of replication, 
which may be the original protein function. Furthermore, the increased evidence for Rif1 as 
a checkpoint-interacting factor in yeast as well as mammalian cells suggests this may also 
be a somewhat conserved role for the protein. It may be that yeast species adopted yeast 








Fig1.10.1 The conservation of Rif1 structural domains in eukaryotes. 
Models of Rif1 demonstrating the protein structure in humans and budding yeast. The blue 
domain represents a sequence with homology to a region found alpha-bacterial 
polymerases and is shown to be capable of DNA binding in RIF1. Adapted from Mattarocci, 






1.10.2 Rif1 in Replication Timing 
Thus far the only truly global role of Rif1 is in control of replication timing. In eukaryotes, 
DNA replication is initiated from specific genomic sites known as origins of replication, these 
origins begin replication (firing) during S-phase according to a program determined by cell 
types and developmental stage. If this program is dysregulated then the premature firing of 
normally late-firing, or dormant origins can lead to activation of the DNA damage response, 
hypothesised to be likely due to replication fork stalling as a consequence of depletion of 
dNTPs (Mantiero et al., 2011). This firing process is best understood in budding yeast where 
origins of replications are well defined, along with a constitutively bound complex termed the 
Origin Recognition Complex (ORC). Prior to firing the pre-replication complex (pre-RC) is 
formed at origins by the addition of Mcm2-Mcm7 hexamer, a replicative helicase. This 
complex then requires activation, critical for activation is the action of two kinase complexes, 
Cdk1 and DDK (Dbf4-Dependent Kinase). DDK is made up of Cdc7 kinase and the activator 
subunit Dbf4, whilst Cdk1 is required for the phosphorylation of associating proteins the role 
of DDK is primarily to phosphorylate the Mcm4 subunit (Sheu and Stillman, 2006). The 
phosphorylation of Mcm4 leads to recruitment of the key protein factors Cdc45, Sld2/Sld3, 
and the GINS complex (Heller et al., 2011; Tanaka and Araki, 2011).   
The potential role for Rif1 in origin firing was first suggested by the association with 
telomeres. Despite the presence of numerous potential origins close to telomeres, they are 
known to replicate late in the S-phase. Whilst this was initially thought to be due to the 
silencing effect created by histone modifications due to Sir3 and Yku70/Yku80, it was also 
revealed that mutation of Rif1 lead to earlier telomere replication independent of this 
pathway (Donaldson, 2005; Lian et al., 2011). Interestingly, despite the most detailed model 
of origin firing coming from budding yeast, the role of Rif1 in replication timing was seen in 
S. pombe and mammalian cells first. In these species, it was noted that the depletion of Rif1 
equivalent led to the loss of replication timing programs (Cornacchia et al., 2012; Hayano et 
al., 2012; Yamazaki et al., 2012). This affected both early and late firing origins, with early 
firing origins firing later and late firing origins firing early.  
The mechanism by which Rif1 controls replication timing was then further elucidated using 
the budding yeast model system, where rif1∆ mutation was confirmed to partially suppress 
temperature sensitivity of cdc7-1 cells (S. Hiraga et al., 2014). These studies determined 
that an interaction between Rif1 and PP1, in yeast the protein Glc7, via the conserved RVxF-
SILK motifs in Rif1 were responsible for controlling this timing. These models proposed that 




mediated phosphorylation of Mcm4, thereby delaying origin firing. As S-phase progresses 
DDK activity becomes higher and Rif1 is itself phosphorylated by DDK to interrupt the 
association with Glc7. The repressive effect on the origin in question is lifted and replication 
is initiated (Davé et al., 2014; S. Hiraga et al., 2014; Mattarocci et al., 2014). The conserved 
PP1-interaction domains found in Rif1 were later confirmed to reflect the conserved 
interaction, carrying out this role in multiple species (S. I. Hiraga et al., 2017; Sukackaite et 
al., 2017).   
Whilst the mechanism of inhibition was clear, these studies did not answer how Rif1 was 
targeted to specific origins of replication within the chromosome, outside of subtelomeric 
origins. However, the ability of Rap1-bound Rif1 to inhibit origins in the subtelomere may 
indicate an ability to act on multiple origins over distance, it is also noteworthy that deletions 
of regions of the HEAT repeats within the N-terminal of Rif1 were found partially suppress 
temperature sensitivity of cdc7-1, independent of the presence RVxF-SILK repeats. This 
suggested a role for protein-protein interactions outside of PP1 in this function. Furthermore, 
mammalian Rif1 appeared to be capable of controlling chromatin organisation, suggested 
that sequestration of late firing origins may be a further mechanism of regulation (Cornacchia 
et al., 2012; Yamazaki et al., 2012).  
This origin selection has since been suggested to be partially managed via the presence of 
G-quadruplexes near late firing origins of replication. G-quadruplexes are secondary DNA 
structures formed by non-Watson-Crick base paring between guanine residues and 
frequently occur in guanine-rich regions of DNA, such as telomeres. Sequences containing 
G-quadruplexes have been seen to be conserved and are frequently associated with 
genomic features in budding yeast (Capra et al., 2010). A study by Kanoh et al., (2015) 
suggested that Rif1 recognises and binds G-quadruplex structures within the chromosome. 
They hypothesised that the binding of Rif1 to multiple G-quadruplex may reorganize local 
chromatin structure to exert long-range effects on multiple late-firing origins (Y. Kanoh et al., 
2015). Interestingly, it appears that Rif1 may act as a multimer in order to carry out this 
function. It was previously noted that in budding yeast Rif1 the CTD domain may form a 
module for tetramerization, this was recently seemingly confirmed in S. pombe, alongside 
the importance of both a high-specificity region of the C-terminal and a lower-specificity 
region of the HEAT repeats for binding G-quadruplex structures (Shi et al., 2013; Kobayashi 
et al., 2019). Together these data suggested that Rif1 is capable of binding internal 
chromosomal regions by means of G-quadruplexes, from this it sequesters multiple late-




budding yeast suggested that whilst free Rif1 is capable of delaying the firing of origins at 
chromosome-internal loci, the telomere sequestration acts as a limiting factor and this likely 
also has the secondary effect of maximising the control of the late-firing telomere-proximal 
origins (Hafner et al., 2018). 
Studies in both yeast and mammalian cells have suggested that the role of Rif1 in replication 
timing have numerous effects on genomic stability during replication, as well as on the 
chromatin structure. It has been suggested that in S. pombe short internal telomeric repeats 
may be capable of binding the shelterin complex, of which Rif1 is a component, to control 
heterochromatin structure and replication timing (Zofall et al., 2016). In budding yeast it has 
been shown that Rif1-dependent inhibition of rDNA replication plays a critical role in genomic 
stability by controlling replication fork progression through these difficult regions (Shyian et 
al., 2016). Interestingly, in mammalian models it has recently been shown that Rif1 has 
secondary roles in replication outside of blocking initiation. It appears to play critical roles in 
the stabilisation of newly synthesised DNA, and in slowing the progression of replication 
forks through difficult to replicate regions (Munden et al., 2018). This role appears to also 
be dependent on the interaction with PP1, and acts to prevent degradation of synthesised 
DNA at stalled replication forks (S.I. Hiraga et al., 2018; Garzón et al., 2019). 
The global conservation of this role, including the conserved mechanism, would seem to 
indicate this may be the original function of Rif1 protein. This mechanism appears to make 
use of many of the structures that have become involved in alternate functions of the protein 
that have been shown. It would therefore appear that the other roles of the protein may have 









 Figure 1.10.2 Rif1 suppresses initiation at origins of replication  
A schematic model of Rif1 suppression. Rif1 may alter chromatin structure through 
interaction with G-quadruplexes located proximal to origins of replication to suppress the 
firing of multiple origins. At suppressed origins Rif1 & PP1 counter-act DDK-mediated 
phosphorylation of the pre-RC. Phosphorylation of Rif1 regulates the PP1 interaction. Figure 






1.10.3 Rif1 at DSBs in Mammalian Cells 
Early observations of RIF1 in mammalian cells quickly observed that RIF1 had no role at 
the telomeres during the normal cell cycle. It was, however, observed that human RIF1 
localized to damaged telomeres, and that after the induction of DSBs RIF1 was seen to co-
localise with DDR factors dependent upon ATM and 53BP1 (Silverman et al., 2004). 
Inhibition of RIF1 activity was noted to lead to defects in the intra-S checkpoint and 
increased sensitivity to DNA replication stress (L. Xu and Blackburn, 2004; Buonomo et al., 
2009).  
RIF1 was quickly shown to have a key role in repair pathway choice at DSBs in human cells. 
It is recruited by a phosphorylated domain of 53BP1, itself dependent on ATM activity, where 
it is targeted to block resection of the 5’ strand (Di Virgilio et al., 2013; Zimmermann et al., 
2013). Depletion of RIF1 was further shown to be capable to suppress the resection and 
RAD51 defect in BRCA1-depleted cells (Escribano-Diaz et al., 2013). This activity acts to 
promote NHEJ in the G1-phase of the cell cycle. During S-phase it is shown that CDK1 
dependent phosphorylation of CtIP causes its association with BRCA1, which act 
antagonistically to displace the RIF1-53BP1 complex from the DNA ends and promote 
resection by the MRN complex (Chapman et al., 2013). 
Initial reports of the function of Rif1 at yeast DSBs, published by our lab, did not seem to 
indicate a role (Xue et al., 2011). However, since this time there has been contradictory data 
published, which may indicate Rif1 is present at budding yeast DSBs. The role Rif1 plays at 
these sites remains unclear, whilst there has been suggestion that Rif1 cooperates with the 
MRX complex to promote DNA-end resection, in contrast to its role in mammals, other data 
has suggested Rif1 may act as a mediating gateway, encasing DNA ends and limiting 
access of various factors (Martina et al., 2014; Mattarocci et al., 2017). The latter of these 
roles is hypothesised to be related to the previously described anti-checkpoint function of 
Rif1 which will be a core element of this study.  
 
1.10.4 Rif1 as an Anti-checkpoint Protein in Budding Yeast 
Induction of DSBs adjacent to telomeric repeats first suggested a potential role for Rif1 as 
an anti-checkpoint protein in budding yeast. These strains showed that both Rif1 and Rif2 
were required to aid in the proper capping of short telomeric repeats. Furthermore, they also 




and that Rif1 function may have stimulated checkpoint recovery at unprotected ends 
(Ribeyre and Shore, 2012).  
The mechanism behind this, on which the following work is based, was studied in further 
depth by Xue, et al., (2011). This work used the cdc13-1 model to establish that during 
telomere uncapping in these strains, rif1∆ mutants exacerbate the temperature sensitivity 
phenotype of cdc13-1, independent of deletion of rif2∆ which has no effect on these cells. 
Interestingly, this phenotype appears to be dosage dependent as overexpression of RIF1 
was shown to lead to decreased temperature sensitivity. Furthermore, a partial RIF1 mutant 
containing deletions of the C-terminal was used for its inability to bind the protein Rap1, this 
mutant does not affect the temperature sensitivity of cdc13-1 (Xue et al., 2011).  
Whilst Rif1 does not appear to affect the resection of cdc13-1 uncapped telomeres, this 
study found Rif1 binding to resected regions, including single gene loci. Depletion of RIF1 
also led to increases in recruitment of checkpoint proteins to these resected regions. Further 
to this, induction of RIF1 was capable of leading to termination of an ongoing G2/M arrest. 
Together these data indicate that Rif1 is capable of binding to regions of ssDNA, and out-
competing the recruitment of checkpoint proteins to damaged regions. This was 
hypothesised to functionally shield from a checkpoint response and act as a molecular band-
aid to damaged DNA (Xue et al., 2011).  
A recent study, published after the onset of this project, determined the crystal structure of 
regions of the Rif1 protein and their ability to bind DNA in the absence of complexed proteins 
such as Rap1. The Rif1 protein is formed of a “HOOK and SHAFT” like structure, assembling 
in vitro as Rif1 head-to-tail dimers around short tracts of DNA containing ss/dsDNA 
junctions. The HOOK region of Rif1 contained two insertion loops on the concave face and 
was shown to be highly conserved across all orthologs. These loops create a region of 
positive charge within the hook for DNA backbone contact. The SHAFT region of the dimer-
mate was proposed to then act as a lid and close over this interaction, encasing the DNA. 
This study showed that mutations of the HOOK region decreased the Rif1 association to 
telomeric repeats flanking an inducible DSB, and an increased delay in recovery from G2/M 
arrest. Furthermore, it was also demonstrated that this mutation also decreased NHEJ 
efficiency of cells. These mutants matched closely to the behaviour of rif1∆ mutants in 
cdc13-1 cells, increasing the sickness of cells and lowering the restrictive temperatures, 
without effecting the length of the telomeric repeats. Together this further supports the role 
of Rif1 in protecting vulnerable telomeres from a checkpoint response, as well as suggest 




However, the particular molecular mechanisms behind this process remain unclear. The 
potential impact this role could have on genomic instability if left unchecked is clear. 
Overexpression of RIF1, or misregulation of function, may allow cells to continue 
propagating with significant levels of damage. This is particularly important if this role is 
determined to be conserved into mammalian cells. Preliminary data produced by the 
Maringele lab has suggested potential phosphorylation events within Rif1 occur during 
telomere uncapping in cdc13-1 (Maringele, unpublished), my study focused around the 









Figure 1.10.3 Rif1 binds to damaged DNA to shield from recognition by checkpoint 
proteins 
(A) Schematic model from Xue et al. (2011) proposing the binding of Rif1 to regions of 
ssDNA after telomere uncapping to suppress the DDR. (B) Crystal structure of Rif1-NTD 
and Rif1 dimer, showing the HOOK and SHAFT structure to create DNA-binding channels, 
and a schematic model of Rif1 protein showing the amino acid residues comprising the 






The aim of my study is to further investigate the anti-checkpoint role of RIF1 that was 
described by Xue et al. (Xue et al., 2011). My core aim is to better understand the manner 
in which Rif1 carries out this role in Saccharomyces cerevisiae, focusing primarily on the 
regulation of activity. The initial examination of this activity was in the telomere-cap defective 
mutant cdc13-1 and this will be the primary model studied in this project. I am to determine 
both the regulatory mechanism of Rif1 anti-checkpoint function, suggested to be 
phosphorylation, and the impact this mechanism has upon protein structure and function. 
Furthermore, I would like to determine whether the anti-checkpoint function observed is 
exclusive to telomere uncapping in cdc13-1, or whether it may have wider ranging effects at 
DSBs breaks or in other forms of genomic instability such as impediments to chromosome 
segregation. The following questions will be of specific interest to address in this study: 
 
• Is Rif1 phosphorylated in response to telomere uncapping in cdc13-1 cells? 
 
• Which alternate stress conditions may lead to Rif1 phosphorylation? 
 
• Where does phosphorylation occur within Rif1 structure? 
 
• Which kinases lie upstream of Rif1 phosphorylation? 
 
• What are the molecular and cellular effects of Rif1 phosphorylation on the protein 





Chapter II: Materials and Methods 
 
2.1 Yeast Strains 
Yeast strains used were all of the W303 RAD5+ background, which contains the following 
mutations: ade2-1 trp1-1 can1-100 leu2-3, 112 his3-11,15 ura3 GAL+ psi+ ss1l-d2. Strains 




For 1L YEPD medium: 10g yeast extract, 20g Bacto Peptone were mixed in ~950mL of 
sterile mQ water, for solid medium: 20g bacto agar was added to the mixture. The mixture 
was autoclaved and cooled to 60⁰C before supplemented with 50mL sterile 40% (w/v) 
dextrose and 15mL sterile 0.5% adenine.  
2. Complete minimum medium 
For 1L solid medium: 1.7g of yeast nitrogen base, 5g of ammonium sulphate, 20g of bacto 
agar, and 1.3g of amino acid powder minus the appropriate amino acid (e.g. –leu represents 
a plate containing all amino acids except leucine), were mixed with ~950mL mQ water. The 
mix was autoclaved and cooled to 60⁰C before supplemented with 5mL sterile 40% (w/v) 
dextrose and 15mL sterile 0.5% (w/v) adenine.  
3. Antibiotic selective medium 
400µg/mL of G418 or 100µg/mL Natamycin were added to the cooled YEPD medium mix to 
make G418 or Natamycin containing agar plates. 
4. Sporulation Media 
For 1L liquid media 10g of Potassium acetate, 1.25g of yeast extract, and 1g of glucose 
were mixed in1L of water. The mixture was autoclaved and allowed to cool. 
5. SOC Media 
For 1L liquid media 20g of tryptone, 5g of yeast extract, 0.5g of NaCl, and KCl to a final 
concentration of 2.5mM, were mixed in 950mL of water. The mixture was autoclaved at 




Strain Genotype Source 
LMY59 MATalpha RIF1::MYC::kanMX6  Laura Maringele 
LMY79 MATalpha cdc13-1 RIF1-13Myc::G418 Laura Maringele 
LMY81 MATalpha cdc13-1 rad9::NATMX RIF1-13MYC::G418 Laura Maringele 
LMY83 MATalpha cdc13-1 mec1::TRP1 sml1::HIS3 RIF1-13MYC::G418 Laura Maringele 
LMY152 MATalpha cdc13-1 dun1::HIS3 RIF1-13MYC::G418 Laura Maringele 
LMY348 MATa cdc13- rif1::G418 Laura Maringele 
LMY373 MATa RIF1-C∆-13MYC::kanMX6 Laura Maringele 
LMY510 MATa cdc13-1 RIF1-C∆-13MYC::kanMX6 Laura Maringele 
LMY810 MATalpha cdc13-1 rad53::HIS3 sml1::URA3 RIF1-C∆-13MYC::G418 Laura Maringele 
LMY814 MATalpha cdc13-1 chk1::HIS3 RIF1-C∆-13MYC::G418 Laura Maringele 
LMY819 MATalpha cdc13-1 dun1::HIS3 RIF1-C∆-13MYC::G418 Laura Maringele 
LMY821 MATalpha cdc13-1 mec1::TRP1 sml1::HIS3 RIF1-C∆-13MYC::G418 Laura Maringele 
LMY832 MATalpha cdc13-1 rad9::NATMX RIF1-C∆-13MYC::G418 Laura Maringele 
LMY856 MATa bub13::HIS3 RIF1-C∆-13MYC::G418 This study 
LMY857 MATa mad3::HIS3 RIF1-C∆-13MYC::G418 This study 
LMY858 MATa cdc13-1 bub1::HIS3 RIF1-C∆-13MYC::G418 This study 
LMY859 MATa cdc13-1 mad3::HIS3 RIF1-C∆-13MYC::G418 This study 
LMY912 MATa cdc13-1 HIS3-RIF1-S45C-S57C-S110C-S183C-Y183F-C∆-13MYC::G418 This study 
LMY917 MATa cdc13-1 bar1::HIS6 RIF1-C∆-13MYC::G418 cdc28-as1::LEU2 This study 
LMY943 MATalpha cdc13-1 HIS3::RIF1-S181C-Y183F-C∆-13MYC::G418 This study 
LMY944 MATa cdc13-1 HIS3::RIF1-S181C-Y183F-C∆-13MYC::G418 This study 
LMY962 MATa cdc13-1 HIS3::RIF1-S181C-Y183F-13MYC:G418 This study 
LMY963 MATalpha cdc13-1 HIS3::RIF1-S181C-Y183F-13MYC:G418 This study 
LMY970 MATa cdc13-1 HIS3::RIF1-S45C-S57C-S110C-S183C-Y183F-13MYC::G418 This study 
LMY971 MATalpha cdc13-1 HIS3::RIF1-S45C-S57C-S110C-S183C-Y183F-13MYC::G418 This study 
LMY974 MATalpha cdc13-1 HIS3::RIF1-S45C-S57C-S110C-13MYC::G418 This study 
LMY975 MATa cdc13-1 HIS3::RIF1-S45C-S57C-S110C-13MYC::G418 This study 
LMY1012 MATa cdc13-1 HIS3::RIF1-S45C-S57C-C∆-13MYC::G418 This study 
LMY1023 MATa cdc13-1 HIS3::RIF1-S45C-C∆-13MYC This study 
LMY1060 MATalpha cdc13-1 HIS3::RIF1-C∆-13MYC::G418 This study 
LMY1061 MATalpha cdc13-1 HIS3::RIF1-C∆-13MYC::G418 This study 
LMY1062 MATa cdc13-1 HIS3::RIF1-C∆-13MYC::G418 This study 
LMY1070 MATa cdc13-1 HIS3::RIF1-S57E-S110E-C∆-13MYC::G418 This study 
LMY1071 MATalpha cdc13-1 HIS3::RIF1-S57E-S110E-C∆-13MYC::G418 This study 
LMY1078 MATa cdc13-1 HIS3::RIF1-S57E-C∆-13MYC::G418 This study 
LMY1079 MATalpha cdc13-1 HIS3::RIF1-S57E-C∆-13MYC::G418 This study 
LMY1088 MATa cdc13-1 HIS3::RIF1-13MYC::G418 This study 
LMY1089 MATalpha HIS3::RIF1-13MYC::G418 This study 
LMY1090 MATalpha cdc13-1 HIS3::RIF1-13MYC::G418 rad9::LEU2 This study 
LMY1091 MATalpha cdc13-1 HIS3::RIF1-13MYC::G418 rad9::LEU2 This study 
LMY1095 MATalpha cdc13-1 HIS3::RIF1-S57A-13MYC::G418 This study 
LMY1096 MATa cdc13-1 HIS3::RIF1-S57A-13MYC::G418 This study 
LMY1097 MATalpha cdc13-1 HIS3::RIF1-S57A-13MYC::G418 This study 
LMY1098 MATa cdc13-1 HIS3::RIF1-S57A-13MYC::G418 rad9::LEU2 This study 
LMY1099 MATa cdc13-1 HIS3::RIF1-S57A-13MYC::G418 rad9::LEU2 This study 
LMY1104 MATalpha cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418  This study 
LMY1105 MATa cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418 This study 
LMY1106 MATalpha cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418 This study 




LMY1108 MATalpha cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418 rad9::LEU2 This study 
LMY1109 MATalpha cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418 rad9::LEU2 This study 
LMY1110 MATa cdc13-1 HIS3::RIF1-S57A-S110A-13MYC::G418 rad9::LEU2 This study 
LMY1126 MATa cdc13-1 HIS3::RIF1-S110A-13MYC::G418  This study 
LMY1127 MATalpha cdc13-1 HIS3::RIF1-S110A-13MYC::G418  This study 
LMY1130 MATa cdc13-1 HIS3::RIF1-S110A-13MYC::G418 rad9::LEU2 This study 
LMY1131 MATalpha cdc13-1 HIS3::RIF1-S110A-13MYC::G418 rad9::LEU2 This study 
LMY1142 MATa cdc13-1 HIS3::RIF1-S57E-13MYC::G418  This study 
LMY1143 MATa cdc13-1 HIS3::RIF1-S57E-13MYC::G418 This study 
LMY1144 MATalpha cdc13-1 HIS3::RIF1-S57E-13MYC::G418 This study 
LMY1151 MATalpha cdc13-1 HIS3::RIF1-S57E-S110E-13MYC::G418 This study 
LMY1152 MATalpha cdc13-1 HIS3::RIF1-S57E-S110E-13MYC::G418 This study 
LMY1159 MATalpha cdc13-1 HIS3::RIF1-S110A-C∆-13MYC::G418  This study 
LMY1160 MATalpha cdc13-1 HIS3::RIF1-S110A-C∆-13MYC::G418 This study 
LMY1162 MATa cdc13-1 HIS3::RIF1-S110A-C∆-13MYC::G418 This study 
LMY1163 MATa cdc13-1 HIS3::RIF1-S110A-C∆-13MYC::G418 rad9::LEU2 This study 
LMY1164 MATalpha cdc13-1 HIS3::RIF1-S110A-C∆-13MYC::G418 rad9::LEU2 This study 
LMY1170 MATa cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418  This study 
LMY1171 MATalpha cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418 This study 
LMY1172 MATalpha cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418 This study 
LMY1173 MATa cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418 rad9::LEU2 This study 
LMY1174 MATalpha cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418 rad9::LEU2 This study 
LMY1175 MATalpha cdc13-1 HIS3::RIF1-S57A-C∆-13MYC::G418 rad9::LEU2 This study 
LMY1180 MATalpha cdc13-1 HIS3::RIF1- S110E-13MYC::G418 This study 
LMY1181 MATa cdc13-1 HIS3::RIF1- S110E-13MYC::G418 This study 
DLY9823 MATalpha cdc13-1 rif1Δ2-176-13MYC::HIS3MX6 David Lydall 
 






2.3 Cryogenic Storage of Yeast Strains 
For long term storage yeast strains were frozen at -80⁰C in 15% glycerol in cryotube vials. 
Strains were removed from storage using a sterile toothpick to gently streak frozen samples 
across YEPD plates and then were incubated at appropriate temperatures.  
 
2.4 Mating and Sporulation 
Haploid yeast cells with opposite mating types were mated on YEPD plates my mixing cells 
of each type together. After o/n incubation at 21⁰C cells were transferred to selective plates 
for screening. Cells were subjected to two rounds of selection, the first selective to a marker 
specific to one parent, and the second selective to a marker specific to the other. Diploid 
cells should contain markers from both parents. Diploids were then placed in 2mL of 
sporulation media and sporulation of diploid cells occurred at 23⁰C on a rotating wheel for 
2-3 days. When the culture contained 70% sporulated cells, as examined by phase contrast 
microscopy, the sporulation culture was spun down and washed twice with sterile water at 
1500rpm for 3min. 0.5ml Zymolyase-20T (1mg/mL) solution and 10µL of β-mercaptoethanol 
were added to cultures and incubated overnight at 30⁰C to lyse diploid cells and the sac 
around tetrads. The following day the culture was incubated on ice for 15min with 5mL of 
1.5% NP-40, it was then sonicated 3x for 30s at centrifuged at 300rpm (in a tabletop 
centrifuge) for 10 minutes. Cells were resuspended in 1mL 1.5% NP-40 and the sonication 
and centrifugation repeated as described above. Cultures were diluted at approximately 
1000 spores/mL and 100µL plated on a fresh YEPD plates for 2-3 days. Colonies were 
selected and replica plated on selective media plates to determine the genotype of spores. 
 
2.5 Spot Tests 
Yeast cells were grown O/N in 1mL YEPD liquid media to saturation, in the morning cultures 
were diluted 1:10 in fresh YEPD and grown until the cell concentration reached 2x107/ml, 
as measured via haemocytometer. 200µL of culture was placed into the first column of a 96-
well plate and then 5-fold serial dilutions were carried out via multi-channel pipette until there 
were six columns of cultures. Meanwhile a frog ponder was sterilised in 100% ethanol and 
flamed, then allowed to cool on the bench for several minutes before transferring diluted 
samples to YEPD or selective plates. Transfer of samples was done by lowering the frog 




lifting away. Plates were dried and incubated at the appropriate temperature for several days 
before imagining.  
 
2.6 Gene deletion or modification using Longtine plasmids 
2.6.1 Principle of transformation & generation of DNA cassettes 
Gene deletions and modifications, such as tagging, were performed via in vivo substitution 
of the wild type gene with a PCR fragment amplified from a plasmid. This reaction 
incorporates the PCR fragment via homologous recombination, and as such the PCR 
fragment is required to contain 40bp sequences at both 5’ and 3’ which are homologous to 
the sequence flanking the target gene. For a gene deletion the fragment is comprised of a 
selective marker such as Kanamycin or HIS3, allowing selection of transformed cells.  
For example, the plasmid pFA6a-His3MX6 used in this study contains a gene for the 
production of histidine. The forward primer was designed to anneal the first 20bp of the His3 
gene, but also contained a 40bp sequence homologous to upstream of the target gene of 
interest. The reverse primer then anneals to the last 20bp of the His3 gene and contained 
40bp homology to the target gene. Homologous recombination results in this PCR product’s 
integration into the genome in the place of the target gene, and the deletion of the target 
gene.  
Modifying a gene such as with the addition of a tag uses the same principle as above. For 
example, when tagging RIF1 with MYC::kanMX6 for forward primer anneals immediately 
upstream of the RIF1 stop codon, and the reverse primer anneals shortly downstream. The 
MYC::kanMX6 is therefore integrated and following transcription and translation the Rif1 
protein will contain a Myc-tag at the C-terminal.  
To amplify the cassettes containing selective markers from plasmids, PCR reactions were 
set up in the following manner: 
• 39µl ddH2O 
• 5µL 10x ExTaq Buffer – Takara Bio Inc. 
• 5µL dNTPs (2.5mM) – Takara Bio Inc. 
• 2µL pFA6a-His3MX6 (for example) plasmid (1.5ng/µl stock) 
• 1µl primer mix (4µL dH2O + 1µl forward primer (200µM stock) + 1µl reverse primer 
(200µM stock) 




The PCR reactions were carried out as follows 
1. 94⁰C 4min 
2. 35x cycles 
a. 95⁰C 30sec 
b. 55⁰C 1min 
c. 72⁰C 1.5min 
After the reaction was completed, 4µL PCR product was checked on a 1% agarose gel for 
the correct size. The remaining PCR product was used for the transformation. 
 
2.6.2 High efficiency lithium acetate transformation 
Yeast cells were inoculated in 5ml YEPD liquid medium and grown overnight on a roller at 
21⁰C. The overnight culture was counted using a haemocytometer and was diluted to a cell 
density of 5x106 cells/ml in 50ml of YEPD medium. The culture was then incubated at 21⁰C 
with shaking for 4-7h until cell density reached 2x107 cells/ml. Cells were then harvested in 
a sterile 50ml tube at 3000g for 3min and resuspended in 25ml sterile water and centrifuged 
again as before. Cells were then resuspended in 1ml 1xLiAc (freshly diluted in TE) and 
transferred to a 1.5ml Eppendorf tube.  Cells were pelleted at 14000rpm for 15sec and the 
LiAc removed by aspiration. Pellets were resuspended in 400µl 1xLiAc to give a total volume 
of 500µl and kept on ice. For each transformation reaction 50µl of cell suspension was 
pelleted at 14000rpm for 15sec, and the LiAc removed by aspiration. The ingredients of the 
transformation mix were added in the following order: 
• 240µL 50%(w/v) PEG 4000 
• 36µL 10x LiAc (1M) 
• 50µl 2mg/mL salmon sperm DNA (boiled for 5min and chilled in ice) 
• 50µL purified PCR product (diluted 1:5 in dH2O) 
The mixture was vortexed vigorously and incubated for 30min at 23⁰C. It was then 
transferred to a 42⁰C water bath for a 20min heat shock (reduced to 5-10min for 
temperature-sensitive strains). Cells were pelleted at 6000rpm for 15sec and the 
transformation mix removed by aspiration, the cells were then resuspended in 200µl sterile 




were selected for testing, those cells with markers containing antibiotic resistance were first 
allowed to grow for 24hrs on YEPD plates before replica plating to a selective plate.  
Colonies grown were streaked on fresh plates and verified for gene deletion or modification 
using a hot-start PCR method. 
 
2.6.2 Hot-Start PCR test of colony transformation 
To determine the presence of the wild type gene or gene deletion/modification in cells, a 
hot-start PCR was performed on freshly grown cells. A forward primer was designed to bind 
upstream of the target site (P1), and two reverse primers were designed; one to bind within 
the WT gene (P2), and one to bind within the gene deletion cassette (P3), both designed to 
produce fragments of different length in use with P1. Therefore P1 & P2 will produce a PCR 
fragment within the WT gene of a known length, and P1 & P3 would produce a PCR fragment 
of a different length in transformed cells. The presence of the WT or deleted/mutated gene 
could therefore be easily distinguished. 
Hot-start PCR master-mix for each reaction was set up as follows: 
• 15µl dH2O 
• 2.5µl Hot Start Taq Buffer – Qiagen 
• 2.5µl dNTPs (2.5mM) – Takara Bio Inc 
• 0.25MgCl2 (25mM stock) – Qiagen 
• 0.5µl primer mix (4µl dH2O + 1µl P1 primer (200µM stock) + 1µl P2/3 (200µl stock) 
• 0.25µl Hot Start Taq Polymerase (Units) – Qiagen 
• 1µl fresh yeast cells diluted in dH2O (Small cluster of cells collected using a toothpick 
and diluted in 10µl dH2O) 
The PCR reactions were carried out as follows: 
1. 94⁰C 15 min 
2. 35x cycles 
a. 94⁰C 30sec 
b. 56⁰C 20sec 
c. 72⁰C 30sec.  




2.7 Western Blot 
2.7.1 Buffers 
TBS stock was produced using Sigma-Aldrich Tris-Buffered Saline tablets, 2 tablets were 
added to 1L of mQ water and left to dissolve overnight, for TBST 1ml of Tween 20 was 
added to this. Running and transfer buffers were bought from BioRad and diluted to 1x 
concentration before use, when transferring large proteins, such as Rif1, the running buffer 
was supplemented with 5ml 100% ethanol. Resolving and stacking buffers used in the 
production of polyacrylamide gels was also purchased from BioRad. 
 
2.7.2 Cell Harvest and TCA Protein Extraction or DAPI Staining 
Cells were inoculated in 50ml of YEPD and grown overnight at 20⁰C in an incubator with a 
shaker at 170rpm, if nocodazole is going to be added as part of the time-course DMSO is 
also added to 1%. In the morning cells were counted using a haemocytometer and diluted 
to 1x107 cells/ml in 50ml of YEPD, 20ml samples were taken for “time 0” samples and 30ml 
of YEPD was added to the flask cultures. Cell concentration was established by 
haemocytometer. The cultures were put at the appropriate temperature, and nocodazole 
added to 1% from 100x stock if required. 20ml samples were taken at 2-hour intervals. 
For DAPI staining, 500µL of cell culture was spun at 13000rpm in a benchstop centrifuge 
for 10sec. The pelleted cells were then resuspended in 500µL of 70% ethanol and 
refrigerated. Cells were washed twice with 500µL of water, using 8s of centrifugation in a 
benchtop centrifuge to pellet cells. They were then resuspended in 500µL DAPI mix 
(0.2µg/mL dissolved in water). The solution was sonicated at an amplitude of 5microns for 
3sec. 8µL was then placed on a glass slide and covered with a coverslip and examined with 
fluorescence microscopy. Cells were classified into the five following categories, at least 100 
cells were counted from each sample.  
     
1 2 3 4 5 









mother cell.  
Single nucleus 
Two buds, two 
nuclei 
None of the 
other types. 




20ml samples taken for TCA extraction were spun at 3000rpm for 2min and resuspended in 
1ml cold 10% (w/v) TCA. Each sample was split in half, with 550µl into each 1.5ml screw-
cap tube and spun at 13000rpm for 10sec. The pelleted cells were stored at -80⁰C prior to 
protein extraction.  
Cells were resuspended in 250µl 10% (w/v) TCA, they were then ribolysed with 250µl glass 
beads using the following program three times with 5min gaps between: 
6500(rpm) – 3x10sec - 005  
400µl 10%TCA was added and vigorously vortexed. The liquid was then transferred to a 
fresh 1.5ml Eppendorf tube by pipette and centrifuged at 13000rpm for 10min at room 
temperature. Liquid was poured off and the tubes spun again for 5sec, remaining liquid was 
removed via aspiration. 170µl of fresh modified Laemmeli buffer was added, made by the 
following recipe: 
• 2.4ml 2xLB (BioRad) 
• 1.2ml 10% (w/v) SDS 
• 0.4ml 100% glycerol 
• 0.4ml β-mercaptoethanol 
Pellet was resuspended in buffer using a tip to mix, followed by vortexing until homogenous. 
30µl of 1M Tris base pH8.6 was added and vortexed again, if the solution was not blue a 
further 30µl 1M Tris base pH8.6 was added. Samples were boiled at 98⁰C for 5min and spun 
for 10min at 3000rpm. Protein supernatant was transferred to a fresh tube and stored in the 
fridge for up to 2 weeks, or aliquoted and stored at -20⁰C for longer storage. 
 
2.7.3 SDS-PAGE, blotting, and detection 
Protein samples were heated to 62⁰C, vortexed for 3sec and then spun at 3000rpm for 1min. 
These samples were then loaded into cast 7.5% polyacrylamide gels, using 6µ of sample 
per well. Electrophoresis was carried out at 110V constant; 2.5hrs for Rif1-CΔ-Myc, 3.5hrs 
for Rif1-Myc, and 90mins for Rad53. For large proteins (≥150kDa) a nitrocellulose 
membrane was used, for proteins smaller than this a PVDF membrane was used instead. 
Prior to the SDS-PAGE finishing the PVDF membrane was soaked in methanol for 30sec 
prior to soaking in transfer buffer, whereas the nitrocellulose membrane (BioRad) was 
soaked only in the transfer buffer. Transfer of proteins from polyacrylamide gel to membrane 




on MW of proteins, for Rif1 the transfer time was extended to 20min rather than 10min. After 
transfer membranes were blocked with 5% milk (Marvel Fat Free dried milk powder) for 
20min before being moved to 15ml 1% milk with the recommended dilution of the primary 
antibody. Membranes were incubated at room temperature in antibody containing milk on a 
rocker for 45min when studying Rif1, or 100min when studying Rad53. After incubation the 
membrane was blocked again in 5% milk for 20min with shaking before 3x5min washes with 
TBST. The membrane was then incubated in 15ml 1% milk again, this time containing the 
recommended dilution of the secondary antibody, for 30min before a final 3x5min washes 
in TBST.  
The membrane was then allowed to drip dry and placed on a clean surface (wiped with 
100% ethanol) and 1ml mix of 500µl of each BioRad chemiluminescent substrates was 
pipetted on top. The membrane was left for 5min and then placed in a clean transparent 
sleeve for imaging. Imaging was performed using a FujiFilm LAS-4000 imaging system. 
 
2.8 Chromatin Immunoprecipitation 
2.8.1 Buffers 
FA lysis buffer was prepared and kept refrigerated before use. The buffer was prepared in 
a total volume of 250ml as follows; 12.5ml 1M HEPES pH7.5, 7.5ml 5M NaCl, 0.5ml 0.5M 
EDTA pH8.0, 2.5ml 10% sodium deoxycholate, 2.5ml Triton X-100, and ddH2O up to 250ml. 
Solutions used to prepare the FA lysis buffer were autoclaved before mixing and 
immediately prior to use of a buffer aliquot EDTA-free Complete mini Roche protease 
inhibitor tablets were added, 1 tablet in 10ml of FA lysis buffer, and mixed until dissolved, 
10%SDS was then added to a final concentration of 0.1%. 
PBS was prepared using Sigma Aldrich PBS tablets, at the recommended concentration of 
100mM NaCl as well as smaller volumes prepared at 200mM NaCl which were used to 
prepare other buffers. PBS-ChIP elution buffer was prepared in 50ml aliquots using 45ml of 
200mM NaCl and 5ml 10% SDS, if SDS had begun to precipitate then the buffer was heated 
before use to dissolve.  
ChIP Elution Buffer (CEB) was prepared and stored at room temperature in 50mL volumes. 






2.8.2 Extraction & Immunoprecipitation 
Yeast cells were grown overnight in liquid YEPD media to a final concentration of 2x107 
cells/mL. 30mL was collected from T0 samples directly, cultures were then diluted 1:1 with 
fresh YEPD media before incubation. 1mL of 36.5% formaldehyde was added to the 30mL 
(final concentration 1%) collected sample for protein cross-linking, Samples were incubated 
at 24°C for 15 minutes with gentle shaking. 4.5mL of 2.5M glycine was added to stop cross-
linking and cells were incubated for a further 5 minutes at 24°C with gentle shaking. Cells 
were then harvested in a benchtop centrifuge spun at 3500rpm for 2 minutes at 4°C, they 
were then washed twice with cold TBS and spun as before each time.  After final wash the 
cell pellet was resuspended in 1mL PBS in a 2mL Sarstedt tube and spun for 1min in a 
micro-centrifuge at 11000rpm. The supernatant was aspirated, and cell pellets were stored 
at -80°C prior to extraction.  
Prior to removal of cells from freezer 1 tablet of protease inhibitor (cOmplete Mini- Roche 
Diagnostics) was added dissolved in 10mL FA lysis buffer (50mM HEPES pH7.5, 150mM 
NaCl, 1mM EDTA pH8.0, 0.1% sodium deoxycholate (v/v), 1% Triton-X(v/v), 0.1% SDS), 
this buffer is referred to as FA-PI. Cells were incubated in 600μL of FA-PI for 20 minutes 
and resuspended, these were spun at 13000rpm for 8sec and resuspended in 600μL of FA-
PI. 0.5mL of glass beads were added and samples were ribolysed 3x on a program of 
6500(rpm) – 3x10sec - 005, cells were incubated on ice for 5 minutes between cycles. After 
ribolysing the bottom of the tube was punctured using a sterilised hot needle and the tubes 
were placed inside a 1.5mL Eppendorf with the lid removed. These two tubes were placed 
together inside a 15mL falcon tube and spun at 3500rpm in a benchtop centrifuge for 2mins. 
300μL of 0.1% Triton-PBS was added on top of the glass beads, and the tubes were spun 
again at 3500rpm for 2 minutes. The 1.5mL tube with collected sample was spun at 
10000rpm for 2minutes at 4°C. The supernatant was discarded and 1mL 0.1% Triton-PBS 
was added to the cell pellets, which were gently resuspended using a pipette tip.  
The resuspended samples were sonicated using a Bioruptor with 4x30sec cycles, and then 
spun down for 15min at 10000rpm. The supernatant was then transferred to a fresh tube. 
400μL was removed per sample for immunoprecipitation (IP) and 40μL was removed for 
Input DNA (IN), excess sample was stored at -80°C. 100μL of antibody mastermix (2μg 
antibody per sample, 100μL PBS per sample) was added to each IP sample, these were 
mixed for on a wheel for 30mins at 4°C. Samples were then added on top of 40μL Protein-
G beads (washed with 500μL 0.1% Triton-PBS), beads were held in place using a magnetic 




The following day the protein beads were transferred to fresh tubes and washed with 1mL 
cold 1% triton-PBS buffer for three minutes with rotation. Supernatant was discarded using 
a magnetic rack to hold beads in place. This wash was repeated two further times, before a 
further three washes were carried out using 0.1% Triton-PBS buffer. After the final wash 
100μL of Proteinase K-CEB mix were added (10μL Prot K: 100μL CEB) to the beads. 
Samples were incubated at 45°C for 1 hr and then transferred to 70°C for a further hour. 
Prior to removal of samples from incubation 10μL 3M sodium acetate was mixed with 600μL 
of Qiagen PB buffer (per sample), 580μL was added to a Qiagen column corresponding to 
each sample. After incubation IP samples were placed on a magnetic rack and liquid was 
removed and added to columns on top of PB buffer mix. Samples were purified according 
to the protocol for Qiagen Spin Column purification. 
 
2.8.3 qPCR 
qPCR mastermixes were set up in multiples of twelve reactions, with each sample analysed 
in triplicate blocks. Mastermixes were made up as follows per 12 samples with final 
concentration indicated: 32μL ExTaq PCR buffer (1x), 24μL dNTPs (200μM), 3.2μL reverse 
primer (300nM), 3.2μL forward primer (300nM), 3.2μL Taqman probe (200nM), 1.5μL ExTaq 
polymerase (0.025 U/μL), and 124μL ddH2O. For each reaction 15μL of mastermix was 
added to 10μL of sample DNA to make a final reaction volume of 25μL. PCR conditions 
were as follows: 
1. 95⁰C 5 min 
2. 40x cycles 
a. 95⁰C 15sec 
b. 63⁰C 1min 
DNA quantity was determined using DNA standards of 0ng, 0.1ng, 1ng, and 10ng to 
generate a standard curve of DNA quantity, which was used to determine DNA quantity in 
experimental samples. All samples were run alongside the corresponding input sample.  
 
2.9 Targeted Mutagenesis of RIF1 
2.9.1 Principle of using Gibson Assembly to generate targeted mutations 
To generate targeted mutations in the RIF1 gene I adopted a system using Gibson Assembly 




of RIF1 using mismatched primers which were assembled into a single structure within a 
longtine plasmid which could then be used to transform yeast cells. This procedure utilised 
several previously detailed protocols, such as LiAc transformation of yeast, which will be 


















Figure 2.9: An overview of the process of integrating targeted mutations into the 
genome using Gibson assembly. 
Gene fragment of interest (grey) and its upstream region (white) were amplified from the 
genome using primers with 40bp tails homologous to region adjacent to a cut site on the 
target plasmid (black arrows with red tails). Gibson assembly method was used to integrate 
cassette into the plasmid downstream of a HIS3 marker (blue). From this plasmid construct, 
overlapping fragments were amplified using mismatched primers to generate base 
substitutions (red stars indicate mismatch and substitution), these fragments were then 
reassembled into a complete plasmid using Gibson assembly methodology. From the 
resulting plasmid a cassette was then amplified using primers with tails homologous to the 
original site from which the fragment was amplified (black arrows with black tails). The 
cassette contains a marker gene as well as the original inserted fragment (now with 






2.9.2 Generation of Plasmid Structure Containing RIF1 fragment 
Genomic DNA was first extracted from a strain containing a WT RIF1. For this 1.5ml of 
YEPD culture was inoculated O/N at 21⁰C. Cultures were spun at 13000RPM for 30sec and 
the supernatant removed by aspiration. 250µl of fresh sferoplasting solution was added to 
each pellet. Fresh sferoplasting solution for four samples is made up of 1ml 0.1M EDTA 
pH7.5, 0.001g Zymolyase and 1µ β-mercaptoethanol. Samples were vortexed until 
homogenous and incubated at 37⁰C for 1hr. 50µl miniprep mix was added (for 100µl; 37.5µl 
0.5M EDTA pH8.5, 37.5µl 1M Tris base, and 25µl 10% SDS) and samples mixed by 
inversion. They were then incubated at 65⁰C for 30min, before the addition of 63µl of 5M 
KAc, mixing by inversion, and a further 30min incubation on ice. Samples were then spun 
at 13000rpm and the supernatants poured into fresh tubes containing 720µl 100% ethanol 
to precipitate DNA. Samples were inverted to mix, and the tubes spun for 5min at 14000rpm 
before the ethanol was poured off. 130µl of TE containing 1mg/ml RNAse A was added to 
the pellets and incubated at 37⁰C for 35min, after which the DNA was precipitated using 
130µl of isopropanol and mixing by inversion before being again spun at 14000rpm for 5min.  
The isopropanol was also poured off and 100µl of 70% ethanol was used to wash the pellet, 
with another 5min spin. Ethanol was removed by aspiration and the pellets were left to air 
dry. They were then resuspended in TE.  
This DNA was used to amplify a section of RIF1 from the genome as well as its upstream 
region, using plasmids that would add 40bp tails to the fragment. The reaction was set up 
as follows: 
• 39µl ddH2O 
• 5µL 10x ExTaq Buffer – Takara Bio Inc. 
• 5µL dNTPs (2.5mM) – Takara Bio Inc. 
• 2µL pFA6a-His3MX6 (for example) plasmid (1.5ng/µl stock) 
• 1µl primer mix (4µL dH2O + 1µl forward primer (200µM stock) + 1µl reverse primer 
(200µM stock) 








The PCR reactions were carried out as follows 
3. 94⁰C 4min 
4. 35x cycles 
a. 95⁰C 30sec 
b. 55⁰C 1min 
c. 72⁰C 1.5min 
The tails to these primers had homology to the sequences flanking a restriction site in the 
plasmid to which this fragment would be inserted, in this case the flanking sequence was 
the bps surrounding the EcoR1 cut site in pFA6a-His3MX6, seen in Figure 2.2.  
pFA6a-His3MX6 was cut at this site for several hours to ensure complete digestion and then 
treated with a phosphatase to prevent religation.  
The plasmid pFA6a-His3MX6 and the amplified Rif1 fragment were then added to a 
premade mix of the relevant enzymes to carry out Gibson assembly. The DNA fragments 
were added in volumes calculated to approximate equimolarity. These mixes were created 
as follows (per reaction): 
• 4µl 5x Isothermal Buffer 
• 0.008µl T5 Exonuclease 
• 0.25µl Phusion DNA polymerase 
• 2µl Taq DNA ligase 
• 8.75µl mQ Water 
The 5x Isothermal Buffer was compiled as follows: 
• 3ml 1M Tris-HCl 
• 150µl 2M MgCl2 
• 60µl 100mM dGTP 
• 60µl 100mM dATP 
• 60µl 100mM dCTP 
• 60µl 100mM dTTP 
• 300µL 1M DTT 
• 1.5µl PEG-8000 




This reaction was carried out at 50⁰C for 1hr, after which 5µl of the reaction was used to 
transform NEB® 5-alpha Competent E. coli (Subcloning Efficiency). To transform 5µl from 
the reaction was mixed with 50µl of E. coli cells and incubated on ice for 30min. The cells 
were then subjected to a 30sec heat-shock at 42⁰C before being returned to ice for 30min. 
850µl of SOC medium was added to the cells and they were incubated at 36⁰C for 1hr to 
encourage growth and expression of the ampicillin resistance gene, before they were plated 
on LB+amp plates and left O/N at 37⁰C. 
Plasmids were extracted using the Monarch® Plasmid Miniprep Kit produced by New 
England Biolabs as directed. The plasmid was then checked on a 1% agarose gel and by 
restriction digest. Those plasmids which were larger and were not digested by EcoR1 could 
be seen to contain the fragment of RIF1, as the EcoR1 consensus sequence is disrupted by 
the integration of the RIF1 fragment. This was sequenced to ensure there were no 








Figure 2.3: Plasmid Map of pFA6a-His3MX6 
pFA6a-HisMX6 was used as the plasmid vector to generate mutations in RIF1 due to several 
factors; a variety of digestion sites suitable for use, the proximity of the EcoRI site 
downstream of the marker gene, and the marker itself would not be a duplicate of any 
markers currently present in the strain to be transformed or strains it would likely be crossed 






2.9.3 Gibson Assembly to generate mutation 
To generate fragments containing targeted RIF1 mutations overlapping primers were 
designed. Each fragment would overlap at each end with the ‘adjacent’ fragment, and the 
mutated sites would be present within these fragments as can be seen in Figure 2.1. To 
amplify these fragments the following PCR reactions were used: 
• 39µl ddH2O 
• 5µL 10x ExTaq Buffer – Takara Bio Inc. 
• 5µL dNTPs (2.5mM) – Takara Bio Inc. 
• 2µL pFA6a-His3MX6-RIF1-aa1-aa250 plasmid (1.5ng/µl stock) 
• 1µl primer mix (4µL dH2O + 1µl forward primer (200µM stock) + 1µl reverse primer 
(200µM stock) 
• 0.5µl Ex-Taq Polymerase (250 Units) – Takara Bio Inc. 
The PCR reactions were carried out as follows 
1. 94⁰C 4min 
2. 35x cycles 
a. 95⁰C 30sec 
b. X⁰C* 1min 
c. 72⁰C 30sec 
*X varies by the primer pairing used. As primers were long to create large regions of 
homology between fragments this temperature was typically 66-70⁰C.  
After amplification these fragments were gel purified on a 1.5% agarose gel and using a 
Monarch® DNA Gel Extraction Kit produced by New England Biolabs.  
The fragments were mixed with pFA6a-His3MX6, digested with EcoR1 and then treated with 
a phosphatase to prevent re-ligation, and mixed into the Gibson Assembly reaction mix as 
previously detailed above. This reaction was carried out for 1hr at 50⁰C and 5µl was used 
to transform E.coli as was detailed above. The plasmids were then extracted and examined, 
larger plasmids were expected to be those which had reconstructed and integrated the 
fragments of RIF1. As such, the RIF1 fragment was amplified, confirming its presence, and 
this fragment was sent for sequencing to confirm the presence of the targeted mutations 





2.9.4 Integrating Mutation via Transformation 
To integrate these mutations into the yeast genome, I used these plasmids in much the 
same way as transformation is usually carried out via longtine plasmid. The transformation 
cassettes were amplified by PCR from the plasmid and contained a HIS3 marker as well as 
the RIF1 containing the upstream region of the gene. This cassette was transformed into 
the genome at the RIF1 locus using high efficiency LiAc transformation, as described above. 
Due to the cassette’s large region of homology with the genome, each potential transformant 












Forward Primer to amplify RIF1 from genome. Includes 40bp tail 




Reverse Primer to amplify RIF1 fragment from genome. Includes 
40bp tail adjacent to EcoR1 cut-site on pFA6a-His3MX6 
N850 AAAACTAACTTGCCACCTCCATGT
CCACAAGCTC 
Forward primer integrating RIF1-S45C mismatch 
N866 TATGAGCTTGTGGACATGGAGGT
GGCAAGTTAGTTTTCATCCAC 
Reverse primer integrating RIF1-S45C mismatch 
N870 CGAAAGCTAGCGTCTTCAAGTGAT
TGCGAGAATAAACAATTTG 
Forward primer integrating RIF1-S57C mismatch 
N853 CTCTTTGGCGTTGGGCATAGATC
GCTTTGTATATG 
Reverse primer integrating RIF1-S57C mismatch 
N857 TACCCTTGTTTCCTTAAAAGGGCA
TGTGAAAATATTACCGTTG 
Forward primer integrating RIF1-S110C mismatch 
N855 GCTACACTTTTTGTAACCGGGCAT
ACATTATCACTATTAGAGGC 
Reverse primer integrating RIF1-S110C mismatch 
N868 TACACAACGGTAATATTTTCACAT
GCCCTTTTAAGGAAACAAGG 
Forward primer integrating RIF1-S181C mismatch 
N869 TACCCTTGTTTCCTTAAAAGGGCA
TGTGAAAATATTACCGTTG 
Reverse primer integrating RIF1-S181C mismatch 
N868 TACACAACGGTAATATTTTCACAT
GCCCTTTTAAGGAAACAAGG 
Forward primer integrating RIF1-Y183F mismatch 
N869 TACCCTTGTTTCCTTAAAAGGGCA
TGTGAAAATATTACCGTTG 
Reverse primer integrating RIF1-Y183F mismatch 
N901 ATATACAAAGCGATCTAGCTCCAA
CGCCAAAGAGG 
Forward primer integrating RIF1-S57A mismatch 
N902 CTCTTTGGCGTTGGAGCTAGATC
GCTTTGTATATG 
Reverse primer integrating RIF1-S57A mismatch 
N903 CTCTAATAGTGATAATGTAGCTCC
GGTTACAAAAAGTGTAGC 
Forward primer integrating RIF1-S110A mismatch 
N904 GCTACACTTTTTGTAACCGGAGCT
ACATTATCACTATTAGAGGC 
Reverse primer integrating RIF1-S110A mismatch 
N890 ATATACAAAGCGATCTAGAACCAA
CGCCAAAGAGG 





Reverse primer integrating RIF1-S57E mismatch 
N886 CTCTAATAGTGATAATGTAGAACC
GGTTACAAAAAGTGTAG 
Forward primer integrating RIF1-S110E mismatch 
N887 GCTACACTTTTTGTAACCGGTTCT
ACATTATCACTATTAGAGGC 




Forward primer to generate cassette for integration of HIS3-RIF1-S* 
mutant structure into genome. Contains tail with homology to 






Reverse primer to generate cassette for integration of HIS3-RIF1-
S45/57/110C mutant structure into genome. Contains tail with 
homology to RIF1 
N853 CTCTTTGGCGTTGGGCATAGATC
GCTTTGTATATG 
Reverse primer to generate cassette for integration of HIS3-RIF1-




Reverse primer to generate cassette for integration of HIS3-RIF1-





Reverse primer to generate cassette for integration of HIS3-RIF1-
S57/110A/E mutant structure into genome. Contains tail with 
homology to RIF1 
 





2.10 Antibodies used in this study 
 
Primary Antibody Origin Cat. No. Company 
Monoclonal anti-Myc Mouse Sc-40 Santa Cruz 





Origin Cat. No. Company 
anti-mouse (HRP) Rabbit ab97046 Abcam 
anti-rabbit (HRP) Goat ab205718 Abcam 
 





Chapter III: Understanding the phosphorylation of Rif1 
 
3.1 Rif1 is phosphorylated during telomere damage in cdc13-1 cells 
Data from Xue et al, (2011) established a model in which Rif1 activity created a threshold of 
tolerance to DNA damage after telomere resection by acting as a molecular band-aid to 
short tracts of ssDNA. Thus, Rif1 hides low levels of damage from recognition by checkpoint 
proteins, thereby functioning as an anti-checkpoint and allowing continued cellular 
proliferation. Extensive damage will stretch beyond the capability of Rif1 to shield from 
recognition, subsequently triggering checkpoint pathways and leading to cell cycle arrest. 
This function of Rif1 was discovered in cdc13-1 cells, and later shown in the context of a 
DSB in yeast (Mattarocci et al., 2017).  
In this study I have been interested in determining how the anti-checkpoint function of RIF1 
is regulated in telomere damage and other types of DNA damage. Unpublished data from 
our lab suggested that Rif1 protein may become phosphorylated during telomere damage. 
Therefore, I investigated this post-translational modification as a potential mechanism by 
which the Rif1 activity may be regulated. 
I first investigated the Rif1 protein using SDS-PAGE and Western Blotting. Cell cultures of 
temperature sensitive cdc13-1 and CDC13 control strains, both with RIF1-MYC, were 
inoculated overnight at 20⁰C. The first samples (T0) were taken directly from overnight 
cultures, which were then incubated at 36⁰C for 6 hours and samples taken every 2 hours.  
Across the six-hour time-course in a CDC13 strain there was no shift in the migration of Rif1 
protein during electrophoresis, and across this time there was no accumulation of cells in 
the G2/M periods of the cell cycle. In contrast, in cdc13-1 cells there was a distinct shift in 
the migration of Rif1. This shift began in the samples taken after 2 hours, where the protein 
appears to be split between a position equivalent to the T0 sample and a second slower 
migrating form at the same position as was seen in samples taken from T4 and T6 (Figure 
3.1A). The appearance of the slower migrating form in these samples correlates to a high 
percentage of cells (≥90%) arresting in the G2/M phase of the cell cycle. The slower 
migrating protein form may indicate size or charge changes in the protein structure, such as 
may result from post-translational modifications. 
As previous published data has indicated that the Rif1 C-terminal domain is not necessary 
for any function in protecting resected telomeres, I investigated whether this protein shift of 




collected as in the previous experiment. Interestingly, in these cells a second slower 
migrating form of Rif1 protein was seen after two hours and was maintained across the time-
course (Figure 3.1B).  
A shift in the migration of a protein is frequently caused by a post-translational modification, 
such as ubiquitination or phosphorylation, which lead to size or electrostatic changes within 
the protein structure. Unpublished data from the lab suggested that the shift occurring here 
in Rif1 migration was due to phosphorylation. To verify this, protein samples from cdc13-1 
cells incubated at 36⁰C for 4 hours (T4) were treated with alkaline phosphatase to remove 
any phosphoryl groups from proteins. These treated samples were compared with a mock-
treated sample, as well as a sample from the overnight culture grown at 20⁰C prior to 
incubation at 36⁰C (T0). The checkpoint protein Rad53, which is known to be 
phosphorylated during telomere damage, was also compared to verify the enzyme activity 
of alkaline phosphatase. The Rad53 control showed a single protein form prior to telomere 
damage in T0 sample, after 4 hours at 36⁰C in untreated samples there were slower 
migrating forms that are the phosphorylated Rad53 protein. However, upon treatment with 
alkaline phosphatase this returned to a single faster migrating protein form equivalent to the 
T0 sample, indicating that phosphoryl groups had been removed from the protein. 
Interestingly, the same is seen in the Rif1 protein analysed here. At T0 there was a faster 
migrating protein form prior to incubation, however, in the T4 untreated sample there was 
also a slower migrating protein form. Upon treatment with alkaline phosphatase this slower 
migrating form disappeared. This indicates that the slower migration of Rif1 was caused by 
phosphorylation of the protein (Figure 3.1C).   
The data shown here suggests that during telomere damage Rif1 protein becomes 
phosphorylated, this phosphorylation is not dependent on the C-terminal domain of the 
protein. This raises the question of the function of the phosphorylation event, and what 






































Figure 3.1. Rif1 is phosphorylated during telomere resection in cdc13-1 cells. 
(A) Western blot of Rif1 protein. Cells were grown overnight at 20⁰C to low cell concentration 
at T0 (1x107cells/mL), they were then shifted to 36⁰C for 6 hours. Yeast strains LMY79 
(cdc13-1 RIF1-MYC) and LMY59 (CDC13 RIF1-MYC) were used. Cell samples were also 
taken for DAPI treatment and cell cycle scoring with fluorescence microscopy. (B) Western 
blot showing Rif1 containing a deletion of the C-terminal (amino acid residue 1451-1916) in 
cdc13-1, yeast strain LMY510, cells shifted to 36ºC after overnight growth at 21⁰C.Cell 
samples were taken for DAPI treatment and cell cycle scoring by fluorescence microscopy.  
(C) Western blot of protein samples showing Rif1 taken prior to, or 4hrs after, shifting cdc13-
1 to 36ºC. 4hr samples were split and were treated with alkaline phosphatase or mock 
treatment (DMSO). Overnight cultures were used to ensure low cell concentrations 






3.2 Rif1 is Phosphorylated During Nocodazole-Induced Arrest 
In studying the regulation of Rif1 activity, unpublished data from our lab suggested that the 
telomere damage in cdc13-1 cells may not be the only condition in which Rif1 protein is 
phosphorylated. I further investigated the factors that lead to Rif1 phosphorylation. 
I first investigated the effects of the spindle poison nocodazole, and the resulting cell cycle 
arrest on Rif1 protein. Nocodazole is a reagent that prevents the polymerisation of the 
spindle fibres through binding to tubulin, and as such chromosomes do not separate properly 
during mitosis (Verdoodt et al., 1999). Errors during spindle formation and chromosome 
separation activate the spindle checkpoint pathway, arresting the cell cycle.  
I began by verifying a phosphorylation of Rif1 in CDC13 cells, when treated with nocodazole. 
An overnight inoculation of the genotype CDC13 RIF1-MYC was grown at 20ºC. A starting 
sample was taken from this culture (T0) before it was split in three. Culture one received 
treatment with nocodazole, culture two received a mock treatment of DMSO, and culture 
three received neither treatment. These cultures were then incubated for 4hrs at 30⁰C. 
Results showed a single clear form of Rif1 protein at T0. However, after 4 hours treatment 
in nocodazole a slower migrating form of Rif1 appeared. This form was not seen in mock-
treated cells, nor in cells left untreated. Interestingly, when examining Rad53 in these 
samples there was also a small migration shift of protein in samples treated with nocodazole. 
This may be related to a previously seen phosphorylation of Rad53 by Cdk1 in metaphase, 
independent of its role in the DNA damage checkpoint (Diani et al., 2009). This was also not 
seen in mock-treated or untreated samples (Figure 3.2A). 
I then performed a time-course to study how phosphorylation changes over time in cells 
containing RIF1 and cells containing the mutation RIF1-CΔ. As such, cell cultures of each 
were grown overnight. Samples were taken from the overnight culture and cultures were 
treated with nocodazole for 6 hours at 30⁰C. The control RIF1 strain showed phosphorylation 
emerging at T4 and T6, although the protein size appears to have made this phosphorylation 
difficult to visualise. However, the truncated Rif1 protein found in RIF1-CΔ cells is strongly 
phosphorylated by T4 and T6 (Figure 3.2B). These results indicate that this phosphorylation 
event occurs with similar dynamics to the phosphorylation in cdc13-1, and does not require 






Figure 3.2 Rif1 is phosphorylated in Nocodazole induced arrest 
Western blot using protein samples from overnight cultures grown at 20ºC to a concentration 
of 1x107 cells/mL, cultures were diluted 1:1 with fresh YPD. (A) CDC13 RIF1-CΔ cultures 
were incubated for 4 hours at 30⁰C in the presence of nocodazole, mock treatment of 
DMSO, or no treatment. Membrane probed for Rif1 or Rad53. (B) CDC13 RIF1 and CDC13 







3.3 Investigating phosphorylation of Rif1 in response to other DNA 
damaging agents 
I have shown that Rif1 is phosphorylated as a result of both telomere damage in cdc13-1 
cells and by treatment with the spindle poison nocodazole. I therefore wanted to answer 
what other factors might cause the phosphorylation of Rif1 in response to damage.  
In order to study this cultures of the strain CDC13 RIF1-CΔ-MYC were treated with one of 
the following reagents: 
• Phleomycin (50µg/mL) – Binds and cleaves DNA to create DSBs 
• Hydroxyurea (100mM) – Stalls replication forks through inhibition of the production of 
deoxyribonucleotides 
• Methyl-methane sulfonate (MMS) (0.05% w/v) – Stalls replication forks, ultimately 
leading to replication fork collapse and creation of DSBs 
• UV Radiation (30J/m2) – Induces pyrimidine dimers which can be converted to DSBs 
during replication 
Cells were treated with reagents and incubated at 23C for 3hrs, except for those cultures 
treated with nocodazole which received 4 hours treatment. Cells treated with UV were 
resuspended in a low volume of PBS for treatment, they were then resuspended in YPD for 
3hrs alongside the other cultures. For this experiment a strain of cdc13-1, or a treatment 
with nocodazole (15µg/mL) were used as controls to show a known phosphorylation of Rif1.  
As expected, the control cdc13-1 showed phosphorylation of both Rif1 and Rad53 after 4 
hours at 36ºC, as well as an accumulation of cells in the G2/M transition. The results for the 
reagents are varied and interesting. In nocodazole, there was phosphorylation of Rif1 but 
only a very slight shift in Rad53 migration, suggesting a very low level of phosphorylation of 
Rad53. In HU and MMS at this temperature there was no phosphorylation of Rif1 after 
treatment with either reagent, however, strong phosphorylation of Rad53 was seen in both 
conditions. In contrast, in both phleomycin and UV damage there was noticeable 
phosphorylation of Rif1. However, both these conditions resulted in moderate 
phosphorylation of Rad53. The protein was clearly not as strongly phosphorylated as in 
cdc13-1 controls or in HU treatment, but it was more heavily phosphorylated than in 
nocodazole treatment (Figure 3.3A).  
To further investigate this finding, I repeated the experiment shown in Figure 3.3A, instead 
incubating samples with reagent at 30ºC rather than 23ºC. Cells were treated with the same 




cdc13-1 strain or nocodazole treatment were again used as controls for known 
phosphorylation of Rif1. 
In this experiment, phosphorylation of Rif1 was seen after incubation in media containing 
nocodazole or phleomycin, as well as after UV radiation, as was seen previously. However, 
phosphorylation of Rif1 was also seen after incubation with HU, which was not seen at 23ºC. 
In these samples there was strong phosphorylation of Rad53 after treatment with 
phleomycin, and more moderate phosphorylation of Rad53 after treatment with HU or 
dosage with UV radiation. However, treatment of cells with MMS did not result in 
phosphorylation of Rif1 or, unexpectedly, Rad53 (Figure 3.3B).  
To verify the results further, the experiment for HU and MMS was repeated at 30ºC. 
Interestingly, using fresh MMS the phosphorylation of Rad53 was returned, however Rif1 
remained non-phosphorylated. In comparison these results appeared to show a divergence 
in Rif1 reaction to HU-induced arrest that was seemingly created by the incubation at higher 
temperature during treatment. Upon incubation at 30ºC with HU, Rif1 protein did not appear 
to become phosphorylated. However, in these cells Rad53 was not phosphorylated (Figure 
3.3C). 
From this data I concluded that spindle damage and telomere damage are not the only 
conditions that lead to phosphorylation of the protein Rif1. UV radiation and phleomycin 
exposure are also capable of leading to the phosphorylation of Rif1, however, treatment of 
cells with MMS does not appear to lead to phosphorylation of Rif1. Our results seem to imply 





































































Figure 3.3. Rif1 is phosphorylated in response to a range of genotoxic stressing 
reagents 
Western blots of yeast strains cdc13-1 RIF1-CΔ-MYC and CDC13 RIF1-CΔ-MYC. Cell 
cultures were grown overnight at 20°C to 1x107 cells/mL at T0. Cells containing the allele 
cdc13-1 were then shifted to 36°C. CDC13 cell cultures were split and treated with 
Nocodazole (15μg/mL), phleomycin (50μg/mL), hydroxyurea (100mM), or MMS (0.05%). 
Those cells treated with UV radiation were exposed to a dosage of 30J/m2 ultraviolet 
radiation and then grown YPD liquid medium for 3hrs. After addition of reagents, or exposure 
to UV radiation, cell cultures were incubated at either 23°C (A) or 30°C (B). cdc13-1 cells 
and those cells exposed to nocodazole were harvested after 4hrs, cells undergoing all other 
treatments were collected after 3hrs. (C) CDC13 RIF1-CΔ-MYC cell culture was grown O/N 
and split (as in A & B). Cells were then treated with Hydroxyurea (100mM) or MMS (0.05%) 
and shifted to 30°C. Cell samples were taken for DAPI treatment and cell cycle scoring by 
fluorescence microscopy, percentage of cells with large budded cells (G2/M) or small 







3.4 The first 176 residues of Rif1 are essential for Rif1-P and the 
protective function of Rif1 in cdc13-1 cells. 
These results showed the phosphorylation of Rif1 protein in cdc13-1 cells at restrictive 
temperatures, as well as cells exposed to other genotoxic stresses. This phosphorylation 
event does not appear to occur within the C-terminus region of the protein, nor does deletion 
of this C-terminus region affect the sickness of cdc13-1 (Xue et al., 2011). In order to 
demonstrate the role of this phosphorylation event, I aimed to locate the residues 
responsible for the modification. 
To first determine if the phosphorylation did occur within the N-terminal domain, experiments 
were conducted utilising a mutant RIF1 gene which encoded a tagged protein with a full C-
terminus region and a smaller deleted region close to the N-terminus. This deletion no longer 
encoded amino acid residues 1-176 of the Rif1 protein and as such this mutant is referred 
to here as rif1-NΔ-MYC (Figure 3.4.1A). 
The growth of this mutant was tested via serial dilution. The mutant was grown alongside 
strains with the genotypes cdc13-1 RIF1, cdc13-1 RIF1-MYC, cdc13-1 rif1Δ, and then finally 
the mutant of interest cdc13-1 rif1-NΔ-MYC. Both cdc13-1 strains with full-length Rif1 protein 
can be seen to have grown normally at 23⁰C, and once placed at 26⁰C began to show signs 
of sickness but retained moderate growth, by 30⁰C neither strain grew. In comparison rif1Δ 
cells, which also grew adequately at 23⁰C, showed severe sickness at 26⁰C, and no longer 
grew at 30⁰C. The mutant rif1-NΔ cells showed an intermediate pattern of growth, neither 
growing as well cdc13-1 RIF1 cells, nor as poorly as cdc13-1 rif1Δ cells (Figure 3.4.1B). 
Perhaps indicating a partial loss of protein function resulting from the mutation.  
However, it is known that this region also contains the RVxF-SILK domains responsible for 
the binding of Rif1 and the PP1 protein; Glc7, in order to regulate the timing of replication at 
late firing origins of replication. Previous studies have, however, determined that the 
mutation of these sites alone is not sufficient to affect the growth of cdc13-1 cells (Mattarocci 



















Figure 3.4.1 The Rif1 N-terminal-proximal region increases the viability of cdc13-1. 
(A) Structural models of the Rif1 proteins containing large deletions of terminus-adjacent 
regions of Rif1. Previously identified sites of potential phosphorylation are indicated (grey 
circles). Sites were identified in several large scale studies identifying multiple proteins 
(Albuquerque et al., 2008; Holt et al., 2009; Swaney et al., 2013) (B) Serial dilutions of 
cdc13-1 RIF1 variants on YEPD medium at a selection of temperatures. Cells were spotted 








As the mutant rif1-NΔ strains increase the temperature sensitivity of cdc13-1, I wanted to 
investigate whether this increased sensitivity may be linked to changes in phosphorylation 
of Rif1. For this experiment overnight cultures grown at 20ºC were shifted to 36⁰C for 6 
hours, with samples taken at 2-hour intervals. For this comparison a cdc13-1 RIF1-MYC and 
a cdc13-1 rif1-NΔ-MYC strain were used. As expected from previous experiments the 
control strain with the complete RIF1 gene showed phosphorylation of the Rif1 protein after 
two hours of incubation of cells at 36⁰C. This phosphorylation was maintained throughout 
the experiment. Rad53 showed a similar pattern of phosphorylation across this time-course, 
becoming phosphorylated by two hours, with even stronger phosphorylation at T4 and T6. 
Interestingly, when I examined samples from the rif1-NΔ mutants there was no 
phosphorylation of the truncated Rif1 protein at any point in the time course. However, 
Rad53 phosphorylation appeared to be largely unaffected. The protein became 
phosphorylated at T2, as in the control, and by T4 and T6 had become more phosphorylated 
again. These mutant cells arrested similarly to the control strain, with a high proportion of 










Figure 3.4.2 The Rif1 N-terminal Region is required for Rif1-Chromatin Binding 
Western blot of Rif1 and Rad53 in cdc13-1 RIF1-MYC (LMY79) and cdc13-1 rif1-Δ2-176-
MYC (DLY9823). Cells were grown overnight at 20ºC (to 1x107 cells/mL) and shifted to 36ºC 
for 6 hours, with samples taken every 2 hours. Samples were separated on 7.5% SDS-
PAGE gels. Cell samples were also prepared for DAPI treatment and analysed with 
fluorescence microscopy to score the stage of the cell cycle. Percentage of cells with large 
























As the N-terminal truncated Rif1 protein was not phosphorylated during telomere damage, 
I then used this strain to further examine the association of Rif1 with the chromosome and 
how it is affected by phosphorylation. For this, I used ChIP to study the association of Rif1 
and the chromosome at three distinct loci: 
• Y’600 - Loci located only 600bp from the telomere. A positive control at T0 as 
fragments would likely contain telomere-bound Rif1 as part of the Rap1-Rif1-Rif2 
complex. Furthermore, multiple Y’ elements at multiple chromosomes will mean 
these loci are present many times in each cell. 
• YER188W – A single gene locus located approximately 8kb from the telomere of 
chromosome V 
• PAC2 – A centromeric locus 300kb from the telomere. This locus acted as a negative 
control of chromosome V. 
For this cell cultures of cdc13-1 RIF1-MYC or cdc13-1 rif1-Δ2-176-MYC were grown 
overnight at 20ºC and then incubated at 36⁰C for 6 hours, with samples taken every 2 hours. 
Protein-DNA interactions were fixed by treatment of the cells with formaldehyde at 24⁰C.  
In the control strain in this experiment, cdc13-1 RIF1-MYC, at Y’600 the Rif1 association 
began at a moderate level, which increased after 2 hours to a peak level. This interaction 
then declined again after 4 hours and fell even further by T6. A similar pattern is also seen 
at YER188W, but at lower levels of association. At PAC2 there was a very low association 
of Rif1 with the chromosome at all time-points.  
In contrast, the association of the truncated Rif1 protein with the chromosome was 
noticeably different. At both Y’600 and YER188W the association of this altered protein was 
much less than that of the full-length protein at all time-points. When the PAC2 locus was 
examined Rif1 association with this locus appears to be relatively similar between the control 
strain and the truncated Rif1. Multiple experimental repeats are shown, demonstrating that 
while signal strength varies between experiments, this pattern of association is consistent 
and repeatable (Figure 4.3.3A-C).  
These results together indicate that the mutation of this region of the Rif1 protein has 
substantial impacts upon the growth of cdc13-1 cells. Furthermore, this region appears to 
house the phosphorylation event that occurs during telomere damage, and without the 




However, it is unclear if this is due partially to the loss of phosphorylation, or entirely due to 













Figure 3.4.3 The Rif1 N-terminal Region is required for Rif1-Chromatin Binding 
(A, B, C) Experimental repeats of ChIP of Rif1 from cdc13-1 RIF1-MYC (LMY79) and cdc13-
1 rif1-NΔ-MYC (DLY9823) cells grown overnight at 20ºC (2x107 cells/mL at T0) and shifted 
to incubation at 36ºC, with samples collected at 2hr intervals. Error bars show standard 






3.5 Rif1 residues phosphorylated in cdc13-1 cells 
The deletion of the N-terminal domain clearly demonstrated the importance of this region for 
proper function of Rif1 in cdc13-1 cells. The knowledge that the phosphorylation site may 
lie within this region made searching for this site easier. As such, I attempted to find the 
location of the phosphorylation sites within the Rif1 N-terminal region, with the aim of 
removing Rif1 phosphorylation without larger structural changes to the protein.  
To carry out this experiment the first stage was to ascertain which amino acid residues were 
the most likely target sites for phosphorylation, and therefore should be targeted for 
mutation. For this, multiple phosphorylation prediction software available online were used 
to analyse the protein sequence, as well as data existing from previous published datasets 
available through SGD. A model of Rif1 protein structure shows the potential 
phosphorylation sites present in the RIF1-CΔ-MYC mutants (Figure 3.5.1A). A subset of 
these sites were chosen based on predictive software (KinasePhos, etc.), data gathered 
concurrently regarding likely candidate kinases (discussed later), and recent publications (J. 
Wang et al., 2018). This suggested the sites S45, S57, S110, S125, S138, and S181 as the 
most likely residues to be phosphorylated.  
The residues S125 and S138 fall between the RVxF-SILK domains, which have previously 
been established to be crucial for the role of Rif1 in controlling replication timing. The 
interaction of Rif1 and PP1 has been shown to be controlled via phosphorylation of the Rif1 
protein, and as such these sites may be involved in this role (Mattarocci et al, 2017). 
However, is has been previously demonstrated that interruption of the RVxF-SILK domains 
does not affect the sickness of cdc13-1 cells, I elected to discount these sites at this stage 
of the experiment. 
Whilst S181 is outside of the N-terminal region deleted in the previously shown data, other 
studies have recently indicated a potential phosphorylation of this site in telomere damage 
resulting from the deletion of the protein Yku70 (Wang et al., 2018). Further to this, this site 
resembles very closely the “ideal” binding sequence of a CDK protein which is S/T-P-x-K/R 
(Nigg, 1993). As such I therefore included S181 and Y183 for mutation in this study. These 
two residues were mutated alongside residues S45, S57, and S110. 
To perform mutagenesis Gibson Assembly of plasmids was used to introduce targeted site-
specific substitutions. A portion of the RIF1 gene and its upstream region was cloned onto 
a plasmid vector, adjacent of a HIS3 marker gene. Primers with targeted mismatches were 




reassembled and sequenced to ensure the mutated sites were included. These gene 
fragments were then transformed back into the yeast genome, alongside the upstream HIS3 
marker sequence, these cassettes contained tails homologous to the target region located 
at the RIF1 locus (Figure 3.5.1B). In the following experiments a control strain is used which 
has had the HIS3 marker inserted into the genome upstream of RIF1, however, the RIF1 
gene sequence has not been changed. As such any differences seen between RIF1 mutants 
and this strain cannot be accounted for by any expression differences that may be generated 
by alterations to the upstream region of RIF1. All mutations were confirmed by sequencing 
before crossing into a range of backgrounds for study.  
The initial mutations made immediately grouped into two types, mutants containing 
substitutions at all 5 intended sites, and those which contained substitutions only at residues 









Figure 3.5.1. The mutation of 5 Serine Residues within Rif1 Protein 
(A) A schematic representation of previously identified potential sites of phosphorylation within Rif1-
C∆ that may be targeted by kinase activity. Those mutated indicated in red. (B) A schematic 
representation of the transformed Rif1 gene locus, mutations marked in red and a HIS3 marker is 






These strains were investigated to study the differences created by residue substitutions in 
Rif1. For the following experiments cell cultures were grown overnight at 20ºC, and T0 
samples were taken directly from these cultures. These cultures were then incubated at 
36⁰C, with samples taken after 2, 4, and 6 hours.  
The first of these experiments shows a cdc13-1 RIF1-CΔ-MYC control strain against a strain 
containing substitutions at all 5 sites in RIF1. As expected, both Rif1 and Rad53 in the 
control strain became phosphorylated after 2 hours at high temperature, this 
phosphorylation increased after 4 hours and was maintained after 6 hours. However, the 
mutant RIF1 cells showed no phosphorylation of the Rif1 protein after incubation at 36⁰C at 
any time-point studied. This contrasts with the phosphorylation of Rad53 which closely 
resembled the control (Figure 3.5.2A).  
Interestingly, when the phosphorylation of Rif1 was examined in a strain with only three sites 
substituted a similar phenotype was seen. In this experiment Rif1 showed no 
phosphorylation at any time-point after incubation in 36⁰C, despite the accumulation of 
phosphorylated Rif1 in the control strain. However, the phosphorylation of Rad53 was very 
similar between both strains (Figure 3.5.2B).  
I also generated strains containing substitutions of S181 and Y183, due to suggestions of 
phosphorylation at S181 in previous studies. When comparing Rif1 in these, the behaviour 
of the protein was similar to the control. After incubation at 36⁰C Rif1 became 
phosphorylated in RIF1-S181C-Y183F and this phosphorylation is maintained throughout 
the 6-hour time-course (Figure 3.5.2C). 
These results strongly indicate that I successfully located residues key to the 
phosphorylation of Rif1 during telomere damage, as well as ruling out a residue previously 
seen phosphorylated in Yku70 damage. These results point to the importance of S45, S57, 
and S110 for phosphorylation of the protein, and as such would be worthy of further study 













Figure 3.5.2 Substitution of S45, S57, and S110 eliminates phosphorylation of Rif1 
during telomere damage. 
Western blots from cells grown overnight at 20ºC (T0) and shifted to a temperature of 36ºC 
for 6hrs, with samples taken every 2hrs. Proteins separated in a 7% SDS-PAGE gel and 
probed for Rif1 or Rad53. Samples compared in a control strain of cdc13-1 RIF1-CΔ-MYC 
and (A) cdc13-1 RIF1-S45C-S57C-S110C-S181C-Y183F-MYC, (B) cdc13-1 RIF1-S45C-






The previous experiments showed that the phosphorylation of Rif1 occurs within three 
residues in the N-terminal domain during telomere uncapping; S45, S57, and S110. To 
determine which of these sites were responsible new RIF1 mutants were generated using 
the existing plasmid constructs containing the fragment of mutated RIF1. Shorter DNA 
cassettes for transformation of strains were generated to progressively exclude the sites 
that were closer to the 3’ of gene fragment. This meant that from a plasmid containing a 
RIF1 fragment containing substitutions at S45, S57, and S110 I generated cassettes which 




This process was sufficient to determine which sites, when mutated, may affect the 
phosphorylation of Rif1. Although all combinations of mutation could not be achieved by this 
methodology, it allowed me to determine if any of these sites were not required for 
phosphorylation. 
In the following experiment cell cultures of cdc13-1 strains containing mutations of the 
potential phosphorylated residues in Rif1 were grown overnight at 20⁰C alongside a control 
cdc13-1 culture.  
As expected, the control samples in this experiment showed a clear shift in Rif1 migration 
upon incubation at 36⁰C, corresponding to the phosphorylation event that occurs. 
Furthermore, as would be expected clear phosphorylation of the Rad53 protein was seen at 
this temperature. As suggested by previous data, there was no change in protein migration 
of Rif1 in samples from the strain containing the RIF1-S45C-S57C-S110C-C∆ mutations. 
Substitution of these sites led to a complete loss of phosphorylation. However, the 
phosphorylation of Rad53 was completely unaffected when compared to that of the control 
strain.  
Interestingly, the substitutions of residue S45 and S57 offer the most information. The 
mutant containing substitutions at both residues, RIF1-S45C-S57C-C∆ showed a clear 
change in protein migration of Rif1. This change indicated that the protein was less 
phosphorylated after the mutation of these two sites. However, it is notable that there did 
appear to be some phosphorylation of Rif1 remaining in these samples. Again, Rad53 was 




in the protein migration of Rif1. In these samples both Rif1 and Rad53 appeared to be 
phosphorylated equivalent to that of the control samples (Figure 3.5.3).  
This data strongly suggests that residue S45 is not the site of phosphorylation during 
telomere damage. Substitution of this site appears to have little to no effect on the 
phosphorylation of Rif1. In contrast, this data strongly points to both S57 and S110 as sites 
of phosphorylation in Rif1 protein. Substitutions at either of these sites appears to reduce 
the overall phosphorylation of the protein. Furthermore, substitution of residue S57 appears 
to have a larger effect on the shift in Rif1 protein migration than substitution of S110 alone. 








Figure 3.5.3 Rif1 Phosphorylation is Split between Amino Acid Residue S57 and S110. 
Western blot using protein samples from cells grown overnight at 20⁰C to low cell 
concentration (1x107 cells/mL) before being incubated at 36⁰C for 4 hours comparing cdc13-
1 cells containing RIF1-CΔ-MYC, RIF1-S45C-CΔ-MYC, RIF1-S45C-S57C-CΔ-MYC, and 







The data shown in this chapter has used mutants with substitutions of cysteine in place of 
serine. This is not standard and may have inadvertently introduced larger structural changes 
into the Rif1 protein than necessary, such as disulphide bridges. From the data gathered I 
also required the generation of fresh mutants in order to generate strains containing isolated 
substitutions of S57 and S110 independent from one another, as well as any other 
mutations. Therefore, these mutants were generated using the same methodology as 
described previously in this chapter, however, alanine residues were instead substituted in 
place of serine residues. 
Three mutants were generated containing isolated substitutions of S57 and S110, and a 




cdc13-1 strains containing the mutations listed above were cultured overnight at 20°C, T0 
samples were taken directly from these and the cultures were then incubated for 36°C for 4 
hours. Cell samples were also taken for analysis and cell scoring by fluorescent microscopy. 
These mutants were compared to samples from a control cdc13-1 RIF1-C∆ strain. 
As in previous experiments, the Rif1 protein from the control strain became phosphorylated 
after 4 hours at 36⁰C. In these cells there was also phosphorylation of Rad53 at high 
temperatures, and these phosphorylation events correlated to an accumulation of cells in 
the G2/M phase of the cell cycle. In contrast, Rif1 phosphorylation was greatly reduced in 
mutants containing a single substitution of amino acid residue S57. At 36⁰C, whilst there 
was shift of the Rif1 protein migration, this phosphorylated form was much less visible and 
most of the protein was non-phosphorylated. However, Rad53 phosphorylation and 
accumulation of cells in G2/M remained unaffected by this mutation (Figure 3.5.4A). 
Interestingly, in the RIF1-S110A-C∆ mutant the data shows that Rif1 phosphorylation was 
higher than that of strains with the substitution of S57 alone. It is however notable that the 
phosphorylation of Rif1 did not appear as substantial as in samples taken from the control 
strain. In RIF1-S110A-C∆ mutants there appeared to be a higher proportion of non-
phosphorylated Rif1 after 4 hours at 36⁰C than in the control. Again, Rad53 phosphorylation 
and the arrest of cells at the G2/M phase of the cell cycle did not appear to be affected by 




Further to this, when both sites were substituted simultaneously there was complete loss of 
phosphorylation of the Rif1 protein. In this strain, 4 hours at 36⁰C did not result in any change 
in the migration of Rif1. Despite Rad53 phosphorylation, and the proportion of cells arrested 
at G2/M closely matching that of the control strain (Figure 3.5.4A).  
This experiment would appear to support previous findings. The data clearly demonstrates 
a loss of Rif1 phosphorylation after the substitution of residue S57 and S110. Furthermore, 
the data suggests that both sites may work together for Rif1 phosphorylation but does not 
necessarily suggest equal function. Phosphorylation at S57 appears to be responsible for 
most of the migratory shift in the Rif1 protein.  
To further verify these results these strains were studied more closely across a time-course 
of exposure to high temperature, to ensure that phosphorylation was not simply occurring 
earlier or later than studied. Cell cultures of each mutant were grown overnight at 20⁰C 
alongside control strains (cdc13-1 RIF1-C∆) and were then shifted to 36⁰C for 6 hours, with 
samples taken at 2-hour intervals. 
The control strain behaved as expected in the three following experiments. At T0 there was 
a single clear protein band of both Rif1 and Rad53. After 2 hours at 36⁰C the migration 
patterns have shifted and there was a clear band of phosphorylated Rif1 and multiple bands 
of phosphorylated Rad53. This phosphorylation remains throughout T4 and T6. During this 
time a high proportion of cells accumulated and arrested in G2/M phase of the cell cycle.  
When examining samples from a strain containing the mutation RIF1-S57A-S110A-C∆ there 
was no migratory shift in the Rif1 protein in any sample across the 6 hours. The Rif1 protein 
did not appear to become phosphorylated despite incubation at 36⁰C. However, Rad53 
phosphorylation occurred similarly to in the control, appearing at T2 and growing stronger 
by T6. These cells also accumulated and arrested at G2/M at the same rate as the control 
strain (Figure 3.5.4B).  
Samples from the mutant RIF1-S57A-C∆ show that the phosphorylation of Rif1 is greatly 
reduced. Whilst there was a small level of Rif1 phosphorylation at T2, it was difficult to 
distinguish. Whilst this phosphorylated protein did become more visible at T4, the vast 
majority of Rif1 protein was non-phosphorylated at all timepoints in these cells and was 




similar Rad53 phosphorylation and accumulation of cells in G2/M as was seen in the control 
strain (Figure 3.5.4C).  
In contrast, the Rif1 protein samples taken from RIF1-S110A-C∆ were the most 
phosphorylated of a non-control strain. In these samples, phosphorylated forms of Rif1 were 
seen after 2, 4, and 6 hours. It is however noteworthy that the migration of these forms was 
not slowed as much after incubation at 36⁰C as protein samples from the control strain, 
suggesting these proteins may have had less phosphoryl groups added. Furthermore, the 
proportion of non-phosphorylated Rif1 protein, as compared to phosphorylated Rif1, was 
higher in these samples than was seen in the control strain. In these strains however the 
phosphorylation of Rad53, and the accumulation of cells in G2/M are similar to that of the 
control (Figure 3.5.4D). 
These results together strongly indicate that the phosphorylation of Rif1 may be located at 
two amino acid residues of the N-terminal region of the Rif1 protein. Furthermore, this data 
supports that the amino acid residue S57 is the most important residue for phosphorylation 
of Rif1, and removal of this dramatically reduces Rif1 phosphorylation, compared to the 




























































































Figure 3.5.4 Substitution of residue Serine-57 and Serine-110 in Rif1 completely 
eliminates phosphorylation during telomere damage. 
(A) Western blot analysis of Rif1 and Rad53 protein taken from cells incubated overnight at 
20ºC (1x107 cells/mL at T0) and shifted incubation temperature to 36ºC for 4 hrs. Cell 
samples were also taken for DAPI treatment and cell cycle scoring via fluorescence 
microscopy. (B, C, D) Western blot analysis of Rif1 and Rad53 protein taken from cells 
incubated overnight at 20ºC (T0) and shifted incubation temperature to 36ºC for 6 hrs, with 
cells harvested at 2 hr intervals.  Cell samples were also taken for DAPI treatment and 
analysis and cell cycle scoring via fluorescence microscopy. Strains used here are; cdc13-
1 RIF1-CΔ-MYC (A, B, C, D), cdc13-1 RIF1-S57A-S110A-MYC (A, B), cdc13-1 RIF1-S57A-








3.6 Residue S57, S110 are required for Rif1 phosphorylation in 
nocodazole-induced arrest 
Prior data shown in this study has indicated that Rif1 phosphorylation is not unique to 
telomere damage and may also be caused by other genotoxic stresses. I investigated 
whether the two residues important for phosphorylation of Rif1 in cdc13-1 cells, could also 
be important during any of these other conditions. I began with a closer examination of 
strains with substitutions of the key residues, S57 & S110, and the impact on Rif1 
phosphorylation in response to the spindle-poison nocodazole.  
CDC13 strains containing the mutation RIF1-C∆, & substitutions of residues S57 and S110 
with alanine, were inoculated overnight at 20⁰C. T0 samples were taken directly from these 
cultures in the morning, and nocodazole was added (final concentration- 15µg/mL). These 
treated cultures were then incubated for 4hrs at 30⁰C. In this experiment a CDC13 RIF1-C∆ 
genotype acted as the control.  
In this experiment the control treatment with nocodazole did result in Rif1 phosphorylation 
as expected. In these samples there was a small shift in Rad53 migration, which may have 
indicated low levels of phosphorylation. These cells also arrested strongly at the G2/M 
transition (Figure 3.7.2A).  
In contrast, this was clearly not the case in those strains containing substitution of both S57 
and S110. In this strain, samples taken after a 4-hour nocodazole treatment clearly showed 
no shift in Rif1 migration, indicating the protein was not phosphorylated. However, similar 
levels of arrest were seen in these cells as in the controls, and the small shift in Rad53 
migration was also seen (Figure 3.7.2A).  
Further to this, the results for samples taken from RIF1-S57A-C∆ mutants are strikingly like 
those of the double mutants. Again, there appeared to be no phosphorylation of Rif1, whilst 
Rad53 phosphorylation and arrest of cells at G2/M was were unaffected by this mutation 
(Figure 3.7.2A).  
Finally, those strains containing substitutions of residue S110, also appeared to have low 
phosphorylation of Rif1. As well as phosphorylation of Rad53, and cell arrest at G2/M, that 
was again unaffected by this mutation (Figure 3.6A).  
This experiment suggested that the Rif1 residues phosphorylated in nocodazole are the 




of S57 and S110 in nocodazole. To ensure the dynamics of phosphorylation did not lead to 
earlier, or later, phosphorylation, these strains were examined more closely across a time-
course.  
CDC13 RIF1-C∆-MYC control strains were grown overnight at 20⁰C, alongside cultures 
containing the relevant RIF1 mutant. The cultures were then incubated for 6 hours at 30⁰C 
in the presence of nocodazole, samples were taken at 2-hour intervals.  
In the control strain used in this experiment Rif1 began to become phosphorylated after 2 
hours treatment with nocodazole, this further increased after 4 hours of treatment. In these 
samples a small change in migration of Rad53 is clear. After 2 hours treatment there was a 
very high accumulation of cells in the G2/M phase of the cell cycle, where they are arrested 
for the duration of the experiment (Figure 3.6B.C.D) 
In the double mutant RIF1-S57A-S110A-C∆, a complete loss of phosphorylation of Rif1 was 
seen at all time-points during the incubation with nocodazole. However, Rad53 
phosphorylation and the number of cells arrest in G2/M was similar to the control strain 
(Figure 3.6B).  
Interestingly, in the genotype RIF1-S57A-C∆-MYC a shift in protein migration of Rif1 was 
seen after 4 hours incubation with nocodazole. This was later than in the control strain, and 
at very low levels which did not increase any further by T6. It appears that while 
phosphorylation did occur in this mutant it was much less than in the control. Once more 
however, Rad53 phosphorylation and the arrest of cells in G2/M was unchanged from the 
control strain (Figure 3.6C).  
Finally, in the genotype RIF1-110A-C∆-MYC there is again a shift in the migration of Rif1 
protein. This occurred after 4 hours, and again at very low levels in comparison to the 
control. The shift, and levels of protein shifted, did not appear to change between 4 hours 
of exposure to nocodazole, and 6 hours. Again, the Rad53 phosphorylation of these cells 
was similar to that of the control strain, and the proportion of cells arrested in G2/M was also 
very similar (Figure 3.6D).  
This data strongly indicates that these residues within the protein Rif1 are required for the 
phosphorylation of Rif1 in nocodazole. Interestingly, it appears that in nocodazole-induced 
































































































Figure 3.6 Substitution of residue Serine-57 and Serine-110 in Rif1 completely 
eliminates phosphorylation during spindle damage 
(A) Western blot analysis of Rif1 and Rad53 protein taken from cells incubated overnight at 
20ºC (1x107 cells/mL at T0) which were then treated with nocodazole (15µg/mL)) and 
incubated at 30ºC for 4 hrs. Cell samples were also taken for DAPI treatment and analysis 
and cell cycle scoring via fluorescence microscopy. (B, C, D) Western blot analysis of Rif1 
and Rad53 protein taken from cells incubated overnight at 20ºC (1x107 cells/mL at T0) which 
were then treated with nocodazole (15µg/mL) and shifted to 30ºC for 6 hrs, with cells 
harvested at 2 hr intervals.  Cell samples were also taken for DAPI treatment and analysis 
and cell cycle scoring via fluorescence microscopy. Strains used here are; RIF1-CΔ-MYC 
(A, B, C, D), RIF1-S57A-S110A-MYC (A, B), RIF1-S57A-MYC (A, C), and RIF1-S110A-






3.7 The same S57, S110 residues of Rif1 are phosphorylated under other 
stresses 
My data showed that the phosphorylation of Rif1 occurring during both telomere damage 
and spindle damage, was eliminated by the substitution of two amino acid residues; S57 
and S110. Further to this our previous data has shown that Rif1 phosphorylation can also 
result during cell cycle arrest stemming from exposure to a range of genotoxic stresses, 
including; phleomycin, UV radiation, and hydroxyurea. From this the question raised was 
whether the phosphorylation event in Rif1 seen in exposure to these reagents, are all located 
within S57 and S110? To examine this, strains of the genotype RIF1-S57A-S110A-C∆-MYC 
were to be exposed to these reagents and the cellular response studied.  
Overnight inoculations of the double mutant RIF1-S57A-S110A-C∆-MYC genotype, as well 
as the control strain of RIF1-C∆-MYC, were grown up at 20ºC. The control strain was then 
treated with nocodazole (15µg/mL) and incubated at 30⁰C for 4 hours. In contrast, the strain 
containing mutations of RIF1 was split and underwent treatment with one of the 5 stresses; 
Nocodazole (15µg/mL), phleomycin (50µg/mL), UV radiation (30J/m2), Hydroxyurea 
(100mM), or MMS (0.05% w/v). These strains were then incubated at 30⁰C for 3 hours. For 
UV radiation treatment, cells were spun down and re-suspended briefly in PBS. They were 
then treated with radiation. After treatment they were re-suspended in YPD and incubated 
alongside other cultures for 3 hours.  
In the control samples of this experiment treatment with nocodazole led to phosphorylation 
of the Rif1 protein. Further to this there was a small shift in the migration of Rad53, indicating 
low levels of phosphorylation. These cells arrested during G2/M at a very high proportion 
after treatment.  
In contrast, the phosphorylation of Rif1 was dramatically reduced by the mutation of residue 
S57 and S110. In these mutants there was no phosphorylation seen after any treatment, 
this was in opposition to results shown in previous experiments (Figure 3.3). Despite this, 
phosphorylation of Rad53 did not appear to be affected by the lack of phosphorylation in 
Rif1, nor does it appear to have affected the arrest of cells at G2/M, or S-phase after 
treatment with hydroxyurea (Figure 3.7).  
This data supports previous data and suggests that the phosphorylation of Rif1 occurs 
entirely within the amino acid residues S57 and S110, regardless of the cause of cell cycle 






























Figure 3.7 Substitution of serine-57 and serine-110 in Rif1 eliminates phosphorylation 
of Rif1 during cell cycle arrest resulting from a range of damaging reagents 
Western blot analysis of Rif1 and Rad53 separated on 7% SDS-PAGE gels. Samples were 
gathered from cells grown overnight at 20ºC (1x107 cells/mL at T0) before treatment with 
nocodazole (15µg/mL), phleomycin (50µg/mL), UV radiation (30J/m2), hydroxyurea 
(100mM), or MMS (0.05%). Cells were then incubated for 3-4 hrs before cell samples were 
harvested. Cells were also harvested for DAPI treatment and cell cycle scoring using 
fluorescence microscopy. A positive control of phosphorylation was used with RIF1-CΔ-
MYC cells treated with nocodazole. All other samples were of the genotype RIF1-S57A-
S110A-CΔ-MYC. Cells treated with UV were first resuspended in a low volume (~5mL) of 
PBS, treated using a stratalinker-3000, and then resuspended in fresh YPD before 








In this chapter I confirmed the phosphorylation of Rif1 during telomere damage, and that 
this phosphorylation event may lie downstream of the activity of checkpoint kinases. 
Furthermore, I showed that this phosphorylation event is still seen after the deletion of the 
C-terminal domain of RIF1, a region previously shown not to influence the viability of cdc13-
1 cells at restrictive temperatures. This led to the closer study of the N-terminus of Rif1 in 
which I found that a small region, consisting of the first 176 residues of the protein, were 
crucial for the majority of Rif1 binding to the chromosome. My studies further indicated that 
the presence of this region improved the viability of cdc13-1 cells at restrictive temperatures. 
Previous studies have suggested there are a number of potential phosphorylation sites 
within the Rif1, which are largely clustered within the N-terminal region and the C-terminal 
region (Figure 3.9.1). Together this data strongly indicated therefore that the 
phosphorylation sites relevant for this study were located in the N-terminal.  
The locations of two key residues within Rif1 were determined, I found that residue S57 and 
S110 of the Rif1 protein appear to share the phosphorylation of Rif1. Of these, I also saw 
that S57 appears to be the more important residue of the two, as a single substitution of this 
residue saw a larger portion of Rif1 remain non-phosphorylated than in a single substitution 
of S110. It is interesting to note that these residues were not indicated as highly 
phosphorylated during a mass spectrometry study identifying phosphorylation during 
telomere uncapping in yku70∆ cells, nor was this region studied during the X-ray 
crystallography of Rif1 structure (Mattarocci et al., 2017; J. Wang et al., 2018). 
It was earlier acknowledged that many of the first mutations made in these cells substituted 
cysteine residues in place of serine. This is unusual, and the more standardly used residue 
to eliminate phosphorylated serine is alanine. This is due to the possibility of cysteine 
residues generating disulphide bridges between residues, the introduction of further 
cysteine residues into the proteins structure could therefore introduce new bridges and alter 
the tertiary structure of the protein. In later experiments these residues were instead 
substituted with alanine.  
The question remaining from this data is what effect the loss of phosphorylation may have 
at a cellular level. If phosphorylation is a regulatory mechanism, as hypothesised, then this 
may act to positively or negatively regulate function. The rif1-N∆ serial dilutions and ChIP 
data shown, may suggest that loss of phosphorylation will lead to increased growth defects 




missing a key region of the protein with many globally conserved functions. It may be that 
the deletion of this phenotype has much more severe, or indeed contradictory phenotypes, 
to mutating the sites of phosphorylation alone.  
Further to this, the results presented suggest that a number of different reagents can 
ultimately lead to the phosphorylation of Rif1, suggesting roles for Rif1 outside of telomere 
damage. Interestingly, this phosphorylation is not exclusive to cell cycle arrest resulting from 
direct DNA damage, as Rif1 also appears to be phosphorylated by treatment of cells with 
the spindle poison nocodazole.  
An interesting question from this data is the role of Rif1 in these other forms of damage. The 
model proposed in Xue et al (2011) could feasibly be applicable to several of these 
conditions. For example, phleomycin and UV damage both lead to DSBs in the DNA of the 
chromosome. For the repair of these in the G2/M stage of the cell cycle homologous 
recombination will be favoured, using the duplicate chromosome as a template for high-
fidelity repairs. It is possible that Rif1 activity in down regulating the checkpoint responses 
may play a role here, alternatively Rif1 may be rapidly phosphorylated in these scenarios to 
ensure that any free non-telomere bound Rif1 cannot interfere with the repair pathway. 
However, in the arrest resulting from nocodazole the role of Rif1 is more difficult to explain. 
This arrests from the spindle checkpoint pathway recognising the improper formation of 
spindle microtubules and does not require DNA damage for activation. The role of Rif1 in 
this, and the need for its phosphorylation, would not be explained by our existing model. 
This would be an interesting avenue of investigation for any future experiments, for instance 
it may be useful to determine if Rif1 association is enriched at kinetochores after treatment 





Chapter IV – Investigating the Kinases Leading to Rif1 Phosphorylation 
 
4.1 Checkpoint kinases are upstream of Rif1 phosphorylation  
Previously published data (Xue et al., 2011) has demonstrated an anti-checkpoint role for 
the Rif1 protein during telomere damage. Further to this, I have demonstrated that during 
telomere damage and other conditions such as spindle damage, Rif1 becomes 
phosphorylated. To help determine the function of phosphorylation, I aimed to establish the 
kinase, or kinases, that may be upstream of this phosphorylation. Unpublished data 
(Maringele, unpublished) suggested that checkpoint kinases may play a role in the 
modification of Rif1 in cdc13-1. To investigate the roles of the checkpoint pathway in the 
phosphorylation of Rif1 the genes RAD9, MEC1, RAD53, DUN1, and CHK1 were deleted 
from cdc13-1 backgrounds to study the effect on Rif1 phosphorylation.   
In the G2/M checkpoint arrest occurring from telomere uncapping in cdc13-1 cells, the 
sensor kinase Mec1 is recruited to ssDNA. This in turn recruits and activates the transducer 
kinase Rad9, which activates separate pathways to arrest the cell cycle via the effector 
kinases Rad53 and Chk1. Dun1 is downstream of Rad53 activity. Therefore, deletion of 
MEC1 and RAD9 will eliminate activation of the effector kinases required for arrest. In cdc13-
1, activation of Rad53 is seen to be more important for the arrest of the cell cycle than the 
activity of Chk1 (Sanchez et al., 1999). 
To confirm the role of DNA damage checkpoint proteins, or cell cycle arrest, in Rif1 
phosphorylation logarithmic phase cultures of checkpoint-proficient and checkpoint-
defective cdc13-1 RIF1-C∆-MYC strains were shifted to the restrictive temperature of 36⁰C 
and samples collected every two hours. These samples were analysed for Rif1 and Rad53 
phosphorylation by Western Blot. In the cdc13-1 RIF1-CΔ-MYC control, Rif1 protein became 
slightly phosphorylated after 2 hours (T2) incubation at 36⁰C, and by 4 hours (T4) there was 
a clear slower migrating protein form, indicating phosphorylation. This was maintained 
through to the samples taken after 6 hours. A similar pattern of phosphorylation in Rad53 
protein was also seen in these strains, with phosphorylation occurring after 2 hours and 
peaking at T4 and T6 (Figure 4.1 A-E).  
In cdc13-1 rad9Δ the phosphorylation of both Rif1 and Rad53 was lost at all time-points 
(Figure 4.1A). Moreover, this same pattern was seen in cdc13-1 mec1Δ sml1Δ for both Rif1 
and Rad53 (Figure 4.1.B) and was seen for Rif1 in cdc13-1 rad53Δ sml1Δ cells, although 




Interestingly, in cdc13-1 dun1Δ there appeared to be a low level of phosphorylation of Rif1 
protein. At after 2, 4, and 6 hours there appears to be a low signal corresponding to the 
phosphorylated form of Rif1. However, compared to the control strain in this experiment 
there appeared to be a larger quotient of the non-phosphorylated form of the protein present 
in these samples. Furthermore, Rad53 phosphorylation is seen to be strong in this genotype 
(Figure 4.1D).  
In contrast to this, in cdc13-1 chk1Δ Rif1 phosphorylation was strong and appeared to be 
full and similar to the control samples. In this strain Rad53 protein was seen to be fully 
phosphorylated (Figure 4.1E).  
The results of these experiments suggest that the activity of Chk1 has little role in Rif1 
phosphorylation, and that Dun1 may be partially involved but not essential. However, these 
results may suggest that Rad9, Mec1, and Rad53 are necessary for the phosphorylation of 
Rif1 during telomere damage. However, as Chk1 and Dun1 are not crucial for arrest in 

















Figure 4.1.1 Rif1 Phosphorylation is eliminated by Removal of DNA damage 
checkpoint proteins 
Western blot showing Rif1 phosphorylation in cdc13-1 cells after growth overnight at 20ºC 
to low cell concentration (T0 – 1x107 cells/mL) and shifted to 36⁰C for 6hrs, as compared to 
cdc13-1cells also containing deletions of the DNA damage checkpoint; mec1Δ (A) rad9Δ 
(B), rad53Δ (C), dun1Δ (D), or chk1Δ (E). After each cell harvest strains containing deletions 





4.2 Spindle checkpoint proteins are necessary for Rif1 phosphorylation 
in nocodazole-induced arrest  
In studying the regulation of Rif1 activity, previous data shown in Chapter 3 demonstrated 
that the telomere damage in cdc13-1 is not the only condition in which Rif1 protein is 
phosphorylated. As I had previously seen that Rif1 was phosphorylated during nocodazole-
induced arrest, I instead investigated whether components of the SAC were upstream of the 
phosphorylation. 
My results this far had suggested Rad53 as a core kinase upstream of Rif1 phosphorylation 
in cdc13-1, and that deletion of RAD9, MEC1, or RAD53, could all eliminate the 
phosphorylation of Rif1. I therefore studied the effect of nocodazole treatment on cells in 
which the DDR had been compromised. To do this, cell cultures experiments were repeated 
as before in Chapter 4.1 but with the addition of nocodazole (15µg/mL) dissolved in DMSO 
as cultures were shifted to 36⁰C. Overnight cultures were supplemented with DMSO to a 
final volume of 1%, to control for the addition of the DMSO containing nocodazole at T0. 
Nocodazole treatment arrests the cell cycle in the checkpoint-defective cells rather than 
allowing continued proliferation during the time-course.  
In the control strain low levels of phosphorylation occurred after two hours. By 4 hours this 
became more distinct and was at a similar level after 6 hours. Over this time, an 
accumulation of cells in the G2/M transition of the cell cycle was seen. Interestingly, a similar 
pattern in cdc13-1 mec1Δ sml1Δ cells was also seen. The slower migrating phosphorylated 
Rif1 became visible after 2 hours, but grew stronger through after 4 and 6 hours, cell scoring 
also showed that these cells are also accumulated in G2/M (Figure 4.2.1A).  
I carried out the same experiment using a strain of the genotype cdc13-1 rad9Δ, again 
alongside a cdc13-1 control, which behaved as expected. The rad9Δ mutant also showed 
strong phosphorylation of Rif1 after 4 hours, which was maintained after 6 hours. In both 
these strains an accumulation of cells in the G2/M transition was seen, indicating an arrest 
due to the action of nocodazole (Figure 4.2.1B).  
These results indicated that these cells arrest in nocodazole and Rif1 becomes 








Figure 4.2.1 Rif1 is phosphorylated by Nocodazole induced arrest, independent of 
DNA damage checkpoint pathways. 
Western blot using protein samples from overnight cultures grown at 20ºC to a concentration 
of 1x107 cells/mL, cultures were diluted 1:1 with fresh YPD. (A) Samples taken from cdc13-
1 and cdc13-1 mec1Δ sml1Δ strains grown O/N and shifted to 36⁰C in the presence of 
nocodazole (15µg/mL), with membranes probed for Rif1-MYC. (B) Samples taken from 
cdc13-1 and cdc13-1 rad9Δ strains shifted to 36⁰C in the presence of nocodazole, with 
membranes probed for Rif1-MYC. Cell samples were taken at each timepoint and treated 
with DAPI to assess stage in cell cycle via fluorescent microscopy. The percentage of cells 










































The phosphorylation of Rif1 in the presence of nocodazole, despite the deletions within the 
DNA damage checkpoint pathway, indicated that the kinase directly upstream of Rif1 
phosphorylation was not Rad53. During mitosis, the proper splitting of genetic material 
between daughter cells is regulated in part by the spindle checkpoint pathway, which 
ensures proper spindle formation and attachment to chromosomes before mitosis is allowed 
to progress. As nocodazole is a spindle poison I therefore investigated if the spindle 
checkpoint may be responsible for the phosphorylation of Rif1.  
In this experiment I used cells containing deletions in genes encoding core proteins from the 
SAC pathway. T0 samples were taken directly from overnight cultures grown at 20ºC, cells 
were then treated with nocodazole and incubated at 30ºC for 6 hours, with samples taken 
every two hours. Cell samples were also taken for cell cycle scoring. The control strain used 
in this experiment was a CDC13 RIF1-CΔ-MYC genotype.  
During the 6 hours in nocodazole the control became phosphorylated after 2 hours. An 
increasing proportion of Rif1 became phosphorylated after 4 & 6 hours. In these samples 
very low levels of Rad53 phosphorylation began to occur after 2 hours, however this did not 
increase further. Over this time-course there was an accumulation of cells in the G2/M phase 
of the cell cycle, as would be expected during a nocodazole-induced arrest of cell cycle 
progression.  
In contrast, a strain containing the mutation bub1Δ did not show phosphorylation of Rif1 at 
any time-point studied. Furthermore, in these cells a lower proportion accumulated in the 
G2/M transition. This is due to BUB1 encoding a major protein in the spindle checkpoint, 
which is inactivated in these mutants. Although it is noticeable there was still a high fraction 
of cells accumulating in G2/M (65% after 4 hours). When observing Rad53 in these samples 
there does not appear to be any phosphorylation after 2 hours, unlike the low level in the 
control (Figure 4.2.2A). 
The loss of phosphorylation is also seen in cells containing the mutation mad3Δ. A strain 
missing another core member of the SAC pathway. It was seen that in these cells there was 
no phosphorylation of Rif1 at any time-point after treatment with nocodazole. Neither was 
there any phosphorylation of the Rad53 protein after the addition of nocodazole to the 
culture. This is in contrast to the slight change in protein migration seen for Rad53 in the 
control strain after 2 hours. It is noticeable however, that in mad3Δ cells there was still high 




The data from these two experiments indicates that the spindle checkpoint pathway is 
required for Rif1 phosphorylation in cells treated with nocodazole. The low phosphorylation 
of Rad53 may also suggest that the Rif1 phosphorylation seen here was largely independent 
from the DNA damage checkpoint pathway.  
To further investigate the presence of independent pathways leading to the phosphorylation 
of Rif1, I examined the response spindle checkpoint-deficient mutants after the introduction 
of the cdc13-1 allele. The control strain of these experiments were the CDC13 RIF1-CΔ-
MYC bub1Δ OR mad3Δ strains studied in the previous experiment. Strains were again 
treated with nocodazole and shifted to 30⁰C. 
It can be clearly seen that the CDC13 RIF1-CΔ-MYC bub1Δ control behaved as expected, 
with neither Rif1 nor Rad53 becoming phosphorylated across a six-hour time-course. 
Interestingly, when this mutation is coupled with the allele cdc13-1 strong phosphorylation 
of Rif1 was seen after 2 hours, which was also seen in samples taken after both 4, and 6 
hours. This was the same when examining the protein Rad53 in these samples. It is also 
noteworthy that these cells arrested strongly in G2/M (Figure 4.2.2C).  
Further to this, a similar result can be seen in cdc13-1 RIF1-CΔ-MYC mad3Δ cells. In the 
control strain neither nocodazole treatment nor incubation at high temperature led to the 
phosphorylation of Rif1 or Rad53 protein. However, in those strains also containing the allele 
cdc13-1 both Rif1 and Rad53 were rapidly phosphorylated, with a strong band of 
phosphorylated protein becoming visible after 2 hours. These cells were also highly arrested 
at the G2/M phase (Figure 4.2.2D).  
These results would both strongly suggest that the SAC is required for Rif1 phosphorylation 
in nocodazole-induced arrest, much like how the DNA damage checkpoint pathway is 
required for Rif1 phosphorylation in cdc13-1 cells. This indicates the key factor for Rif1 
phosphorylation may be the arrest of the cell cycle in G2/M phase, suggesting that a kinase 




























































































Figure 4.2.2 Rif1 Phosphorylation Is the Result of Independent Activation of the DNA 
Damage Checkpoint or the Spindle Assembly Checkpoint. 
Western blot using protein samples from cultures grown overnight at 20ºC to a concentration 
of 1x107 cells/mL. T0 samples were taken directly from these overnight cultures, which were 
diluted 1:1 with fresh YPD before treatment. Cells were shifted to 30⁰C with the addition of 
Nocodazole (15µg/mL), using strains bub1Δ (A), mad3Δ (B), cdc13-1 bub1Δ (C) and cdc13-
1 mad3Δ (D) targeting the proteins Rif-CΔ and Rad53. Cell samples were also taken for 






4.3 Cdc28 (Cdk1) is upstream of Rif1 phosphorylation during cdc13-1 
dependent DNA damage.  
Data in Chapter 3 showed that the phosphorylation of Rif1 can be induced by numerous 
genotoxic stresses upon the cell. Furthermore, results shown in this chapter suggested the 
separate pathways were required for Rif1 phosphorylation. This implied one of two 
scenarios. The first of these was that the phosphorylation events seen in arrest resulting 
from various stresses were separate events, controlled by different kinases in each pathway. 
The second explanation was that there may be a single kinase controlling Rif1 
phosphorylation that is highly active during G2/M. 
In S. cerevisiae there are 5 major CDKs, of these Cdk1, in yeast the protein also referred to 
as Cdc28, is the core CDK for regulation and progression of the cell cycle. Cdk1 has 
previously been observed to phosphorylate Rif1 during DNA replication, and is known to be 
a key kinase in driving progression through G2/M (Davé et al., 2014; S. Hiraga et al., 2014). 
As such, I questioned whether Rif1 may be one of these factors that is phosphorylated in an 
extended G2/M arrest by the activity of Cdc28. Upon examination of Rif1 there are 11 sites 
which could function as the minimum core “SP” target site for Cdc28 activity, of which 8 have 
been identified as likely phosphorylated residues by previous studies, and there are 6 sites 
which could function as the core (TP) target site, only one of which has been previously by 
previous studies (Figure 4.3.2A)(Nigg, 1993; L. J. Holt et al., 2009; D. L. Swaney et al., 
2013). Furthermore, the phosphorylated sites identified in the previous chapter would meet 
the criteria for the minimum sequence required for recognition by Cdc28.   
In the following experiments I utilised the mutant allele cdc28-as1. This allele encodes a 
protein with an enlarged ATP-binding pocket which allows it to bind the non-hydrolysable 
ATP-analogue 1-NM-PP1. Treatment of cells with 1-NM-PP1 rapidly and specifically down-
regulates the activity of Cdc28, with only a small reduction in Cdc28 activity in the absence 
of the inhibitor (Bishop et al., 2000).  
A culture of cdc13-1 cdc28-as1 RIF1-CΔ-MYC was grown at 20ºC overnight to T0. This 
culture was then split, and one of the two cultures was then treated with addition of the 
Cdc28-as1 inhibitor, and both cultures were incubated for 6 hours at 36ºC with samples 
taken every 2 hours. The control in this experiment was therefore the culture that remained 
untreated.  
Without the inhibitor treatment Rif1 underwent phosphorylation, as would be expected of a 




visible in samples taken after 4 hours. When examining Rad53 protein in these strains a 
similar pattern was seen; at 2 hours there was very little visible phosphorylation of Rad53, 
however, after 4 and 6 hours the protein was clearly phosphorylated. The treated samples 
in this experiment, however, differed greatly. After treatment with the inhibitory molecule 
Rif1 phosphorylation was greatly reduced. After 2 or 4 hours there was no phosphorylation 
of Rif1, however, after 6 hours there appeared to be some low levels of phosphorylated Rif1. 
At 4 hours, when Rad53 phosphorylation has become strong in the control, the treated cells 
show much lower phosphorylation of Rad53. This trend continues after 6 hours, whilst 
Rad53 phosphorylation has become stronger in these strains after 6 hours, it does not reach 
the level of phosphorylation seen in control strains samples taken at 4 hours.  
From these results it appears that Cdc28 is indeed required for phosphorylation of Rif1. 
Interestingly, it is known that the activity of Cdc28 is required for control of Exo1 and Sae2 
resection to promote HR pathway choice during DNA repair in S/G2, studies have also 









Figure 4.3.1 Rif1 is Likely to be a Target of the Yeast Cdk1 Protein, Cdc28 
(A) A schematic of the Rif1 protein showing the location of all “S/T-P” residue sequences 
that constitute the minimum required target recognition sequence for Cdc28 kinase. Circular 
icons indicate those sites which have been identified as potential sites of phosphorylation 
by previous studies. (B) Western blot indicating the phosphorylation of Rif1 & Rad53. 
Samples were taken from a single overnight culture grown at 20°C to 1x107 cells/mL. T0 
samples were taken and this culture was split in two and the NM-1-PP1 (500mM) inhibitor 
was added to one of these, mock treatment of 0.5% (v/v) DMSO. The cultures were shifted 
to 36°C for 6hours, with samples taken at 2-hour intervals. 
 






In previous experiments in cdc13-1 cells I have shown that Rad53 may have been upstream 
of Rif1, or at least that the cell cycle arrest downstream of Rad53 was required. As such the 
small increase in Rif1 phosphorylation after 6 hours, shown in Figure 4.3.1B, may be the 
result of a delayed phosphorylation of Rad53 and activation of the checkpoint pathway due 
to the inhibitor molecule losing efficacy. The experiment was redesigned to allow the DNA 
damage checkpoint in cdc13-1 to activate and arrest the cell cycle prior to inhibition of 
Cdc28.  
For this experiment, an overnight culture of cdc13-1 cdc28-as1 RIF1-CΔ-MYC was grown 
and was then split in two and T0 samples were taken. These two cultures were then 
incubated at 36ºC for 6 hours, with samples taken every 2 hours. However, in these 
experiments the inhibitor was only added to one of these two cultures after the induction of 
the G2/M arrest, at either 2, or 4 hours post temperature shift. The control culture was left 
untreated.  
In the control cultures for this experiment phosphorylation of Rif1 was strong after two hours 
at 36ºC. After four hours there was even less of the non-phosphorylated form of Rif1 present 
in these samples. At all time-points from 2 hours onwards, strong phosphorylation of Rad53 
was seen. When assessing these cells by cell scoring, there was a substantial accumulation 
of cells in G2/M phase 
When examining the samples from cells treated with inhibitor there was also 
phosphorylation of Rif1 after 2 hours. However, after the inhibitor molecule is added to the 
culture, there was a complete loss of Rif1 phosphorylation. In samples where the inhibitor 
was added at 2 hours, the samples taken after 4 and 6 hours did not contain the 
phosphorylated form of Rif1. Furthermore, pattern of phosphorylation of Rad53 was very 
similar the control, seen at all time-points after incubation at 36ºC. However, after the 
inhibition of Cdc28 the proportion of cells in the G2/M transition dropped at T4, although it 
did begin to climb again at T6 and at both time-points there was still a disproportionate 
number of cells in the G2/M stage than would have been expected in non-synchronised 
freely dividing cells (Figure 4.3.2A). 
The samples taken from a culture where the inhibitor was added after 4 hours showed 
similar results. After 2 and 4 hours Rif1 and Rad53 became phosphorylated, similar to the 
controls. However, after the addition of the inhibitor at 5 hours the band of phosphorylated 
Rif1 completely disappeared, leaving only a single faster migrating band. When examining 




phosphorylated. Interestingly, in this experiment there was only a small drop in the 
proportion of cells arrested in G2/M between T4 and T6, when Cdc28 inhibitor was added 
to the culture (Figure 4.3.2B).  
The data here provides clear evidence that Cdc28 is upstream of Rif1 phosphorylation. This 
may suggest that the role of the DNA damage and spindle assembly checkpoint pathways, 
in relation to Rif1 phosphorylation, were to arrest the cell cycle in G2/M. This in turn induces 
higher levels of Cdc28 activity, which phosphorylates Rif1. Interestingly, it can be seen that 
the inhibition of Cdc28 led to the disappearance of existing phosphorylated Rif1. The rapid 
disappearance of the phosphorylated form of Rif1 may suggest this is a dynamic event which 
requires Cdc28 activity in order to be maintained. This would further suggest the existence 



















































Figure 4.3.2 Rif1 Phosphorylation is Rapidly Lost after the Inhibition of Cdc28 
Western blots showing Rif1 & Rad53 from yeast strains with the mutant alleles cdc13-1 and 
cdc28-as1. Samples for each were taken from single overnight cultures grown at 20°C to 
1x107 cells/mL, which were split in two and shifted to 36°C. NM-1-PP1 inhibitor (500mM final 
conc.) was added to one of the two resulting cultures either after 2hrs (A) or after 4hrs (B). 
Cells were harvested every two hours; samples were also taken for DAPI treatment and cell 








In this chapter I aimed to determine the factors that lead to the phosphorylation of Rif1; this 
included both the pathways leading to it, and the kinase, or kinases, which may directly 
interact with Rif1. This aspect of my study began with the examination of Rif1 
phosphorylation in cdc13-1 cells undergoing telomere capping.  
The primary conclusion from the data in this chapter is the importance of G2/M arrest in the 
phosphorylation of Rif1. In cdc13-1 cells with defective DNA damage checkpoint pathways, 
the phosphorylation of Rif1 is lost. However, arrest of cells with nocodazole also led to a 
phosphorylation of Rif1. This suggested that Rif1 phosphorylation may not be a direct result 
of the pathways activated, but an outcome of G2/M arrest, which was lost due to the defects 
in arrest in checkpoint-defective mutants.  
The high activity of Cdk1 in G2/M and its importance in mitotic progression, as well as the 
known interaction between Cdk1 and Rif1 in replication and a number of potential Cdk1 
consensus sites in Rif1, led to the consideration of Cdc28 as the kinase directly upstream 
of Rif1 phosphorylation. The inhibition of this kinase in the presence of DNA damage, and 
ongoing G2/M arrest, demonstrated that it appears to be responsible for the phosphorylation 
of Rif1. It is also of interest to note that Cdk1 phosphorylation of Exo1 and Sae2 has 
previously been seen to control the resection of DSBs in yeast, to control repair pathway 
choice in S/G2. Rif1 and Cdk1 have both been seen to be involved with repair pathway 
choice in mammalian cells (Aylon et al., 2004; Silverman et al., 2004; Huertas et al., 2008; 
Tomimatsu et al., 2014).  
 Furthermore, the loss of this kinase also leads to the loss of the phosphorylation of Rif1, 
suggesting a counteracting phosphatase. This may indicate that Rif1 phosphorylation is 
carefully mediated during G2/M arrest, and the identification of this phosphatase may be an 
interesting avenue for future study. One candidate may be Cdc14, a phosphatase with an 
important role in mitotic progression and previously identified interactions with Rif1 




Chapter V: The phenotypic effects of Rif1 phosphorylation 
 
5.1 Investigating the effect of non-phosphorylated Rif1 on the survival of 
cdc13-1 at restrictive temperature 
Previously published data led to the conclusion that Rif1 protein acted as a molecular shield, 
covering ssDNA and protecting it from recognition by DNA damage proteins (Xue et al 
2011). This can be seen in the growth of cdc13-1 at restrictive temperatures. cdc13-1 rif1∆ 
strains show reduced viability, whereas strains with overexpression of RIF1 show improved 
viability. My study hypothesised that phosphorylation of Rif1 may be a key control 
mechanism regulating activity, to properly balance an anti-checkpoint function with the need 
for extensive damage to be repaired. With the data shown so far, the question remained to 
be answered; how does the mutation of S57 and S110 affect the growth phenotype of cdc13-
1cells, and therefore the role of Rif1 as an anti-checkpoint protein? 
This experiment used serial dilutions of yeast cultures to compare the growth of cdc13-1 
strains at a range of temperatures. Whilst the primary question was the effect of 
phosphorylation on Rif1 function, it was also necessary to determine whether the 
introduction of the HIS3 marker interfered with Rif1 function. This marker was introduced 
during mutagenesis and lies upstream of the Rif1 gene, as such it may affect the promoter 
and expression of RIF1 (Figure 5.1.1A). In this experiment strains containing the HIS3 
marker were compared to the growth of a WT strain as well as multiple cdc13-1 variants 
including; rif1∆, RIF1, RIF1-MYC, and RIF1-C∆-MYC. WT grew at all temperatures as 
expected, whereas the cdc13-1 strains including RIF1, RIF1-MYC, or RIF1-C∆-MYC all 
began to show reduced growth at 26⁰C, with sickness increased further at 27⁰C. By 30⁰C 
these strains showed no growth. In contrast, cdc13-1 rif1∆ strains already show no growth 
at 26⁰C. The strains containing the HIS3 marker (indicated as *) grew similarly to one 
another and did show a small difference to Rif1 under its own promoter, however, they also 
showed better growth compared to rif1∆. This indicates that Rif1 is largely functional in these 
strains, and sufficiently expressed (Figure 5.1.1A). This experiment verified that the 
introduction of the marker in our mutants may introduce an increase in temperature 
sensitivity which should be accounted for when studying the growth of these strains and the 
effect of the mutation within RIF1. 
Another serial dilution was then carried out to study the effect of amino acid substitutions 




any differences were due to the substitution alone, and not effect on expression. Mutations 
were studied both in strains with the full length RIF1 genotype, and the RIF1-C∆ variant.  
*RIF1-C∆ cells began to see reduced growth at 26⁰C, and grew poorly at 27⁰C. By 30⁰C no 
growth was seen, as expected. The growth seen in all mutant strains is somewhat improved 
over the control strains. In the double mutant, *RIF1-C∆-S57A-S110A, improved growth was 
seen at both 26⁰C, and 27⁰C. In these mutants, growth was largely unaffected by 
temperature at 26⁰C and these cells appeared to grow moderately at 27⁰C. Interestingly, 
strains containing a substitution of only S57 displayed similar growth to those the double 
mutants, however at 27⁰C it appeared the S57 substituted cells may have been slightly more 
temperature sensitive. In contrast, those strains with a substitution of S110A did see 
improved growth over the control strain, however not to the extent of the double mutants or 
even substitution of only S57. At both 26⁰C and 27⁰C the temperature sensitivity of *RIF1-
C∆-S110A was seen to cause intermediate growth between the control strains and the 
*RIF1-C∆-S57A, or *RIF1-C∆-S57A-S110A, mutants. This pattern is also true for cells 















 Figure 5.1.1 Substitution of Serine-57 and Serine-110 in Rif1 reduces the sickness of 
cdc13-1 cells. 
(A) Schematic diagram of RIF1-S57A-S110A with mutated sites indicated in red, and the 
HIS3 marker upstream of RIF1 TSS. (B-C)Serial dilutions of cells across YPD plates, and 
then incubated at indicated temperatures for 3 days before being photographed. (B) 
Comparison of strains containing the HIS3 marker upstream of Rif1, indicated by *, against 
studied Rif1 variants in cdc13-1 cells. (C) Comparison of cdc13-1 strains containing RIF1 
with mutations to generate substitutions at S57/S110 against the control strain of strain 








These mutations were then combined with a rad9∆ mutation, in order to answer whether 
these mutations would have any effect on growth in a strain in which Rif1 is not 
phosphorylated during telomere damage. I verified the effect of the HIS3 marker when also 
coupled with a rad9∆ mutation. From this we can see that in those strains containing *RIF1 
rad9∆ or *RIF1-C∆ rad9∆ the growth phenotype is much like that seen in RAD9+. These 
strains displayed a slightly increased temperature sensitivity compared to their equivalents 
without the marker (Figure 5.1.2A). The decreased temperature sensitivity of cdc13-1 rad9∆ 
cells is a known effect (Weinert and Hartwell, 1993) 
Mutants containing double substitutions of S57 and S110 within the Rif1 protein were 
combined with the rad9∆ mutation. The control strains acted as expected, showing sickness 
at 27⁰C and by 28⁰C showed considerable reduction in growth. The mutants in this 
experiment had no effect on growth at any temperature, regardless of which amino acids 
were substituted (Figure 5.1.2B). This suggests that the improvement of growth observed 
in non-phosphorylated mutants was dependent on the activity of Rad9, perhaps as G2/M 









Figure 5.1.2. Substitution of Serine-57 and Serine-110 in Rif1 does not affect the 
sickness of cdc13-1 rad9Δ cells 
Serial dilutions of cells across YPD plates, and then incubated at indicated temperatures for 
3 days before being photographed. (A) Comparison of strains containing the HIS3 marker 
upstream of Rif1, indicated by *, against studied Rif1 variants in cdc13-1 rad9Δ cells. (B) 
Comparison of cdc13-1 rad9Δ strains containing RIF1 with mutations to generate 






5.2 Rif1 phosphorylation mutants do not affect the growth after other cellular stresses  
Finally, I aimed to determine if the improved growth created by substitution of residues S57 
and S110 in Rif1 during telomere damage could also be seen during other damage types, 
in which I have shown Rif1 to be phosphorylated. To carry this out, serial dilutions were 
carried out first on plates exposed to UV radiation at a range of doses, and then on plates 
containing hydroxyurea at a range of concentrations.   
As in previous experiments (Chapter 5.1), the first plate shown is a control designed to 
assess the impact of the HIS3 marker on the growth of these cells, and the impact of losing 
Rif1 function entirely, when cells are treated with UV radiation. In these plates it was seen 
that after a dosage of 125J/m2, cells began to see reductions in growth. This steadily 
worsened at each interval examined until dosages of 200J/m2, after which growth was 
extremely poor. In this experiment rad9Δ mutations sensitize the cells to exposure to UV 
radiation, in contrast the addition of the HIS3 marker did not appear to affect the growth of 
cells (Al-Moghrabi et al., 2001). At all radiation doses these strains appeared to grow 
similarly to their equivalents that did not contain the upstream marker. Similarly, rif1Δ did not 
appear to affect the growth of cells. Further to this, mutants containing substitutions within 
RIF1 did not appear to grow differently in comparison to the controls without substitutions. 
These results suggest that not only does this mutation of Rif1 not affect the cell’s response 
to UV radiation, it may suggest that despite the presence of Rif1 phosphorylation the protein 
function may not have a role in the response to UV radiation (Figure 5.2A).  
The effect of HU on cells with different RIF1 mutations was then tested using serial dilutions 
on plates on containing HU at 0mM, 100mM, 200mM, or 250mM. On the control plate WT 
cells saw very little impact on growth from the lowest HU concentration (100mM), however 
200mM and 250mM began to increase sickness and led to reduced growth. The control 
rad52∆ strains saw no growth at 100mM or above as expected (Lee et al., 2003), rif1Δ cells 
grew very similarly to the WT. Interestingly, it appears that the HIS3 marker led to a small 
reduction in growth on these plates, as they appeared to grow slightly worse than their 
equivalents at 200mM and 250mM doses of HU (Figure 5.2B). 
However, when the growth of cells containing substitutions of the S57 and S110 was 
examined it was seen that these mutations do not appear to impact the growth. These cells 
grew identically to the control strains on each plate. This again suggests that the removal of 
Rif1 phosphorylation does not appear to affect the growth of these strains when grown in 












Figure 5.2 Substitutions of Rif1 serine-57 and serine-110 do not affect the sickness of 
cells exposed to hydroxyurea or UV radiation. 
Serial dilutions of cells across YPD plates to compare strains containing the HIS3 marker 
upstream of Rif1, indicated by *, against studied Rif1 variants, and of strains containing RIF1 
with mutations to generate substitutions at S57/S110 against the control strain of strain 
containing the HIS3 marker but no substitutions within RIF1. (A)Cells were first exposed to 
the indicated dosage of UV radiation and then grown for two days at 23ºC before being 
photographed. (B) Cells were grown on YPD agar plates containing the stated concentration 









The results from this chapter demonstrated the importance of phosphorylation in the growth 
phenotype of cdc13-1 cells. Strains expressing Rif1-S57A-S110 showed improved growth 
over a strain in which Rif1 contains no substitutions. This suggests that the improved growth 
phenotype may be due to loss of Rif1 phosphorylation. Interestingly, a single mutant 
containing the mutation RIF1-S57A showed similar growth to double mutants whereas 
single mutants containing only the mutation rif1-S110A do not display as strong an 
improvement in growth at high temperature. This corresponds to the levels of 
phosphorylation seen in these strains in Chapter 3. In these experiments the double mutant 
and RIF1-S57A showed near complete loss of phosphorylation, whilst RIF1-S110A had only 
a moderate decrease in phosphorylation in comparison. Furthermore, results showed that 
these improvements in growth are dependent upon the action of Rad9 to implement an 
arrest of the cell cycle at G2/M phase. 
Interestingly, these improvements in growth seem to be specific to cdc13-1 as they were not 
seen in CDC13+ cells exposed to HU or UV radiation, despite the DNA damage and Rif1 





Chapter VI – The molecular effects of Rif1 phosphorylation 
 
6.1 Rif1 Phosphorylation May Lead to Dissociation from Sites of DNA 
Damage 
Previously published data from our lab showed that Rif1 binds damaged DNA resulting from 
telomere uncapping and shields it from recognition by DDR proteins (Xue et al., 2011). As 
such, I investigated the effect of Rif1 phosphorylation upon Rif1 association with the 
chromosome during telomere damage.  
Across the course of this study I generated mutations of RIF1 which are incapable of 
phosphorylation, without compromising the DNA damage checkpoint pathways or causing 
large disruptions of Rif1 protein structure. These strains were ideal to test the effect of Rif1 
phosphorylation on association ssDNA during telomere resection.  
To study the effect of Rif1 phosphorylation on the protein’s association with the chromosome 
I used chromatin immunoprecipitation. The association of Rif1 with the chromosome was 
studied at four genomic loci:  
• Y’600 - A locus located only 600bp from the telomere. A positive control at T0 as 
fragments would likely contain telomere bound Rif1 as part of the Rap1-Rif1-Rif2 
complex 
• YER188W – A single gene locus located approximately 8kb from the telomere to 
which ssDNA is known to reach during telomere damage. 
• YER186C – Single gene locus located approximately 15kb from telomere. 
• PAC2 – A centromeric locus 300kb from the telomere. This loci as a negative control 
which resected DNA will not stretch to during telomere damage. 
 
For this experiment, a control strain of cdc13-1 RIF1-MYC was grown overnight alongside 
a second culture of the strain cdc13-1 RIF1-S57A-S110A-MYC at 20⁰C. These samples 
were then incubated for 4hours at 36⁰C, with samples taken at 2-hour intervals. Shown here 
are multiple repeats of this experiment, using multiple strains of the RIF1-S57A-S110A 
mutant.  
At YER188W the association of Rif1 in controls began at low levels in one of the cdc13-1 
RIF1-S57A-S110A-MYC strains studied. This saw a large increase in association after 2 




to approximately the level of association seen at the start of the experiment. This was true 
for all loci studied, with a general overall decrease in association corresponding to distance 
of the locus from the telomere. This pattern was seen in both experimental repeats using 
this strain (Figure 6.1A-B). 
The strain containing the Rif1-S57A-S110A protein form contained differences in both the 
level and pattern of protein association with the chromosome. At YER188W the protein 
association began at similar levels to the control. However, it noticeably increased more 
than the Rif1 protein association in controls after 2 hours at 36⁰C. Peak association at the 
2-hour time-point was approximately a third higher in both experimental repeats of this 
mutant strain. After 4 hours there was a markedly slower decline, with chromatin association 
levels intermediate to those seen at the beginning of the experiment and after 2 hours. This 
pattern was seen at both Y’600 and YER186C in both experimental repeats. Association 
with the PAC2 locus was low at all time-points (Figure 6.1A-B). 
This experiment was then repeated with a separate strain also containing the mutation RIF1-
S57A-S110A to verify this association pattern was not unique to the strain used. The 
experiment was carried out as performed previously.  
In this experiment, the control strain again behaved as expected. At YER188W Rif1 was 
associated at low levels at the beginning of the time course, this was followed by a several-
fold increase in association after two hours of incubation at 36⁰C. This then declined again 
after 4 hours. This pattern was seen at all loci studied, however only at Y’600 did this 
association decline to levels equivalent to those seen at the beginning of the time-course. 
At Y’600 the peak after the first 2 hours was also proportionally lower than other loci, with a 
less than 2-fold increase in this 2-hour window. This pattern was seen in both experiment 
repeats using this strain (Figure 6.1C-D) 
At YER188W the strain expressing Rif1-S57A-S110A showed a similar chromatin 
association at the beginning of the experiment. There was then a large increase in Rif1 
association after 2 hours of incubation at high temperature. In these experiments the 
association increased by over 5-fold, and Rif1 was approximately twice as highly associated 
at peak as in control strains. Interestingly, in these strains the decline after 4 hours still 
occurred but was much lower than previously seen, chromatin association remaining several 
fold higher than seen in controls. This pattern held across most loci, however it can also be 




repeat, and in one repeat the association of Rif1-S57A-S110A at YER186C did not decline 
in samples taken after 4 hours incubation at high temperature (Figure6.1C-D).  
The final repeat of this experiment also included a comparison of the chromatin association 
of a control Rif1-C∆ and Rif1-S57A-S110A-C∆. In this experiment Rif1-C∆ control shows the 
expected pattern of association at YER188W, peaking after two hours of high temperature 
incubation and then declining. This was also seen at YER186C, however, at Y’600 
association of this protein is lower at all time-points (Figure 6.1D).  
Similarly, to full length Rif1 protein, the substitutions S57A and S110A again led to increases 
in the association of Rif1 with chromatin. At YER188W, association was similar to the control 
at the start of the time-course, however after 2 hours there was a greater increase and 
association was approximately 2-fold higher. It then declined again in the following two-hour 
interval but at a lower rate, with chromatin association much higher than in the controls. This 
pattern was also true at the YER186C locus, and at PAC2 association was low. Interestingly, 
whilst the starting association at Y’600 was as low as in the controls there was an increase 
in association after 2 hours that was not seen in the controls (Figure 6.1D).  
Despite variation in signal strength between experiments, this data clearly showed an 
increase in Rif1 association with chromatin after the substitution of amino acid residues S57 
and S110. This occurs in both the full-length protein and the variant containing a deletion of 
the C-terminal region. This strongly supports the hypothesis that phosphorylation of Rif1 














Figure 6.1 ChIP of Rif1 in mutants containing substitutions of serine-57 and serine-
110 show higher association with the chromosome. 
ChIP of Rif1 from samples grown overnight at 20ºC (T0) to logarithmic growth phase (2x107 
cells/mL). Cultures were then shifted to 36ºC with samples taken after 2 and 4hrs. Each 
represents separate repeats of each experiment and error bars show standard deviation 
from 3 qPCR measurements in each experiment. (A, B) cdc13-1 RIF1-MYC compared to 
the mutant strain cdc13-1 RIF1-S57A-S110A-MYC. The experiment was also repeated 
using a different mutant strain of the same genotype (C) cdc13-1 RIF1-S57A-S110A-MYC 
and again also using strains with deletions of the Rif1 C-terminal region; cdc13-1 RIF1-CΔ-
MYC (LMY510) and cdc13-1 RIF1-S57A-S110A-CΔ-MYC (LMY1042) (D). ChIP was studied 
across four loci; Y’600 (800bp from telomere), YER188W (8kb from telomere), YER186C 
(15kb from telomere), and PAC2 (300kb from telomere). Error bars show standard deviation 






6.2 Rif1 association in checkpoint-defective cdc13-1 
To further verify that the phosphorylation of Rif1 led to its removal from sites of damage, I 
also examined the chromatin association of Rif1 in checkpoint defective cdc13-1 cells in 
which I have shown that Rif1 does not become phosphorylated. These ChIP experiments 
were carried out as in Chapter 6.1, but only examined at the loci Y’600, YER188W, and 
PAC2. Each experiment compared checkpoint-defective strains to a cdc13-1 RIF1-MYC 
control.  
At YER188W in both experiments the controls behaved as expected from previous 
experiments. There was a sharp rise in association during the first two hours, with 
association of Rif1 and chromatin peaking at the 2-hour timepoint. After this point there was 
a decline in association. In the first experiment shown this decline was rapid, with less 
association seen after 4 hours than at the beginning of the experiment, whilst in the other 
this decline is slower. This pattern was also seen at Y’600, and association with PAC2 
remained comparatively low (Figure 6.2A-B) 
mec1∆ mutation led to a noticeable change in this pattern of association with the chromatin. 
Rather than a sharp increase in Rif1 association in the first two hours of incubation, there 
was only a small increase at YER188W. However, this association steadily increased across 
the entire time-course rather than declining after 2 hours. After 4 hours the association of 
Rif1 was much higher in this mutant than in the control. A similar pattern was seen at Y’600, 
however there was also a small decline in association during the first two hours of the 
experiment after which association rises. PAC2 association was low at all time-points 
(Figure 6.2A). 
Interestingly, the mutation dun1∆ largely did not affect the pattern of Rif1 at any loci. At 
YER188W Rif1 association began at a lower level in this strain and did not peak as highly 
after 2 hours. However, after 4 hours the association of Rif1 was slightly higher in dun1∆ 
than in controls. In contrast, at Y’600 the association of Rif1 started similar to controls and 
was then lower in dun1∆ cells after both 2 and 4 hours. This mutation did not affect Rif1 
association with the PAC2 locus (Figure 6.2A).  
The mutation rad9∆ also led to substantial changes to the pattern of Rif1 association with 
the chromatin. At YER188W there was little change to Rif1 association in the first two hours 
of incubation at high temperature, there was then a ~2-fold increase after 4 hours to similar 
levels seen in the control after 2 hours. The pattern at Y’600 was similar, however there was 




increased to a similar level seen in the control after 2 hours incubation. The association of 
Rif1 in this mutant was higher at PAC2 than in the controls, at several time-points (Figure 
6.2B).  
These results supported the previous conclusion that in strains in which Rif1 is not highly 








Figure 5.2.1 Chromatin Immunoprecipitation of Myc-tagged Rif1 in cdc13-1 cells 
undergoing Telomere Uncapping. 
ChIP of Rif1 from cells grown overnight at 20⁰C to low cell concentration (2x107 cells/mL) 
and shifted to 36⁰C for 4 hours, with samples taken every 2hrs. Samples were taken from 
cdc13-1 strains. qPCR measurements made from three loci; Y’600 (0.6kbp from telomere), 
YER188W (8kb from telomere) and PAC2 (300kb from telomeres). Error bars show 
Standard Deviation of three individual measurements from qPCR. (A) cdc13-1 RIF1-MYC, 
cdc13-1 dun1 Δ RIF1-MYC, cdc13-1 mec1Δ RIF1-MYC. (B) cdc13-1 RIF1-MYC and cdc13-
1 rad9Δ RIF1-MYC. After each cell harvest those strains containing deletions of the 







This chapter aimed to address a key question about the phosphorylation of Rif1; what is the 
role of this modification on the role of Rif1 at a molecular level? To answer this question, I 
have shown the results of experiments using ChIP data to assess the chromatin binding of 
Rif1 during telomere damage in strains that do not contain phosphorylated Rif1, and in 
mutants in which I have shown Rif1 does not become phosphorylated during telomere 
damage.  
 
To interpret this, it was important to both understand the binding of the Rif1 protein in cdc13-
1 cells, as well as how this association was affected in strains in which Rif1 phosphorylation 
has been removed or lowered. It is interesting to note that unlike in previous published data 
I observed a rising and falling pattern of Rif1-chromatin association across the 6-hour time-
course (Xue et al., 2011). This held in multiple experiments. This may imply that the 
phosphorylation of Rif1 may act as a negative regulatory mechanism on chromatin 
association. This is supported by the data I obtain from ChIP using deletions of the genes 
RAD9, and MEC1. In both strains Rif1 does not become phosphorylated, and association 
does not rapidly fall after 4 hours. However, in cdc13-1 dun1Δ strains I can see that the 
pattern of Rif1-chromatin association across 4 hours closely resembles that of the control.   
An alternative explanation for the rising and declining chromatin association of Rif1 in 
uncapped telomeres might be that Rif1 is simply moving with the ss/dsDNA junction, and 
that the spike seen after 2 hours is as the junction travels through the region studied. Whilst 
this explanation may have some merit, I do not believe it to be the case. If this were true 
then I would not expect to see a peak of Rif1 association at loci telomere proximal, such as 
Y’600, after telomere uncapping has been initiated for a prolonged time as the junction would 
have long moved through this site. I certainly would not expect to see a binding spike which 
correlates across multiple sites after 2hrs, as the junction would not be expected to be 
passing through all sites at this time point. These results do suggest a genome-wide effect 
on Rif1 association, which would make a modification to the protein itself a more convincing 
explanation as to the pattern of binding observed.  
It is known that in the absence of checkpoint kinases, such as Mec1 or Rad9, there are 
wide-ranging effects; from loss of cell viability, to increases in ssDNA during telomere 
uncapping (Jia et al., 2004). However, data from mutants further verifies that increased 




Furthermore, the previous chapters found that the phosphorylation events occurring within 
Rif1 in these arrests were also eliminated by the substitution of S57 and S110. These 
mutations have been shown here to lead to increased association of Rif1 with sites of ssDNA 
during telomere damage. This strongly supports the hypothesis that the phosphorylation of 
Rif1 has a negative regulatory effect on its binding with DNA damage, and its anti-checkpoint 
role. Furthermore, these mutants do not contain the side-effects known to occur from the 
deletion of checkpoint pathway genes, such as changes to DNA resection, or the absence 






Chapter VII Investigating the Effect of Mimicking Rif1 Phosphorylation 
 
7.1 Investigating the Phosphorylation of Phosphomimetic RIF1 Mutations 
When examining the behaviour of phosphorylated proteins via mutations, as well as 
producing protein variants that have the sites of phosphorylation removed it is also possible 
to create proteins with residues that are phosphomimetic. This means that at sites of 
phosphorylation the residue is substituted with an alternative amino acid that resembles size 
and charge of the phosphorylated form of the original residue. For serine residues, these 
are commonly changed to glutamic acid or aspartic acid. If successful, this would mimic the 
presence of constitutively phosphorylated Rif1. The mutagenesis Gibson assembly 
procedure used previously in Chapter 3 was used again to substitute amino acid residue 
S57 and S110 with glutamic acid.  
In the first experiment shown the Rif1 protein containing phosphomimetic residues was 
examined during telomere damage. For this, three strains were grown overnight at 20⁰C: a 
control strain cdc13-1 RIF1-C∆-MYC, a mutant containing a substitution at both residues 
cdc13-1 RIF1-S57E-S110E-C∆-MYC, and a mutant containing only one substitution cdc13-
1 RIF1-S57E-C∆-MYC. They were then incubated at 36⁰C for 4 hours. 
The control samples Rif1 showed a clear shift in protein migration after incubation at 36⁰C. 
This was matched by a shift in Rad53 protein, indicating that both proteins had become 
phosphorylated as expected. 
However, when examining the mutant Rif1 strains the results were unexpected. At T0 the 
migration of both mutated forms of Rif1 was identical to that of the control, despite the 
modifications to mimic phosphorylation. Furthermore, after 4 hours both proteins underwent 
shifts in migration. A RIF1-S57E-S110E-C∆ mutant appeared to show some 
phosphorylation of the protein, although not to the same level as in the control. A mutant of 
residue S57E alone appeared to be further phosphorylated than the strain containing 
substitutions at both this site and S110 (Figure 7.1A).  
These results were somewhat unexpected. Not only do they indicate that the Rif1-S57E-
S110E strain may be phosphorylated, this slower migrating band appears at 36⁰C indicating 




To validate these protein shifts were the result of phosphorylation, the previous experiment 
was repeated to gather fresh samples. Samples taken after four hours incubation at 36⁰C 
underwent treatment with alkaline phosphatase, or a mock treatment.  
In the control cdc13-1 RIF1-C∆-MYC T0 sample there was a single non-phosphorylated 
protein form of both Rif1 and Rad53. In T4 samples from this culture a slower migrating form 
was seen for Rif1, and several slower migrating protein forms for Rad53 in the mock treated 
samples. However, in those samples treated with alkaline phosphatase these slower 
migrating forms were eliminated and restored both Rif1 and Rad53 to single, faster migrating 
protein bands. 
In the strain containing RIF1-S57E-C∆-MYC it was also seen that the slower migrating form 
of Rif1 protein seen in the mock treated samples was eliminated by treatment with alkaline 
phosphatase. Similarly, this was also seen in RIF1-S57E-S110E-C∆-MYC samples. 
Elimination of Rad53 phosphorylation was also seen, verifying activity of the alkaline 
phosphatase (Figure 7.1B).  
These results confirm that the slower migrating Rif1 protein in RIF1-S57E-S110E and RIF1-
S57E strains is a phosphorylated form of the protein. This would suggest that despite these 
mutations the protein can still become phosphorylated during telomere damage. The 
phosphorylation seen has likely moved to different residues which may have become 













Figure 7.1 Rif1-S57E-S110E Becomes Phosphorylated During Telomere Damage 
 (A) Western blot analysis of Rif1 and Rad53 protein taken from cells incubated overnight 
at 20ºC (T0) and shifted incubation temperature to 36ºC for 4 hrs. Cells used were cdc13-1 
RIF1-S57E-S110E-CΔ-MYC, cdc13-1 RIF1-S57E-CΔ-MYC. (B) Samples taken from strains 
above after 4hrs at 36ºC were treated with alkaline phosphatase or underwent mock 






7.2 Examining the growth of phosphomimetic RIF1 mutants 
RIF1 variants containing phosphomimetic substitutions were shown to gain further 
phosphorylation in Rif1 during telomere damage that did not simply correlate with the 
addition of phosphomimetic residues. I therefore studied whether these strains would 
exacerbate or alleviate the sickness of cdc13-1 cells grown at high temperature. Serial 
dilutions were carried out to determine the effect of phosphor-mimetic mutations on the 
temperature sensitivity of cdc13-1.  
The controls strains in this experiment were cdc13-1 *RIF1 studied in chapter 5, these acted 
as expected, demonstrating a slight increase in temperature sensitivity. The mutants 
containing phosphomimetic residues behaved interestingly in this experiment, as they also 
appeared to decrease the temperature sensitivity of cdc13-1. The RIF1-S57E-S110E and 
the RIF1-S57E saw the largest increase in growth at 26⁰C and 27⁰C. Whilst the mutant 
RIF1-S110E did not see as substantial an increase, it did however still see an improvement 
over the control strain. This is true for both RIF1 and RIF1-C∆ cells (Figure 7.2). 









Figure 7.2 Phosphomimetic substitutions of Rif1 reduce the sickness of cdc13-1 cells 
Serial dilutions of cells across YPD plates, and then incubated at indicated temperatures for 
3 days before being photographed. Comparison of cdc13-1 strains containing RIF1 with 
mutations to generate phosphomimetic substitutions at S57/S110 against the control strain 
containing the HIS3 marker, indicated by *, but no substitutions within RIF1. 






7.3 Discussion  
Unfortunately, the results presented in this chapter would suggest that the integration of 
phosphomimetic residues into Rif1 was not successful in accurately mimicking the structure 
or activity of a permanently phosphorylated Rif1. This is not unexpected as phosphomimetic 
residues are not perfect replications of the structural/charge changes introduced by 
phosphoryl groups, nor can it reflect the dynamic nature of phosphorylation. 
The data gathered suggests that the integration of glutamic acid at sites of phosphorylation 
does not accurately mimic phosphorylation, as growth in spot tests resembles that of strains 
with alanine substitutions, nor does it eliminate phosphorylation. Interestingly, this may 
suggest that there are further potential phosphorylation sites in Rif1, which for some reason 
are not used in Rif1-S57A-S110A. This may indicate that these sites are only exposed once 
the protein has become phosphorylated. However, these sites do not affect growth and so 
are not sufficient to mimic the role played by phosphorylation of S57 and S110. It may be of 
interest to determine in future whether these sites are also exposed and phosphorylated 
following the phosphorylation of S57 and S110 during telomere uncapping. It is possible 






Chapter VIII: Final Discussion 
 
8.1 Rif1 Phosphorylation in cdc13-1 cells 
At the outset of this study, we hypothesised that the phosphorylation of Rif1 played a role in 
the regulation of function. Post-translational modifications are known to play major roles in 
the regulation of protein function, Rif1 is seen to undergo several modifications which 
mediate activity. Palmitoylation of Rif1 by Pfa4 was first shown to anchor it to the inner 
nuclear membrane, to control its influence on HM silencing (Park et al., 2011). This was 
recently developed further to show that S-acylation of Rif1 at C466 and C473 may help to 
promote NHEJ in budding yeast (Fontana et al., 2019). Interestingly, post-translational 
modifications of Rif1 are also seen to influence repair pathway choice in mammalian cells; 
Rif1 ubiquitination and SUMOylation are required to promote 53BP1-Rif1 dissociation from 
the DSB, and DSB repair by HR (Zhang et al., 2016; Kumar and Cheok, 2017). Furthermore, 
there have been a number of potential phosphorylation sites previously identified in budding 
yeast Rif1, and phosphorylation by Cdk and DDK was shown as the mechanism controlling 
Rif1 function in the suppression of late firing origins of replication (Swaney et al., 2013; Davé 
et al., 2014). Previous studies have also suggested phosphorylation of Rif1 in the yku70∆ 
model of telomere damage. This study, using mass spectrometry, showed less 
phosphorylation at S110 during telomere uncapping at restrictive temperatures, and 
increased phosphorylation at residue S181 (Wang et al., 2018). Both of these residues were 
studied here in cdc13-1, with different results. This may be due to the differences in the 
damage occurring at telomeres in yku70Δ cells compared to cdc13-1 cells. 
I have shown that phosphorylation of Rif1 occurs during telomere uncapping in cdc13-1 cells 
at the N-terminal region, specifically residues S57 and S110. This appears to confirm the 
starting hypothesis that phosphorylation acts to regulate Rif1 anti-checkpoint function as I 
also demonstrated that phosphorylation acts to inhibit the association of Rif1 with DNA, and 
decreases the viability of cdc13-1 cells. Further to this, I have shown that Cdc28 lies 
upstream of Rif1 phosphorylation. 
The data presented here can be integrated into the model previously developed in Xue et 
al. (2011). This model showed Rif1 binds to regions of ssDNA in order to shield it from 
recognition by the DNA damage checkpoint proteins, when damage becomes extensive 
then Rif1 is not capable of shielding larger regions and a checkpoint response is triggered 
(Xue et al., 2011). Through the integration of my phosphorylation data we propose that the 




dissociation from the chromosome and leaving resected regions vulnerable. A checkpoint 
response from extensive damage leads through Rad53 and arrests the cell cycle. The G2/M 
arrest brings about an increase in Cdc28 activity, eventually leading to the targeted 
phosphorylation of Rif1 by Cdc28. This promotes dissociation of remaining Rif1 from the 
chromosome and leaves larger regions vulnerable to recognition, or accessible to DNA 
repair factors. This phosphorylation aids in the previously proposed function of Rif1 to set 
the threshold of tolerable DNA damage before the cell cycle is initiated. In strains without 
Rif1 capable of effectively binding damaged regions, such as cdc13-1 rif1-NΔ cells, lower 
viability is seen as this threshold is lower (Figure 8.1). 
Interestingly, Cdc28 is known to promote homologous recombination during S and G2 
phases of the cell cycle in yeast and in mammals. In mammalian cells RIF1 is also known 
to repress homologous recombination during G1 through an interaction with 53BP1, and is 
removed from DSBs by BRCA1 during S and G2 phase. BRCA1 interacts with the 
phosphorylated form of the protein CtIP, a phosphorylation dependent upon CDK1 activity. 
Whilst the interaction of Rif1 with DSBs in yeast currently has conflicting evidence, recent 
evidence from Mattarocci et al (2017) suggested that Rif1 also acted to attenuate end 
resection and promote NHEJ in yeast. If this is true then phosphorylation of Rif1 by Cdc28 
may be another method of promoting resection alongside the activation of exonuclease 











Figure 8.1 Rif1 phosphorylation by Cdc28 leads to dissociation from damaged DNA 
regions  
Under normal growth conditions Rif1 is found at telomeres in complex with Rap1 and Rif2. 
In a cdc13-1 strain at restrictive temperatures the CST complex is compromised leading to 
5’ telomeric resection, freeing telomere-bound Rif`1. As damage becomes more extensive 
Rif1 becomes incapable of shielding role with sufficient efficiency and regions of ssDNA are 
vulnerable to recognition by checkpoint proteins (Model adapted from Xue et al. (2011)). 
The recognition of damage by checkpoint proteins causes an arrest of the cell cycle, 
ultimately leading to a prolonged period of increased Cdc28 activity. Cdc28 in-turn acts to 
phosphorylate Rif1. Phospohrylation of Rif1 causes it to increasingly dissociate from the 






8.2 The location and function of Rif1 phosphorylation 
Previous studies demonstrated the C-terminus of Rif1 was dispensable for the anti-
checkpoint role observed, this project supplemented this with the observation that the 
phosphorylation of Rif1 during telomere damage was not affected by this truncation (Xue et 
al., 2011). To determine the role of phosphorylation, I demonstrated that the modification 
itself could be isolated to within 2 residues in the N-terminal region of Rif1. A number of 
phosphorylation sites have previously been identified in Rif1 from large-scale screens, the 
two sites identified here were amongst those sites (Swaney et al., 2013b). A study carried 
out by Wang et al., (2018) had previously shown increased phosphorylation of S181, and 
decreased phosphorylation of S110 during telomere damage in yku70∆ cells grown at 
restrictive temperatures (Wang et al., 2018). The results of my analysis of these sites has 
several differences in cdc13-1 cells. I demonstrated that the mutation of S181/Y183 did not 
lead to any noticeable effects on the phosphorylation of the Rif1 protein during telomere 
uncapping. Furthermore, my data suggests that the mutation of this site leads to an overall 
reduction in phosphorylation of Rif1 in cdc13-1 cells. My study has not examined the RIF1 
mutations in yku70∆ mutants, and these may be worthy of further study in the future.   
This study used mutants generated to directly demonstrate the role played by 
phosphorylation. ChIP data in checkpoint deficient cells demonstrated that Rif1 binding was 
affected by loss of phosphorylation, however the numerous side-effects including the loss 
of a G2/M checkpoint means these different binding patterns during telomere damage could 
have been caused by a multitude of factors. The ChIP data directly comparing Rif1 and Rif1-
S57A-S110A however, offers a much clearer picture. We had previously seen that in rif1-
N∆ mutants that the association of Rif1 and the chromosome was negligible. However, it 
appears that this was due to the large regional loss of the protein, as opposed to the 
elimination of Rif1 phosphorylation. In RIF1-S57A-S110A cells we saw that the loss of 
phosphorylation led to an increase in the association of the Rif1 with the chromosome. This 
can be seen in both protein abundance on the chromatin, even after the protein has begun 
to dissociate these levels are higher in the mutant cells. The overall dissociation however 
may suggest that the association is not guided by phosphorylation of Rif1 alone.  
  
As this phosphorylation appears to play such a strong role in the regulation of Rif1 activity, 
it would be interesting to determine the mechanism by which phosphorylation promotes the 
removal of Rif1 from the chromosome. My prediction of the role utilises the crystal structure 




presence of short tracts of DNA containing ssDNA-dsDNA junctions, Rif1 formed dimers to 
bind to these structures in vitro. Individual Rif1 proteins formed what they termed a “HOOK 
and SHAFT” structure, with the HOOK region of one dimer-mate forming a channel with the 
SHAFT region of the second dimer-mate, in a head-to-tail dimer configuration. These HOOK 
regions contain two loops of high electrostatic potential and it was hypothesised that the 
channels created in these dimers were suitable for DNA binding (Figure 8.2A-B). The 
residues I have determined to be the location of the DNA binding sites were not part of the 
protein structure examined in this study, and so would fall more proximal to the N-terminus 
than, although likely close to, the DNA channels in these dimers. We propose that this region 
may form a clasp on these dimers in vivo that acts to promote the secure binding of Rif1 
dimers to damaged regions that we refer to as the Phospho-Gate Domain (PGD). This 
suggests an explanation for how the rif1-NΔ mutant sees increased sickness and poor 
chromosome association, despite the loss of phosphorylation. Without this PGD it may be 
that the dimer structure is less secure and more easily removed from the chromosome 
(Figure 8.2C-D). Further to this I suggest that the phosphorylation occurring within this 
region acts as a key to unlock this clasp and further promote dissociation. The model by 
which this takes place is shown below. We also propose that mate-dimers may act together 
to allow the interaction of two PGDs to form a plier-like structure around the DNA, creating 
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Figure 8.2 The Phospho-Gate-Domain:  The Rif1 N-terminal cooperates to create a 
clasp to unlock the dimer structure. 
(A) Crystal structures of the Rif1 dimers forming around DNA. Figure from Mattarocci et al. 
(2017) (B) The concave face of the HOOK domain creates a binding interface for DNA 
through positively charged residues contain in the Loop I and Loop II structures. The binding 
channels and are sealed by the ‘lid’ created by the SHAFT domain of the dimer-mate. (C-D) 
The region immediately adjacent to the N-terminal of Rif1 creates the phospho-gate domain 
(PGD). In non-phosphorylated Rif1 this region may act as a clasp between the two dimers, 
securing it on the chromosome and closing the loop-encasement of the DNA. After 
phosphorylation the conformation of the region changes so as to open the gate. This leads 
to a less secure association of the dimer to the chromosome, and possibly may promote 
dimer dissociation, ultimately leading to Rif1 being removed from DNA. Protein structure 
informing these figures was taken from Mattarocci et al. (2017) (E-F) The study by 
Mattarocci et al. (2017), proposed that multiple Rif1 dimers may interact for secure binding 
to the DNA, we propose that the PGD may be one mechanism that promotes the secure 






8.3 Phosphorylation of Rif1 outside of S57 and S110 
The number of potential phosphorylation sites raised by previous studies raises a further 
question as to why they have not been observed for phosphorylation in this study. The data 
collected in RIF1 mutants containing phosphomimetic residue substitutions of S57 and S110 
may combine with our proposed model to potentially answer this question. One answer to 
this may be that the phosphorylation of S57 and S110 act as a first step to further 
phosphorylation of Rif1 protein. In Rif1-S57E-S110E mutants we see that mutation of these 
sites alone is not sufficient to alter the migration of the protein, therefore further migration 
changes must be due to phosphorylation at alternative sites. As these alternative sites are 
present on Rif1-S57A-S110A but are not used, this suggests that these sites are exposed 
by the integration of the phosphomimetic residue. This suggests that the phosphorylation of 
Rif1 at S57 and S110 may expose further residues for targeting by kinases. Furthermore, 
the phosphorylation seen in Rif1-S57E-S110E does not produce as large a change in protein 
migration as in WT structure Rif1 as the phosphomimetic residues only partially mimic the 
structure of phosphorylated Rif1. However, it must be noted that whether these alternative 
sites are usually phosphorylated in telomere damage or not, the data shown here suggests 
that the phosphorylation of these residues alone does not have a noticeable effect on 
phenotype.  
 
8.4 Rif1 Phosphorylation Outside of cdc13-1 
The model proposed explains how Rif1 may act in cdc13-1 cells, as well as how the anti-
checkpoint function is regulated. However, the phosphorylation I have seen in this study 
suggests a role for Rif1 in arrest resulting from other reagents. However, serial dilutions of 
mutants did not help to elucidate a role for Rif1 in these conditions. Substitution of S57 or 
S110 did not appear to affect the growth of cells exposed to UV radiation, or HU-
supplemented media. This raises the question of what the function of phosphorylation is in 
cells in these conditions. This may be an intriguing question for future study.  
Recent studies have further developed the idea that Rif1 may play a role at DSBs in yeast, 
despite previous evidence from our lab contrary to this (Xue, et al., 2019). A number of the 
reagents tested do induce DSBs in the chromosome, it may be seen with further study that 
the phosphorylation of Rif1 in these cells may play the same role as Rif1 in cdc13-1 and 
promote dissociation from the DSB in order for repair factors to better access the site. 
Recent studies have also shown potential roles for Rif1 in protecting stalled replication forks 




HU could also suggest a role for Rif1 in protecting stalled replication forks in budding yeast 
that may also be regulated by phosphorylation of the N-terminal (Garzón et al., 2019).  
The phosphorylation of Rif1 in nocodazole is a more perplexing modification that will require 
further study to determine the role that is played by Rif1 after impediments to spindle 
formation. Whilst I have shown that this phosphorylation was the result of Cdc28 activity, a 
molecular role for Rif1 or the function of phosphorylation during spindle damage is unknown. 
As well as the survival of rif1Δ cells exposed to spindle damaging agents, it may also be 
worthwhile to examine the abundance of Rif1 at kinetochores in cells exposed to a factor 
such as nocodazole. A presence here may suggest a role for Rif1 in regulating the spindle 
checkpoint proteins. Furthermore, it is known that the protein Glc7, which Rif1 interacts with 
during origin suppression, is also involved in regulation of the spindle checkpoint. This 
interaction may be relevant for this role.  
 
8.5 Rif1 in Budding Yeast and Humans 
The final key question left from this study is; how applicable is the Rif1 anti-checkpoint 
function outside of budding yeast? Whilst RIF1 has been demonstrated to be involved in the 
DSB repair pathway choice in mammalian cells, it is unclear whether this functions similarly 
to the anti-checkpoint function observed in budding yeast. Recent studies have suggested 
that the highly conserved N-terminus domain of RIF1 is also capable of DNA-binding in 
murine models, however this corresponds to the HOOK domain identified by Mattarocci et 
al, which does not start immediately at the N-terminal in budding yeast, instead this domain 
is named for a region beginning ~180 residues from the N-terminal (Mattarocci et al., 2017; 
Moriyama et al., 2018). This 180 amino acid region is instead likely found in the C-terminal 
of higher eukaryotes, as it has been shown that the RVxF-SILK domains contained in this 
region have been translocated during the evolution of higher eukaryotes (Sreesankar et al., 
2012). However, if this shared binding domain does correspond to a shared function, then 
it is not unfeasible that alternative phosphorylation sites have been chosen over the course 







Figure 8.5 Human RIF1 is unlikely to phosphorylated at a conserved serine residue 
for any anti-checkpoint roles. 
(A) pBLAST output using the protein sequence of human RIF1 to search for alignment with 
the first 185 residues of scRif1. The residue 57 key to Rif1 phosphorylation, and conserved 
adjacent residues, in budding yeast are highlighted. (B) Structural diagrams of budding 
yeast Rif1 and human Rif1. The location of S57 residue is notated, alongside the RVxF-
SILK domains (translocated to the C-terminal of the protein in humans), the Phospho-Gate 
Domain (PGD), the RBM, the CTD, and the DNA-binding domain found in humans, and 






I analysed a section of the N-terminal region corresponding to the first 180 amino acid 
residues of yeast Rif1 and used pBlast analysis to search for sequence homology with 
hRIF1. As previous studies suggest, portions of this this mapped to a region close to the C-
terminal of hRIF1, however, results suggested substantial deviation in the protein sequence 
has occurred over the course of evolution. The most homologous sequence identified was 
a region stretching from aa14-71 in yeast Rif1 and 2217-2186 in hRIF1. This region had 
33% matches in residue sequencing, and 47% overall positive similarity. However, a region 
this short still provided a relatively high e-score that was not registered as significant. 
Interestingly, residues S56-58 did precisely map onto a short section within this homologous 
section (Figure 8.5A). However, it must also be considered the role we propose that the 
phosphorylation of Rif1 plays in yeast, and how this is related to the structure of the protein. 
If our model is correct, this implies that the phosphorylation of Rif1 acts to mediate the 
interaction of an adjacent region to the DNA, as well as the HEAT repeats. If this site of 
phosphorylation was translocated to the C-terminal region of hRIF1 then it is unlikely to have 
maintained this role in mammalian cells without large changes to the 3D structure of the 
protein allowing modifications close to the C-terminal to interrupt protein interactions close 
to the N-terminal (Figure 8.5B). It is more likely that alternate residues in the N-terminal 
region of hRIF1 would have be utilised. Interestingly, there are only 8 instances of the core 
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